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Human lymphatic filariae currently infect around 120 million people. 
Larval stages are transmitted by vector mosquitoes and rapidly colonise and 
develop in the lymphatic system where they live for 5 to 10 years. During their 
development, larvae present a series of stage-specific antigens to the host's immune 
system. Successful immunisation regimes in animal models have indicated that 
antigens presented early on infection are particularly effective in inducing 
protective immune responses. Epidemiological studies have also suggested that 
infected individual control their infections by developing immunity to larvae, 
thereby preventing new infections 
Reverse transcription polymerase chain reaction (RT-PCR) of RNA from 
the infective larval stages of Brugia malayi with the nematode-specific 5' spliced 
leader sequence and oligo d(T) has been used to identify genes expressed during 
early larval stages. Products resolved on agarose gels show a number of prominent 
bands and cloning of these bands has revealed a total of 14 genes. Of these four 
genes have been analysed in detail. 
One highly stage-specific transcript Bm-cpi-1, a cystatin-type cysteine 
proteinase has been characterised in parallel to a second, constitutively expressed, 
cystatin, Bm-cpi-2, identified by EST sequencing. The two inhibitors have been 
functionally expressed in E. coli and have distinct inhibitory specificities. In 
addition, both CPIs have been localised to the parasite surface and found in parasite 
secretions. 
An abundant transcript, Bm-alt- 1, is a member of a large family of genes 
found in nematodes but lacks clear homologues outside the nematode phylum. 
Analysis of Expressed Sequence Tags (ESTs) deposited in dbEST has identified a 
total 10 family members in B. malayi. Genomic structures of the two most 
abundant family members have revealed conservation in the position of introns. 
However there is considerable sequence divergence within introns, with one gene 
containing distinct repeat units within its introns. In addition, heterogeneity is seen 
within this due to variation in the number of repeat units. 
Two further genes have been characterised. One is a homologue of the 
human histamine-releasing factor, a constitutively expressed, cytokine-like 
molecule of interest as a potential modulator of antiparasite responses. A second is 
a member of a family of proteins of unknown function, rich in glycine and tyrosine 
residues, which may form part of the nematode cuticle 
The discovery of these abundant genes provides candidates for future 
analysis of immune evasion by filariae and identifies potential targets for 
vaccination or chemotherapy. 
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Lymphatic filariasis is a chronic, debilitating and often disfiguring disease 
that affects about 100 million people living in the rural and slum areas of many 
tropical countries (Michael et al., 1996; World Health Organization, 1995). The 
causative agents in man are three species of filarial worms, Wuchereria bancrofti, 
Brugia malayi and B. timori. These are multicellular, parasitic nematodes with a 
complex life cycle that includes an obligatory maturation period within a vector 
mosquito. The infection is widespread throughout the tropical and subtropical 
areas of Asia, Africa, the Western Pacific and some parts of the Americas. 
1.1 	Life Cycle 
In common with all nematodes, filarial worms progress through five 
developmental stages during their life cycle (designated Li to L5). Four of these 
stages are delineated by moults - the shedding of a mutilayered collagenous 
exoskeleton termed the cuticle. The mature (adult or L5) stages differ in size. 
They are thread-like in appearance: the male measures 22 mm in length and 0. i mm 
in diameter while the female is considerably longer measuring 48 mm in length and 
0.15 mm in diameter. After mating, the female constantly produces thousands of 
embryonic first stage larvae, the microfilariae (MO. Adult female parasites remain 
reproductively active for 5 - 10 years in the lumina of the host lymphatic system 
(Vanamail et al., 1989). Mf are enclosed by a acellular sheath, a complex structure 
which is a remnant of the vitelline membrane formed during in utero development. 
Mf migrate to the blood stream where they are taken up with the blood ingested by 
a blood feeding vector. In the mosquito midgut they shed their sheaths and 
penetrate the gut wall to reach the haemocoele through which they migrate to the 
thoracic flight muscles. Lymphatic filarial larvae at this stage of development are 
almost unique amongst nematodes as they occupy an intracellular niche within the 
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large cells of the thoracic muscle. Here they develop into thicker, shorter "sausage" 
forms. This is followed by a programmed set of cell divisions that result in the 
differentiation of the oesophagus, intestine and rectum (Schacher, 1962b). The Li 
to L2 moult takes place between days 6 and 10 post-infection depending upon 
environmental conditions. The L2 to L3 moult occurs between days 8 and 11 post-
infection by which time the gut appears longer and more developed and the genital 
primordium is formed. The L3 larvae measure 1.5 mm in length and 0.02 mm in 
diameter (Schacher, 1962b). 
Considerable attrition occurs during the vector stages of development. 
Infection levels varying depending upon the particular filariae-vector combination. 
Even in a susceptible mosquito host, such as Aedes aegypti, up to 80% of Mf fail to 
develop to infective larvae. Parasites are killed through a combination of physical 
incompatibility and an active immune response against the parasites (Denham and 
McGreevy, 1977). Two loci are known to confer resistance to B. malayi in Ae. 
aegypti. One is the originally described r gene, which affects susceptibility to 
filarial worms inhabiting the thoracic musculature (MacDonald and Ramachandran, 
1965). The other locus exhibits an additive effect on susceptibility. Whereas the 
products of these genes probably act on the parasite within the thoracic muscles, 
physical factors act in the fore and midgut to prevent infection. Some species have 
pharyngeal armatures capable of damaging Mf as they are ingested. Clotting of the 
blood meal is also important as Mf are trapped in the gut of mosquitoes which show 
rapid coagulation. In the midgut other mechanisms have also been suggested, 
including damage by digestive enzymes, limitation of migration by the peritrophic 
membrane and antifilarial toxins (Denham and McGreevy, 1977). One response of 
the mosquito to filarial infection seen in some, but not all, vector/filariae 
combinations is melanotic encapsulation (Nayar et al., 1993; Oothuman et al., 
1974; Zhao et al., 1995). This response kills the parasites in capsules composed of 
haemocytes and/or polyphenolic materials and can take place in the haemocoele or 
the thoracic muscles (Chikilian et al., 1994). 
Transmission to a mammalian host is possible soon after the second moult. 
At this point the larvae migrate from the thoracic muscles and distribute themselves 
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throughout the body cavities of the mosquito with a strong preference for the head 
and labium (Schacher, 1962b). Development is then arrested until transmission to 
the final host is accomplished. During feeding the larvae burst out of the proboscis 
and remain in a pool of haemolymph around the wound. After the mosquito has 
withdrawn its proboscis the larvae enter the new host through the lesion left by the 
bite (McGreevy et al., 1974). In cats it has been shown that larval migration to the 
nearest lymph node is accomplished within a few hours of infection (Ewert and El 
Bihari, 1971; Ewert and Ho, 1967). Later they migrate to the afferent lymphatic 
where they stay for the rest of their lives. The mechanisms by which the larvae 
seek, recognise and colonise the lymphatics are unknown but presumably involve 
interactions with host factors. Proteolytic enzymes such as collagenase may be 
involved in these processes (Petralanda et al., 1986). In the definitive host the L3 
re-initiates its developmental program that culminates in a moult to fourth stage 
larvae at around day nine post-infection. Newly formed L4 larvae are 3 to 6 mm in 
length. A final L4 to adult moult takes place 3 to 4 weeks post-infection. Adult 
male worms are distinctly smaller than the females (around 4 cm, compared with 8 
- 10 cm) 
After transmission, filariae exit from a state of developmental arrest. The 
early period of infection is characterised by an intense period of development and 
adaptation to a new, radically different environment. Within the first 2 weeks of 
infection 2 of the 4 moults are completed (Fig 1). Previous studies have shown that 
the surface of the early infective forms of several nematode species is a dynamic 
structure. For the intestinal parasites Trichenella spiralis and Toxocara canis it has 
been demonstrates that the infective larvae release a significant amount of their 
surface molecules during the first few hours of development (Maizels et al., 1984; 
Philipp et al., 1980). The dynamic nature of the surface has also been observed for 
filarial larvae. After labelling surface components with 125!,  B. malayi larvae lost 
over 90% of labelled molecules after eight days of jird infection (Marshall and 
Howells, 1986). Radiolabelling has also been used to demonstrate the variety of 
highly stage specific proteins on the surface of B. malayi (Storey and Philipp, 1992) 
and A. viteae (Apfel et al., 1992) during the first few days of infection. This 
phenomenon has also been shown for B. malayi larvae undergoing L2-L3 
development in the vector (Ibrahim et al., 1992). These changes, indicated by 
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changing patterns of labelled proteins as development proceeds, are largely 
uncharacterised at the molecular level and few genes corresponding to these 
proteins have been identified. Some studies have attempted to discover cues for 
these changes. A 23 kDA molecule was prominently labelled after micro-injecting 
[35S]methionine into vector blackfly during the later stages of Onchocerca lienalis 
and 0. volvulus. During subsequent in vitro culture shifting temperature from 26°C 
to 37°C specifically triggered secretion of the molecule (Bianco et al., 1990; Bianco 
et al., 1995). This molecule has subsequently been identified as a member of the 
Onchocerca family of abundant larval transcripts (alt) (Yang Wu and Ted Bianco, 
University of Liverpool, personal communication), homologous to the B. malayi alt 
genes described in chapter 5. 
Day 8 
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a Data from 8,-ugia pahangi infections in Anopheles spp, Schacher (1962a) 
Data from Brugia pahangi infections in the cat. Schecher (1962b) 
Figurel.1. The Life Cycle of Lymphatic Filarial Parasites 
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1.2 	Human Lymphatic Filariasis 
Filarial worms are noted for their narrow host specificity. The superfamily 
Filariodea contains 535 species infecting almost all main orders of vertebrates but 
only eight are known to infect man (Sasa, 1976). Of the filariae that infect humans, 
only the lymphatic filariae (Wuchereria bancrofti, Brugia malayi and B. timori) and 
the cutaneous dwelling filariae, Onchocerca volvulus, are considered of major 
public health importance. 
More than 1.1 thousand million people (20% of the world's population) now 
live in areas where they are at risk of infection with lymphatic filarial parasites 
(Ottesen et al., 1997) and a minimum of 120 million people are currently infected 
(Michael et al., 1996). Despite causing little mortality, lymphatic filariasis has 
been identified as the leading cause of long-term disability (World Health 
Organization, 1995) leading to huge economic losses. In India, conservative 
estimates indicate that the indirect economic cost of lymphatic filariasis is US$ 1.5 
billion per year (Ottesen et al., 1997). 
A total of 44 million people suffer from pathological effects of the infection 
(Ottesen et al., 1997). Clinical manifestations in all three human lymphatic filariae 
are very similar and include painful attacks of lymphadenitis and chronic 
obstructive lesions such as lymphoedema, and elephantiasis (Partono, 1987). These 
obstructive lesions are most probably caused by immune-mediated destruction of 
resident adults and migrating larvae in the lymphatic system (Maizels and 
Lawrence, 1991; Ottesen, 1992). 
Not all people in an endemic area, however, present symptoms. One of the 
most intriguing aspects of filarial infections is the extremely broad spectrum of 
clinical presentation found among individuals in endemic regions (Ottesen, 1992). 
At one extreme there are individuals with no clinical manifestations or indication of 
infection at all, although epidemiological studies demonstrate that exposure to 
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infective larvae is equivalent to those individuals with clinically expressed 
filariasis. It is difficult to ensure that this group of people, termed endemic 
normals, consist only of those truly immune and parasite-free, and to exclude those 
who harbour a sub-clinical infection, as rigorous techniques to determine 
parasitological status, such as lymphosonography, are not in widespread use. Sera 
endemic normals contain high levels of antifilarial antibody and active cellular 
responses to the parasite can be demonstrated (Maizels et al., 1995). At the other 
extreme, are the group of people exhibiting clinical symptoms ranging from acute 
(recurrent episodes of filarial fever accompanied by inflammation of lymphatic 
tissue) to chronic (obstructive disease including elephantiasis of the limbs and other 
regions and hydrocoeles). 
Two other categories can be distinguished in endemic areas. The first are 
those who are entirely asymptomatic but carry detectable levels of Mf in their 
peripheral blood. The final group suffers from tropical pulmonary eosinophilia, an 
occult form of filariasis characterised by extremely high levels of IgE, eosinophilia 
and asthmatic attacks. Circulating Mf are not found in these individuals but they 
may sometimes be found in biopsies of lung and other tissues. 
Epidemiological evidence suggests that many residents of endemic areas 
eventually progress through this clinical spectrum from asymptomatic 
amicrofilaraemics to chronic obstructive disease (Bundy et al., 1991; Day et al., 
1991b). In most endemic areas, the prevalence of acute filarial disease increases 
between birth and early childhood, and reaches a plateau in older age groups. 
Acute symptoms precede the onset of chronic obstructive disease. Hydrocoeles and 
elephantiasis are rarely found in adolescents but become increasingly common with 
prolonged residence in an endemic area and some studies have shown a temporal 
correlation of the onset of chronic pathology with the disappearance of Mf from the 
circulation. However conversion to chronic disease is not inevitable, some long 
term studies have described communities in which 80% of microfilaraemics remain 
disease-free for 16 years (Meyrowitsch et al., 1995). The possibility that lymphatic 
lesions are the products of the immune-mediated destruction of resident adult worm 
and migrating larvae presents a formidable task for immunoparasitologist in the 
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development and implementation of vaccines against filarial worms. Thus a key 
question is whether it is possible to stimulate immunity without accelerating the 
progression of individuals from the asymptomatic to the pathologic groups. 
1.3 	Animal Models 
A significant obstacle to understanding the biology and immunology of the 
most pathogenic and widespread filarial worms, W. bancrofti and 0 volvulus, is that 
they cannot be maintained in laboratory animals. Infections in monkeys (Misra et 
al., 1997) and chimpanzees (Greene, 1987) have been reported but infection levels 
are poor, and these animals are extremely difficult to obtain due to their protected 
status. 
Fortunately, Brugia spp. is more cosmopolitan. B. malayi develops to 
maturity in jirds rats, hamsters, ferrets, dogs and cats with varying degrees of 
success and the natural filarial worm of the cat, Brugia pahangi, also infects a 
similar range of laboratory animals with equal if not greater success. The jird 
(Meriones unguiculatus) is the most susceptible animal for both species with up to 
50% of larvae developing to adults. This level is only achieved if the larvae are 
inoculated into the peritoneal cavity, where adults and Mf remain for the duration 
of the infection. Other routes of infection result in substantially reduced recovery 
of adult worms and Mf. For all routes of infection male jirds are markedly more 
susceptible than their female littermates. Thus intraperitoneal infection of male 
jirds is now routinely used for the maintenance of B. malayi and B. pahangi in 
many laboratories (McCall et al., 1973). 
The rat and the multimammate rat (Mastomys natalensis) are variably 
permissive to infection with Brugia spp. However, the obvious choice for a 
convenient, well-defined laboratory host for filarial infection would be the inbred 
mouse. Unfortunately, numerous attempts at infection of a wide variety of strains 
have shown that mice are largely resistant to the development of infective larvae of 
all species of human lymphatic filariae (Ahmed, 1967; Laing et al., 1961). Again 
most strains are more permissive to Brugia spp, but larvae can only survive for 
Page 7 
short periods of time and will undergo limited development before the parasites are 
cleared (Lawrence, 1996). Reports vary considerably in their estimates of how 
long worms survive. One of the most thorough investigations (Carlow and Phillip, 
1987) reported that less than 30% of worms are recovered 10 days after a primary 
infection and none after day 30. Secondary infections showed considerably 
increased resistance to infection, with no recovery after 10 days. Implants of adults 
and Mf parasites can however be maintained in mice for longer periods, allowing 
the study of parasite factors on host cell populations (Allen et al., 1996; Lawrence, 
1996) 
Despite a lack of full development, some characteristics of human filariasis 
can be seen in during infection of mice with Brugia sp. Mice can develop strong 
Th2-cell responses, anergised immune responses and some pathological reactions 
in response to infection (Lawrence, 1996). In addition, SCID and athyniic mice are 
susceptible to full infection with the development of Mf-producing adults and 
develop lymphatic pathology that is reversible if adult worms are removed by 
chemotherapy (Nelson et al., 1991; Vickery et al., 1985). If athymic mice are 
reconstituted with splenocytes from an intact donor that has been previously primed 
with infective larvae progressive lymphatic fibrosis that is irreversible is seen 
which has the appearance of the pathological effects of elephantiasis (Vickery et 
al., 1991). Thus it seems that pathology in mice has both immune, and non-
immune components. 
The course of infection of cats infected with B. pahangi, which parasitises 
them in the wild, mimic those of humans infected with B. malayi and W. bancrofti 
in many important respects (Denham and Fletcher, 1987). Multiple inoculation of 
larvae representing the kind of exposure experienced by patients living in endemic 
areas results in transient enlargement of the lymphatics. Most cats develop patent 
infections but eventually lose their circulating Mf suddenly. These post 
microfilaremic cats exhibit prominent, but temporary, lymphodema. Although 
permanent damage leading to elephantiasis is not seen as it is in human infections it 
is likely that this natural host-parasite relationship displays many features of human 
infection. Despite this, the Brugia-cat model is far from ideal when issues of 
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availability, cost and lack of suitable reagents to study immune responses are taken 
into account. 
Litomosoides sigmodontis, a natural filarial parasite of the cotton rat, has 
recently been shown to undergo full development in mice (Petit et al., 1992). The 
L sigmodontis/mouse model has a number of features useful for the investigation of 
the host response to filariae. In addition it is a convenient primary screen for drug 
and vaccine candidates. In the BALB/c mouse subcutaneous infection of is 
characterised by a initial period during which up to 75% of larvae are killed before 
penetration of the host lymphatic vessels. Thereafter, the parasite burden is stable 
for around 60 days (Marechal et al., 1996). Infections in other strains of mice show 
varying degrees of resistance and unlike resistance induced by irradiated larvae 
attrition occurs at the L4 and adult stages. In B1OD2 mice the recovery rate during 
the first month is similar to that seen in BALB/c mice but thereafter it declines 
without producing a patent infection (Petit et al., 1992). The differences in 
susceptibility in various mouse strains means that this model may have the potential 
to increase understanding of the immune response to filariae in a way that Trichuris 
muris has for intestinal nematodes (Grencis, 1996) and Leishmania major has for 
intracellular protozoa (Reiner and Locksley, 1995). It is interesting that in the 
Litomosoides model the pattern of susceptibility (BALB/c susceptible, BlO 
resistant) is the reverse of the Trichuris model (Grencis, 1996) as it is thought that 
resistance to nematode infections is defined by the hosts ability to mount a strong 
Th2 immune response. BALB/c mice are able to mount a strong Th2-type response 
but are fully susceptible to L. sigmodontis (Marechal et al., 1997). 
1.4 Chemotherapy 
At present, control of lymphatic filariasis is dependent on repeated 
anthelminthic treatment and vector control regimens. Until recently, the only 
anthelminthic used to treat lymphatic filariasis was diethylcarbamazine (DEC). 
Administration of the drug leads to rapid decreases in circulating Mf and repeated 
administration is reported to kill a proportion of the adult worm burden. Various 
treatment regimes have been used usually with higher doses giving rise to side 
reactions (fever, vomiting, painful lymph nodes and headaches) associated with the 
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death of Mf (Mackenzie and Kron, 1985). An alternative approach to the 
administration of DEC is its addition to salt. This allows very low doses to be 
given through daily use of salt and has been shown to dramatically reduce 
microfilarial density with no apparent adverse side reactions (Gelband, 1994). 
Recent studies have shown the combination of ivennectin and DEC, given 
on a yearly basis, is superior to either drug given alone, both in parasite reduction 
and in sustaining the effect for one year (Ismail et al., 1998; Kazura et al., 1993; 
Moulia-Pelat et al., 1995; Nicolas et al., 1997; Shenoy et al., 1998). DEC and 
ivermectin are much less effective against adult parasites with studies using 
ultrasonography to detect adult parasites in situ reporting no effect (Dreyer et al., 
1996; Dreyer et al., 1998). This raises the problem of a recurrence of transmission 
if the drug is not re-administered to the whole community. The possibility of drug 
resistance also exists if only partial killing of parasites is attained. Another 
drawback is that DEC is not recommended by the World Health Organization 
(WHO) for use in areas where lymphatic filariasis exists alongside Loa Loa due to 
the quick killing of their MI, which leads to dangerous adverse reactions (Ottesen et 
al., 1997). Administration of these drugs does not prevent the re-establishment of 
infection and there is no clear evidence that killing an existing worm burden results 
in a boosting of the immune response to incoming larvae. Treatment is required at 
least once a year until both adults and Mf are killed and infection is eliminated from 
the vector population and animal reservoirs. 
Many species of filariae harbour intracellular bacteria within the cells of the 
hypodermis and reproductive tissues, representing a novel target for antifilarial 
drugs. First seen in electron micrographs they are related to the Wolbachia 
symbionts of vector insects (McLaren, 1975). Sequencing of 16S ribosomal genes 
from bacteria isolated from different filariae have shown that they are a distinct 
group inhabiting almost all filariae except the rodent filariae, A. viteae, and the deer 
parasite Onchocerca flexuosa. An important finding is that treatment of filarial 
infections with antibiotics effective against rickettsial bacteria reduces larval 
development and renders adult worms infertile (Hoerauf et al., 1999). 
Investigations into whether antibiotics are directly toxic to worms or whether 
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worms die if their bacteria are eliminated have suggested the latter. Tetracycline is 
ineffective against A. viteae, which lack Wolbachia and loss of bacteria is seen long 
before worm death in L. sigmodontis (Hoerauf et al., 1999). This raises the 
possibility that filariae rely on some of the genome of Wolbachia for establishment 
or maintenance in their mammalian host. It is however possible that death of 
Wolbachia within worms releases toxins. Nethertheless treatment of the bacteria 
would be a useful addition to available therapies. 
1.5 	Vaccination 
A major goal of current research on parasitic diseases is vaccine 
development. Mass vaccination programs offer the opportunity of long term 
immunity, ideally, without the need for boosting. Clearly the first need is to 
identify which of the many thousand potential antigens encoded within the filarial 
genome will be useful in a vaccine. Equally important is the need for a clear 
understanding of the immune mechanisms that drive parasite clearance as distinct 
from the mechanisms that induce pathology. 
In endemic areas evidence does exit for a degree of protective immunity in 
long term residents of infective areas. By far the largest group within an endemic 
area are those people who have no clinical symptom of infection and are 
amicrofilaraemic. Although a proportion of these individuals will have infection 
levels undetectable by current methods some will undoubtedly have effective 
immunity. Moreover, by grouping infected individuals by age it has been shown 
that accumulation of adult worms tapers off at around 20 years of age (Vanamail et 
al., 1989) and that this coincides with the presence of antibodies to the surface of 
the infective larvae (Day et al., 1991a). Taken together these data indicates the 
existence of concomitant immunity similar to that found in schistosomiasis 
(Woolhouse and Hagan, 1999). 
Animal models have provided the strongest evidence that protective 
immunity can be induced and that the larval stages are the most effective target. 
Substantial levels of immunity can be generated by irradiated Us (Oothuman et al., 
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1979; Storey and Al Mukhtar, 1982; Wong et al., 1969; Yates and Higashi, 1985), 
trickle infections (Denham et al., 1992; Lucius et al., 1986), drug abbreviated 
infections (Chusattayond and Denham, 1984; Grieve et al., 1988) and secreted 
larval antigens (Lucius et al., 1991). 
The most widely used and successful of these techniques is inoculation of 
irradiated larvae. The first irradiation attenuated larval vaccines to be developed 
were against the cattle lungworm Dictyocaulus (Peacock and Poynter, 1980) and 
D.filaria of sheep (Jovanovic et al., 1965). Both vaccines proved to be very 
successful and are still widely used in the veterinary field. 
The exact effect of radiation on the biology of the larval parasites and the 
immune mechanisms involved in resistance against infective larvae are unknown. 
Depending upon the dose, irradiation will retard parasite maturation and migration 
to the preferred site of development within the host. Moreover, natural infections 
have been reported to produce more lymphatic pathology than infections with 
irradiated larvae (Oothuman et al., 1979). It has been suggested that the basic 
principle underlying an attenuated vaccine may be to stimulate immune responses 
towards the early stages of its development in the mammalian host (Denham and 
McGreevy, 1977). Thus when the immunised host is re-infected the immune 
responses could destroy the larvae, preventing infection. It is known that after 
exposure to ionising radiation, larvae spend longer periods in the L3 and L4 stages 
and thus larval antigens expressed only in the early stages of development will be 
presented to the host for longer periods. Importantly, a general observation has 
been that dead worms or somatic extracts provide modest or no protectionS 
(Abraham et al., 1988; Carlow and Phillip, 1987). 
There is some evidence that other life cycle preparations can be effective at 
killing parasites. Immunisation with soluble microfilarial extract is effective at 
reducing the numbers of jirds reaching patency and also reduces adult worm burden 
(Kazura et al., 1986). A 75 kDa surface-associated chitinase is the target of 
protective monoclonal antibodies (Fuhrman et al., 1992), and vaccination reduces 
microfilaraemia without affecting adult worm numbers (Wang et al., 1997). 
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Jird L3 44-91% (Yates and Higashi, 1985) 
Mouse L3 955% (Hayashi et at., 1984) 
Mouse L3 46% (Carlow and Phillip, 1987) 
Mouse L3 76% (Carlow and Phillip, 1987) 
Mouse L3 56% (Kazura et at., 1986) 
Cat L3 80% (Oothuman et at., 1979) 
Jird L3 39-76% (Chusattayanond and 
Denham, 1986) 
Mouse L3 94% (Hayashi et at., 1984) 
Jird L3 60-90% (Lucius et al., 1991) 
Jird L3 67.4% (Lucius et al., 1991) 
Dog L3 88% (Wong et al., 1969) 
Dog L3 97% (Grieve et at., 1988) 
L. sigmodoites I Irradiated L3 	Mouse 	L3 	50-57% 	(Le Goff et al., 1997) 
Table 1.1: Non-defined vaccine preparations used to protect against filarial infections in animal 
models. 
Although microfilarial antigens have the potential to block transmission, the effect 
of immunising actively infected individuals against Mf is unknown. Pathological 
reactions to dying Mf may result. Taken together the infective larval stage is the 
most attractive stage to attack with a vaccine since the vulnerability of this stage 
has been demonstrated and pathological reactions are likely to be less severe 
compared with other stages. 
1.6.1 Identification of protective antigens 
Work to date on selecting molecules for a filarial vaccine has largely been 
concerned with the identification of protective antigens without a full 
understanding of what determines a protective immune response. Most effort has 
been concentrated on identifying differences in antibody recognition in infections 
displaying different clinical and parasitological manifestations. This, however, has 
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several limitations. At present there is little evidence for antibody-mediated 
protection against filarial infection. Infections in mice have shown that T cells 
alone can mediate clearance of an infection (Suswillo et al., 1981), indicating that 
antigens capable of stimulating good T cell responses would also be important. If 
antibodies are important in protection it may be that the effector mechanisms 
induced by the antibody are important, rather than antibody per se. Another 
problem is defining a response that is linked with protection in patient sera. The 
antibody profiles of individuals will represent the recent history of the infection 
including responses to dead larval parasites and Mf. Thus the antibody profile of 
an infected individual will reflect the antigenicity of each molecule, which is 
unconnected to its potential as an immunogen. Thus many studies have identified 
highly immunogenic paramyosin (Li et al., 1991) and heat shock proteins (Selkirk 
et al., 1987), tropomyosin, (Hartmann et al., 1997a), chitinase (Adam et al., 1996) 
and myosin (Wang et al., 1997). These responses may be evoked as a consequence 
of parasite death but not be a cause of it. Recently, vaccination of jirds with highly 
immunogenic proteins (heat shock protein, collagen and myosin) showed that they 
failed to induce protective responses (Peralta et al., 1999). Differential screening 
by western blot identified a 43 kDa L3 chitinase recognised by all patients 
rigorously selected as putatively immune (endemic normals) but infrequently but 
patients harbouring Mf (Freedman et al., 1989; Raghavan et al., 1994). 
Another approach has been to define antigens from larval stages 
without selecting for antibody reactivity. The success of live, irradiated vaccines 
and excretory/secretory (ES) antigens (Lucius et al., 1991) contrasted with the 
relative inefficacy of dead preparations suggest that key antigens are expressed 
following infection. Careful implantation of various stages of post parasitic larvae 
has identified larvae undergoing the L3 - L4 moult as the most potent source of 
protective antigens (Eisenbeiss et al., 1994). Highly stage-specific antigens have 
also been defined (Bianco et al., 1990; Bianco et al., 1995; Frank and Grieve, 1991; 
Frank and Grieve, 1996; Frank et al., 1996; Scott et al., 1990; Storey and Philipp, 
1992). These studies not only offer the chance of identifying potential vaccine 
candidates but offer insights into the biology of the parasite during this stage of 
development. Efforts have begun to identify genes encoding proteins specific for 
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the infective larval stage (Blaxter et al., 1996; Gregory et al., 1997; Martin et al., 
1996; Scott et al., 1995; Yenbutr and Scott, 1995). 
1.6.2 Surface antigens 
By analogy with microbial infections where surface antigens are the targets 
of protective immune mechanisms, antigens expressed on the surface of filariae are 
considered likely vaccine candidates. In addition information about the biology of 
the parasite can be gained by identifying and characterising these proteins. A 
mouse monoclonal antibody against a chitinase present on the surface of fully 
mature Mf is capable of reducing infections in vector mosquitoes and Mf levels in 
infected gerbils. The homology with chitinases suggests a role in the penetration of 
the mosquito midgut. The surface-associated proteins of adult parasites originally 
visualised by surface-specific labelling techniques are now being identified. The 
dominant protein is gp29IBm-gpx (Cookson et al., 1992), a secreted glutathione 
Gene Identification Species Vaccination model Stage Reference Protection 
Name specificity (stage) 
MOv 2 Retinol-binding 0. volvulus A. viteae/jird All stages (Jenkins et al., 45.5%*(adult) 
protein 1996) 89% (Mf) 
Mov14 Tropomyosin 0. volvulus 0. liensis/mouse All stages (Taylor et al., 48 - 62% (MO 
1996) 
A. viteae/jird (Taylor et al., 46% (adults) 
1996) 
OvB20 Novel 0. volvulus A. vireae/jird Mf, L3 (Taylor et al., 54.5%*(adult) 
1995) 97% (MO 
0. lienalis/mouse (Taylor et al., NS 
1995) 
AvL3- 1 LIM domain A. viteae viteae/jird ND (Oberlander et NS 
protein al., 1995) 
OvGl5 Heat shock 0. vol vulus malayi/jird 7 (Peralta et al., NS 
protein 70 1999) 
Ki 1 Myosin 0. volvulus B. malayi/jird 7 (Peralta et al., NS 
1999) 
AP2 al-type IV B. malayi B. malayi/jird ? (Peralta et al., NS 
collagen 1999) 
F7R2 Chitinase B. malayi B. malayilfird Mf (Wang et al., t NO 
1997) 
SXP-1 Novel B. malayi B. malayi/jird 7 (Wang et al., t (MO 
1997) 
BM5 Paramyosin B. malayi B. malayilfird All stages (Li et al., 1993) 43 (MO 
62 kDa Aspartyl tRNA B. malayi B. malayi Mf/mouse Mf, adults (Kazura et al., 40-60% 
antigen synthetase 1990) 
Ov-ALT-1 Novel 0. volvulus 0. vol vulus/mouse All stages (Joeseph et al., 39% 
1998) 
*Average of 2 experiments 
NS, not significant 
ND, not determined 
t, significant but % reduction not given in the text 
Table 1.2. Recombinant antigens used to protect against a challenge offilarial parasites. 
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peroxidase with a preference for lipid substrates (Tang et al., 1995). Two other 
surface-associated antioxidants, superoxide dismutase (Ou et al., 1995) and 
thioredoxin peroxidase (Ghosh et al., 1998). Another major surface protein present 
in preparations for all life cycles stages is p15/400, nematode polyprotein antigen, a 
lipid binding protein possibly involved in scavenging of host lipids (Kennedy et al., 
1995). 
1.6.3 Excretory/secretory products. 
Lymphatic-dwelling filarial parasites release a wide variety of antigens 
when maintained in culture (Kaushal et al., 1982; Kwan-Lim et al., 1998; Maizels 
et al., 1986; Maizels et al., 1985), including anti-oxidants (Cookson et al., 1992; 
Tang et al., 1994), retinol binding protein (Selkirk et al., 1993), and acetylcholine 
esterase (Rathaur et al., 1987) macrophage migration inhibitory factor (MIF) 
(Pastrana et al., 1998) and protease inhibitors (Yenbutr and Scott, 1995). Attention 
has focused on released molecules with the assumption that accessibility to the 
effector arms of the immune system is a prerequisite for effective vaccine 
candidates. In addition secreted components potentially include immune 
modulators and molecules diagnostic of active infection. 
1.7 	The filarial genome 
The filarial nuclear genome is similar in size to that of C. elegans, the first 
multicellular organism to be sequenced in full (The C. elegans Sequencing 
Consortium, 1998). There are predicted to be around 19,000 proteins coding genes 
in C. elegans and a similar number is expected in filariae. In common with C. 
elegans, and perhaps universal amongst nematodes, is the trans-splicing of most 
mRNAs (Blaxter and Liu, 1996). 
Trans-splicing involves the addition of short leader sequences onto the 5 
ends of mRNA (Nilsen, 1993). In trypanosomatidae all nuclear mRNAs are trans-
spliced to a 35-96 nt sequence at their S'end donated from a 137 nt precursor. In 
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nematodes some, but not all, mRNAs receive a 22 nt trans-spliced sequence (SL-1) 
from a 100 nt donor (Blaxter and Liu, 1996). The significance of this sequence is 
not yet known but it is estimated that more than 70% C. elegans transcripts receive 
this sequence during maturation of the primary mRNA transcript. 
C. elegans is unusual among eukaryotes in that a significant number of its 
genes are arranged in polycistronic pre-RNA5 derived from co-transcribed gene 
clusters, or operons (Spieth et al., 1993; Zorio et al., 1994). A further, distinct, 
trans-spliced sequence, SL2, has also been found on the 5' end of a much more 
limited set of mRNAs and at present it appears that this splicing event is associated 
with downstream genes in operons (Spieth et al., 1993). Whereas the first gene in 
an operon receives SL1 or is not trans-spliced at all, genes located downstream 
either receive SL2 or a mixture of SL1 and SL2 (Evans et al., 1997; Zorio et al., 
1994). In C. elegans other trans-spliced sequences (SL1 - 5), more closely related 
to SL-2 than SL-1, have been described. (Ross et al., 1995). 
A common feature of operons in C. elegans is that each gene is about 100 
bp downstream from another gene with the same 5 '-3 'orientation. Searching two 
megabases of C. elegans genomic sequence has revealed that perhaps 25% of genes 
are organised in operons (Zorio et al., 1994). 
It is likely that SL-1 and SL-2 do not solely function within operons as there 
are many trans-spliced genes not organised in such a way. The sequence probably 
acts as a good translational initiation site, although other functions are possible 
(nuclear export or protection of mRNA from degradation (Maroney et al., 1995), 
for instance) 
Although the function of the splice leader sequence is not fully understood 
they can be conveniently used to isolate the 5' end of cDNAs or to construct 
libraries (or pools of 1st strand cDNA) (Blaxter et al., 1996; Gems et al., 1994; 
Gems and Maizels, 1996; Gregory et al., 1997; Martin et al., 1996; Scott et al., 
1995; Yenbutr and Scott, 1995). 
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Filarial nematodes possess six chromosomes (5 autosomes and a XY sex 
determination pair). A large portion of the 100 Mbp genome is repetitive DNA. 
Approximately 10% of the B. malayi genome is made up of a single repetitive 
element, the HhaI repeat (around 30000 copies/genome) (McReynolds et al., 1986). 
This 322 nucleotide repeat is arranged in tandemly repeated arrays and is found in 
similar copy numbers in other species of Brugia but not in W. bancrofti (Xie et al., 
1994). Overall the genome has a high AT content of 71% (Rothstein et al., 1988). 
Up to 1994 a small set of around 60 Brugia gene sequences had been 
submitted to the public databases, largely identified through immunoscreening of 
adult cDNA libraries. Given an estimated complement of around 15 - 20000 genes 
encoded within the genome a radical departure in methodologies for gene discovery 
was needed. In the last few years, the Filarial Genome Project has been initiated to 
facilitate parasite gene discovery. A major part of the project has been the 
generation of a series of cDNA libraries representing all stages of the life cycle of 
B. malayi. Genes are then identified by the Expressed Sequence Tag (EST) 
approach. Clones are selected randomly from cDNA libraries, and single pass 
DNA sequencing reactions are performed to provide a 100 - 500 nucleotide 
sequence "tag" for each selected clone. As each gene is represented in a cDNA 
library at approximately the abundance of its mRNA, a record of gene expression 
through the life cycle can be generated (Blaxter, 1995). This effort is ongoing and 
there are currently around 20,000 ESTs deposited in the public database, dbEST, 
defining around 6,500 genes. If the total number of genes in B. malayi is similar to 
that predicted from the entire genome of C. elegans then around one third of B. 
malayi genes have already been identified. Although the entire sequence of the C. 
elegans genome is now available, 38% of B. malayi ESTs are novel, having no 
matches to sequences in the public databases (Williams et al., 1999). These 
potentially represent a collection of filarial-specific genes and are likely to include 
many genes that are valuable as vaccine candidates and drug targets. 
With the assumption that many proteins expressed at the infective larval 
stage facilitate transmission to the mammalian host, the aim of this thesis was to 
identify and characterise genes abundantly expressed at this stage. 
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2.1 	Parasite isolation 
Vector stage parasites were obtained from Aedes aegypti mosquitoes 
infected with B. malayi by membrane feeding on human citrate-treated blood mixed 
with peritoneal-derived microfilariae to a concentration of 16,000 mf/ml. 12 - 14 
days after infection infective larvae were recovered by gentle crushing of 
mosquitoes between a glass plate and a test tube, following which larvae were 
separated from mosquito debris in a Baermann apparatus containing Grace's insect 
tissue culture medium (Gibco-BRL, UK) maintained at insectory temperature 
(27°C). 
Male jirds (M. unguiculatus) were infected intraperitonealy with infective 
larvae and used as a source of developing larvae, adult worms and microfilariae 
(Mf). Parasites were removed from the peritoneal cavity of jirds that had been 
euthanised by cardiac puncture under anesthesia, and washed in RPMI 1640 
containing 25mM HEPES and glutamine (Gibco-BRL, UK). Mf were isolated from 
lavage fluid by gentle centrifugation (1000 rpm for 10 mm) and purified by passage 
through PD1O Sephadex ® G-25 M columns (Pharmacia Biotech AB, Uppsala, 
Sweden) 
2.2 Preparation of parasite antigen 
B. malayi antigen was prepared by homogenization of mixed sex adult 
worms or Mf in PBS (Sigma, cat. no. P-4417, tablets giving 0.1M phosphate, pH 
7.4) on ice followed by centrifugation at 12,000 x g for 20 mm. The resultant 
supernatant was passed through a 0.2 tim filter prior to protein concentration 
determination by the Coomassie Plus protein assay (Pierce, Rockford, Illinois). 
2.3 Isolation of parasite RNA 
Total RNA from all parasite stages was isolated using RNAzoP' or 
TRISOLV. Parasites were in a minimum volume of PBS were mixed with 
TRISOLV/RNAzo1 (1 volume sample: 9 volumes of TRISOLV/RNAzo1) and 
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disrupted in an eppendorf homogenisers (Biomedix, Pinner, UK). To 0.5 ml of 
homogenate was added 100l of chloroform (HPLC grade, 99.9%), shaken 
vigorously for 15 sec, placed at room temperature for 2-3 minutes, and then 
centrifuged at 12,000 g (4°C) for 15 mm. The upper aqueous phase was transferred 
to the fresh tube, mixed with 250/d isopropanol (>99%, molecular biology grade 
Sigma), and stored at room temperature for 5-10 minutes. After centrifugation at 
12,000 g (4°C) for 10 mm, the RNA was washed with 1.5 ml of 75% ethanol by 
vortexing, and subsequently centrifuged for 5 min at 7,5000 g (4°C). At the end of 
the procedure, the RNA pellet was dried completely and immediately dissolved in 1 
mM EDTA (pH 7) or autoclaved MilliQ water. 
2.4 Generation and cloning of abundant transcripts. 
Total RNA was extracted from vector-derived infective larvae and larvae 
harvested from jirds 9 days and reverse transcribed using the GeneAmp RNA PCR 
kit (Perkin Elmer, CA, USA). Each reaction (20 .il) contained 2.5 .iM DG d(T), 
1mM of each dNTP, 1U of RNase inhibitor, 2.5U of MuLV reverse transcriptase. 
Reverse transcription was carried out at 42°C for 15 minutes with the poly (A)+  tail 
complementary oligo-dT primer DG d(T) (Appendix 3) which contains 5' Barn HI 
and Xba I restriction sites. PCR was then carried out on the resultant first-strand 
cDNA using an SL1 oligo incorporating 5' Not I and Xba I restriction sites 
(Appendix 3) and Pfu DNA polymerase (Stratagene Inc. La Jolla, CA, USA). 
Thirty-five cycles of amplification were performed using a program of 94°C for 1 
min 55°C for 3 min and 72°C for 15 mm. 
PCR products were identified by electrophoresis on a 3% Metaphor agarose 
gel (FMC, UK) followed by brief staining with ethidium bromide (0.5 j.ig/ml in 
water). Abundant bands were excised and purified using Geneclean (Bio 101, La 
Jolla, CA, USA). Purified bands were re-amplified and restriction digested with 
Barn HI and Not I together for 3 h at 37°C. Bands were then purified (Clean-up 
Kit, Promega, Wisconsin, USA). pBluescript KS (Stratagene, Appendix 4) was 
digested with BamH I and Not I (10 U each enzyme for 4 h at 37C), purified 
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(Clean-up Kit, Promega, Wisconsin, USA) and alkaline phosphatase-treated to 
reduce background from plasmid digested with only one restriction enzyme (1 unit 
for 15 min at room temperature, then 55°C for 15 min after adding another 1 unit of 
enzyme). The enzyme was removed (DNA Clean-up Kit, Promega) and ligation 
performed for 4 h at 16°C in the presence of 2 U of T4 DNA ligase. Ligated DNA 
was transformed into competent XL1-Blue E. co/i (Stratagene) and recombinants 
identified by X-gal (5-bromo-4-chloro-3-indolyl-13-D-galactoside)/IPTG 
(isopropyl-3-thiogalactopyranoside)/ampicillin selection. 
32P labelling of the RT-PCR products was carried out to allow better 
visualisation of individual bands. For this 4JLl of RT-PCR product was re-amplified 
through 4 cycles in the presence of 401t Ci 32P-dCTP (Amersham International, 
Bucks, UK). After electrophoresis the gel was dried down overnight between 
layers of absorbent towels and autoradiographed. 
2. 5 Southern Hybridisation. 
To assess diversity of sequences amongst clones produced from each 
abundant band, inserts were PCR amplified with SL1 and DGDT primers. The 
PCR product of one clone was also labelled with digoxigenin (Boehringer 
Mannheim, UK) following the manufacturer's instructions and used to probe a 
Southern blot of all of the PCR products separated on a 2% agarose gel. 
2.6 RT-PCR from vector- and mammalian-stage parasites 
RNA from infected mosquitoes was extracted using either TRIZOLV or 
RNAzo1 B (Biotex Inc). Total RNA from individual bloodfed mosquitoes was 
isolated without any attempt to recover the larvae. For each mosquito 40 Id of first 
strand cDNA was synthesized using the GeneAmp RNA PCR Kit (Perkin-Elmer) 
with the kits oligo d(T)16 primer. To detect larvae within infected mosquitoes each 
first strand cDNA was amplified with primers specific for Bm-cpi-2. Total RNA 
from these positive mosquitoes was pooled and PCRs using gene-specific primers 
carried out using 51l pooled vector stage cDNA or 1-2 jil mammalian stage first 
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strand cDNA. As a control, identical volumes of each cDNA was also amplified 
with primers specific for -tubulin (Guenette et al., 1992). 25 jd PCR reactions 
were performed under standard conditions; (94°C for 1 mm, 55°C for 1 mm, 72°C 
for 1.5 mm, 35 cycles; 72°C for 10 mm) and included 50 jiM of each primer, 0.2 
mM each dNTP and 1.25 U Taq polymerase. Total RNA from larvae during the 
first 25 days of infection of the jird was reverse transcribed with the GeneAmp kit 
using the kits oligo d(T)16 primer and amplified 
2.7 Isolation of parasite genomic DNA 
Genomic DNA was isolated from B. malayi adult parasites. Parasites were 
homoginised in a pestle and mortar immersed in liquid nitrogen followed by 
digestion with proteinase K (Sigma) in lysis buffer (100 mM NaCl, 50 mM EDTA, 
1% SDS, 1% 2-ME, 10 g/ml RNase, 100 [tg/ml. proteinase K, 100 mM Tris-Cl, pH 
8.5) at 65°C for 30 min with occasional inversion. Genomic DNA was extracted 
with 0.5 ml phenol by inversion for 5 mm. After spinning 10 min at 12,000 rpm, 
the upper aqueous phase was extracted with 0.5 ml of phenol/chloroform and 
chloroform. After spinning 10 min at 12,000 rpm, 0.4 ml of the upper aqueous 
phase was added to lml of 100% ethanol (kept at -20°C). Precipitated DNA at the 
interface was hooked out and washed twice with 70% ethanol and once with 95% 
ethanol. The DNA pellet was briefly air dried and then re-suspended in TB buffer 
(10 mM Tris-HC1 pH 8.0, 1 mlvI EDTA pH 8.0). Genomic DNA preparations were 
kept at 4°C. 
2.8 PCR of genomic DNA 
PCR was performed in 0.5 ml Eppendorf tubes. Twenty-five microliter 
reactions contained 1.25 —2.5 U Taq polymerase, 5JLm each dNTP, SOng each oligo. 
The amount of DNA and the cycling conditions differ for each template and primer 
combination. For most PCR reactions the following cycling condition were used: 
94°C, 3 minutes, followed by 35 cycles of 94°C, 15 seconds, 55°C, 20 seconds, 
72°C, 3 minutes, then 10 minutes at 72°C. 
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The products of the PCR reactions were mixed with DNA loading Buffer 
(6x stock solution: 30% glycerol, 0.25% bromophenol blue, 0.25% xylene blue) 
and analysed by electrophoresis in TAE (50x stock solution: 242g Tris base, 37.2 g 
Na2EDTA2 H20 or 100 ml of 0.5 M EDTA, 57.1 ml glacial acetic acid, d H20 to 1 
litre) on agarose gels with ethidium bromide staining (stock solution 50g/ml). 
2.9 PCR of eDNA libraries 
cDNA Libraries constructed from vector-derived L3, L4 (harvested 10 days 
after infection of jirds), adult male and microfilariae were provided by the Filarial 
Genome Project. PCR was carried out on 1 1 aliquots of each amplified library 
with gene specific primers listed in Appendix 3. Thirty-five cycles of amplification 
were performed using Promega Taq polymerase under the following cycling 
conditions: 94°C for 1 mm, 55°C for 1 min and 72°C for 1.5 mm. 
2. 10 Cloning of PCR products 
Taq polymerase amplified PCR products were ligated directly into pGEM-T 
(Promega, Appendix 4). Ligations were carried out following the manufacturer's 
instructions. For each ligation reaction, 2 fl of gel-purified PCR product were 
mixed with 1 tl of T-vector, 1 tl of lOx ligation buffer (0.5 M Tris pH 7.4, 0.1 M 
M902, 0.1 M dithiothreitol, 10 mM spermidine, 10 mM ATP, 1 mg/ml BSA), 1 p1 
of T4 DNA ligase (3 Weiss Units/p.!) and 5 p.1 of dH 20. Ligation mixes were 
incubated at 15°C overnight, and 5 p.1 taken for transformation of chemically 
competent E.coli (XL-1 blue MRF' or JM1O9). 
2.11 Preparation of competent E.coli cells 
A single colony of E.coli was added into 100 ml of LB broth in a 1 liter 
flask and incubated with shaking for approximately 3-6 h until the cell density was 
4 - 7x107 viable cells/ml (0D600 of 0.4-0.6). The culture was transferred into ice-
cold 50 ml tubes, chilled on ice for 10 min and then centrifuged at 4000 rpm for 10 
min at 4°C. The pellet was then re-suspended in the original culture volume of an 
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ice-cold CaC12/glycerol solution (60 mM CaCl2 and 15% glycerol, filter sterilised) 
incubated on ice for 30 mm. The cells were then collected by centrifugation as 
above, re-suspended in 1/2 of the original culture volume of an ice-cold 
CaC12/glycerol solution, and incubated on ice for 10 mm. The cells were then 
collected by centrifugation again, re-suspended in 1/30 of the original culture 
volume of an ice-cold CaC12/glycerol solution and stored on ice overnight. The 
following morning the cell suspension was dispensed as 100 111 aliquots into 
prechilled eppendorfs and stored at —70°C. 
2.12 Transformation of E.coli 
Competent cells (50-100 tl) were mixed with either 5j..tl of a ligation 
reaction or lOng of cut plasmid DNA. The cells were then incubated on ice for 30 
mm, heat-shocked at 42°C for 40 seconds and incubated on ice for 2 minutes. To 
each transformation mixture, 100-200 tl of room temperature SOC medium 
(GIBCO-BRL) was added and the mixture was incubated at 37°C for 1 hr. This mix 
was then plated out on LB agarose plates containing the appropriate antibiotic and 
incubated at 37°C overnight. For PCR products inserted into the coding sequence 
of 0-galactosidase blue/white screening was carried out. Transformation mixes 
were plated out onto LB-agarose/antibiotic plates spread with 50zl X-gal (50 mg/mi 
solution in dimethyl-formamide) and 151d 100mM IPTG. Plates were incubated 
overnight at 37°C and white colonies picked. Cells containing plasmids with inserts 
were identified by PCR of colonies. Picked colonies were transferred to 15 JL1 LB 
and 1 Itl of this was used in 20 /Ll PCR reactions with either vector-specific or 
gene-specific primer pairs. Cycling conditions were those used for amplification of 
genomic DNA. 
2.13 Clone excision 
For EST clones obtained as phage (lambda Uni-Zap, Stratagene) plasmids 
were excised as follows: XL-1-Blue MRF'cells were grown overnight in LB 
medium then diluted 1/100 and grown for 2 - 3 hours to an 0D600 of 0.2 - 0.5. 
The cells were then spun (1500g) and re-suspended to an 0D600 of 1.0 in lOniM 
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MgSO4. 200jil of cells were then added to 250z1 phage stock and 1l ExAssist 
helper phage (>1 x 106 pfu4Ll, Stratagene) and incubated at 37°C for 15 minutes. 3 
ml LB was then added and the mixture incubated for a further 2 hours with shaking. 
pBluescript plasmid particles were then obtained by heating the mixture to 70°C for 
15 minutes and centrifuging at 4000g for 15 minutes. 100d supernatant was then 
added to 200d SOLR cells (Stratagene) grown from a 1/100 dilution overnight 
culture to an 0D600 1.0. After incubating at 37°C for 15 minutes 10-50tl were 
plated onto a LB- 50ig/ml ampicillin plate and incubated overnight at 37°C. 
Single colonies were then picked and grown overnight in LB-ampicillin. Plasmid 
was obtained using the QlAprep Spin Miniprep Kit (Qiagen). 
2.14 Plasmid DNA purification 
Plasmid DNA was prepared by QlAprep Spin Miniprep Kit (QIAGEN Inc.), 
according to manufacturer's instructions. Single colony or frozen culture bacteria 
were inoculated into 10 ml of LB broth containing the appropriate antibiotic and 
grown overnight at 37°C with shaking. The cells were collected by centrifugation at 
3,000-4,000 rpm for 10 mm. Plasmid DNA was store at 4°C or —20°C for long 
term storage. 
2.15 DNA sequencing 
Automated sequencing of plasmid DNA was carried out using dye 
terminators with the PRISMTM  cycle sequencing kit (Applied Biosystems Inc.) and 
the 377 automated sequencer (ABI). Protocols were carried out as described by the 
manufacturer (ABI PRISM dye Terminator protocol, P/N 402078). For each 
reaction, the reagents were aliquoted into a 0.5 ml PCR tube as follows: 4 p1 
Terminator Ready Reaction Mix, 2 p1 dsDNA Template (0.2 mg/ml), 0.5 p1 
sequencing primer (20-30 jig /ml), 3.5 p1 H20 with total volume 10 p1. Cycle 
sequencing was performed on a HYBAID DNA thermal cycler (OmniGene) with 
the following condition: 25 cycles (96°C for 30 sec, 50°C for 20 sec, 60°C for 4 
mm, respectively). After completion, reaction products were mixed with ijil of 3 M 
sodium acetate (pH4.6 or 5.2) and 25 p1 of cold 95% ethanol, and placed on ice for 
Page 27 
10 mm. After centrifugation at 13,000 rpm for 20 mm, the precipitated pellets were 
washed again using 125 .t1 of cold 70% ethanol and finally resuspended in 3 j.tl 
loading buffer (5 parts of deionised formamide to 1 part of 50 mg/ml Blue dextran 
in 25 mM EDTA, pH8.0). Samples were heated to 90°C for 3 min and 1.5 j.tl of 
each sample was loaded. 6% Denaturing gels were run at 50 W for 7 h. 
Chromatograms were viewed and data was edited using the SeqedTM program 
(ABI) and using MacVector program version 6.0. (Oxford Molecular Group, UK) 
2. 16 Cloning into expression vectors 
Recombinant proteins were produced in pET-29-T and pET-22 expression 
vectors (Novagen, Madison, WI, USA). In this family of related plasmids, 
expression of target genes is controlled by the bacteriophage T7 promoter. Since E. 
coli RNA polymerase does not recognise the T7 promoter, transcription of the gene 
is absence in host cells used to establish the plasmid thus increasing the chance of 
maintaining a plasmid expressing toxic proteins. Expression is achieved in host 
cells with an introduced T7 polymerase gene under the control of the lac promoter. 
Thus expression is induced by IPTG. 
pET-29-T is a T-tailed member of the pET family (Appendix 4). Taq 
polymerase PCR products were gel purified and ligated directly into the vector with 
2-3 U T4 DNA ligase. The ligation mix was transformed into chemically 
competent Xl- 1 Blue cell and plated on to LB agar containing 30ig/m1 kanamycin. 
To ensure selection of plasmids with inserts in the correct orientation for expression 
colonies were PCR screened with T7 promoter primer in combination with a 3' 
insert-specific primer. 
Bm-CPI-1 and -2 were cloned into pET-22 (Appendix 3) using Msc I and 
Xho I restriction sites (CPI-1) and Barn HI and Xho I sites for CPI-2. Primers 
incorporating these restriction sites (Appendix 3) were used to amplify the CPI 
fragments from a L3 cDNA library (SAW94WL-BmL3). pET-22 plasmid DNA 
and the PCR products were digested with the appropriate enzymes followed by 
purification using microconcentrators (Microcon, Millipore). Purified cut plasmid 
and cut insert DNA were ligated overnight at 16°C with 3-5 U T4 DNA ligase. 
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Colonies were PCR screened with a combination of T7 promoter primer and 3' 
insert-specific primer as described above. 
2.17 Recombinant protein expression in E.coli 
pET29-T vector and pET-22s were used to express polypeptides fused with 
hexa-Histadine-tag in E. coli BL21 (DE3) host. 
Two microlitres of ligation reaction containing recombinant plasmids were 
transformed into XL-1 blue MRF' cells then grown on LB-kanlamp agar plates 
overnight at 37°C. Positive clones were identified by direct PCR. Plasmid DNA 
was prepared with the QlAprep Spin Miniprep Kit (QIAGEN Inc.) and sequenced 
to provide confirmation of identity. Positive plasmid DNA with correct sequence 
was transformed into BL21 (DE3) cells, and grown on LB-kan/amp agar plates 
overnight at 37°C. 
Single colonies were picked and put into 10 ml of LB-kan/amp and grown 
at 37°C with shaking to an 0D 600 of 0.6-0.8 (about 3-6 h). 5 ml of culture was 
removed as a control before induction, and to the remaining culture 1 M IPTG was 
added to a final concentration of 1mM in order to induce expression of the fusion 
protein. Cells were then grown for a further 3-6 h. Cells were collected by 
centrifugation at 5,500 rpm for 10 minutes at 4°C and resuspended in 1 ml of ice-
cold lx PBS. The cells were lysed by sonication on ice and the lysate 
microcentrifuged. A sample of both the supernatant and pellet was analysed by 
SDS-PAGE and Coomassie staining to indicate the expression and solubility of the 
His-tag fusion protein. 
2.18 Purification of recombinant proteins 
Preparing the cell extract. 1 litre of bacteria expression culture was 
harvested by centrifugation at 10,000 - 20,000 x g for 20 mm, resuspended in 20 ml 
ice-cold Binding buffer (8X Binding buffer: 40 mM imidazole, 4 M NaCl, 160 mM 
Tris-HC1, pH 7.9) and sonicated with the sample on ice. The lysate was centrifuged 
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at 10,000 - 15,000 x g for 15 min and the supernatant was filtered through a 0.45 
mm Millex-HV Filter Unit (Cat No SLHVR25LS, MILLIPORE) to prevent 
clogging of the resin 
Preparing the resin. A few ml of deionized water was added to the dry column 
(PIERCE) and the column flowing was started. The bottle containing His-Bind 
resin (Novagen) was gently mixed by inversion and 5 ml of resin was then added 
into column, which can be used to purify up to 20 mg of target protein. When the 
level of storage buffer (20% ethanol) drops to the top of the column bed, the 
column was washed with the following sequence: 7.5 ml of deionized water, 12.5 
ml of 1X Charge buffer (8x Charge buffer: 400 mM NiSO4), 7.5 ml of 1X Binding 
buffer. 
Performing column chromatography. When the Binding buffer drains to the top of 
the column bed, the column was loaded with the prepared extract, washed with the 
following sequence: 25 ml of 1X Binding buffer, 15 ml of 1X Wash buffer (8X 
Wash buffer: 480 mM imidazole, 4 M NaCl, 160 mM Tris-HC1, adjust final pH to 
7.9), 25 ml of 1X TBS (150 mM NaCl, 20 mM Tris-HC1, pH 7.9). Recombinant 
proteins were eluted with 15 ml of TBSE (TBS containing 50 mM EDTA), injected 
into dialysis cassettes (PIERCE) and then dialysed in TBS for 24 h at 4°C. 
2. 19 Detection of cysteine protease inhibition by recombinant CPIs 
A fluorogenic assay was used to detect inhibition of papain and cathepsin B 
by both CPI's (Katunuma and Kominami, 1995). Assays were carried out at pH 5.5 
in 0.3 M acetate buffer containing 0.5mM DTT and either 0.15jiM papain 
(Calbiochem) or 0.1tM bovine cathepsin B (Sigma). Enzyme solutions were pre-
incubated with 0-1.5 tig of purified recombinant protein in a total volume of imi at 
37°C for 10 minutes after which lOjiM Z-Phe-Arg-AMC substrate (Bachem, UK) 
was added. Increases in fluorescence were measured over 2 minutes using a Perkin 
Elmer LS50B spectrofluorimeter using excitation and emission wavelengths of 360 
and 440 nm respectively. Initial reaction rates were calculated for each 
concentration of recombinant protein used as the change in fluorescent 
units/minute. As a negative control, Bm-ALT- 1, an unrelated recombinant protein 
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B. malayi expressed with identical fusion partners, was tested under identical assay 
conditions. 
2.20 Production of antisera in mice 
6-8 week old mice were generally purchased from Harlan-UK (Bicester, 
UK), or obtained from source (Ann Walker House, Edinburgh University). For 
immunisation, mice were injected subcutaneously with 2Otg recombinant protein 
in complete Freunds adjuvant and boosted 1 month later with 10g antigen in 
Freunds incomplete adjuvant. Mice were bleed for antisera 1 month after the boost. 
For each antigen 6 BALB/c mice were immunised. To reduce the risk of genetic 
restriction in the response to the antigens, 6 CBA mice were also immunised with 
CPI- 1, CPI-2 and ALT-i. 
2.21 Vaccination 
Male jirds (M. unguiculatus) were immunized subcutaneously with 75 tLg of 
rALT-1 in Complete Freund's Adjuvant (CFA) or with CFA alone (6 jirds/group). 
At weeks 32 and 33, boosts were given of 25 Itg rALT-1 in Incomplete Freund's 
Adjuvant or IFA alone, and at week 45 a final boost of 7.5 ag in IFA was given. 
Two weeks later, all jirds were challenged with 300 larvae of B. malayi introduced 
intraperitoneally. After 4 weeks, jirds were euthanized and parasites recovered 
from the peritoneal cavity and testes. Parasite recoveries and counting were 
performed without knowledge of the experimental status of each animal. 
2.22 SDS-PAGE 
Proteins were resolved on 15% SDS-PAGE gels (Acrylamide:bis-
Acrylamide ratio, 74:1). The stacking gel consisted of 5% acrylamide/0.125M 
Tris/0.1%SDS and the main (separating) gel contained 15% acrylamide/0.375M 
Tris-HC1/0.1% SDS. Gels were electrophoresed at 20mA in running buffer 
containing 0.38M glycine/ 0.5M Tris/ 0.1% SDS. 
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Separated proteins were then either stained with Coomassie blue staining solution 
(50% methanol, 10% acetic acid, 0.25% Coomassie Blue R-250) or 
electrophoretically transferred onto a membrane for Western blotting. 
2.23 Western blotting 
Proteins separated by SDS-PAGE were transferred onto PVDF (Immobilon, 
Millipore) or Hybond-C nitrocellulose (Amersham) membrane. Proteins were 
transferred to the membrane in a LKB Novablot apparatus in transfer buffer (0.19M 
glycine, 0.025M Tris base, 0.05% SDS, 10% methanol). Transfer was conducted at 
0.8mAlcm2 gel. Transferred proteins were visualised by Ponceau S solution (cat. 
no. P-7170, Sigma). 
The membranes were incubated in blocking solution (5% fat-free dried 
skimmed milk, MARVEL) in PBS, pH 7.4) overnight, rinsed once in PBS-TT 
(0.1% Triton X-100 and 0.05% Tween-20 in PBS), and then incubated with diluted 
antibody (1:100-500) in blocking solution containing 0.1% Triton X-100 and 
0.05% Tween-20 for 1 h at room temperature. After washing with PBS-TT, the 
membranes were incubated with peroxidase-conjugated rabbit anti-mouse IgG 
(BioRad, UK). Bound antibodies were detected by chemiluminescence using 
ECLPlus Western blotting detection system (Cat No RPN2131, Amersham Life 
Science) and Hyperfilm ECL (Cat No RPN3103H, Amersham Life Science) 
following the manufactures instructions. 
2.24 Metabolic labeling of parasites 
Approximately 50 mixed sex worms or 500 larvae were maintained at 37°C 
in RPMI supplemented with 25mM HEPES, 1% glucose, 2mM L-glutamine and 
100 U/ml penicillin, 100/Lg/ml streptomycin and lmCi Trans 35S-label (ICN, CA, 
USA). During the culture period a solution of 7.5% sodium bicarbonate was added 
each day to maintain a neutral pH and glucose was added to a final concentration of 
1% every two days. After 5 days of culture the medium was centrifuged at 12,000g 
to remove microfilariae and filtered through a 0.22tm filter. 
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2.25 Surface-specific labelling of parasites 
Surface exposed molecules of adult and L2 parasites were labelled by the 
lodogen reagent (Pierce, Rockford, IL, USA), which acts as surface-specific 
catalyst as it is insoluble in aqueous solutions. In the presence of sodium 121  Iodine 
lodogen introduced radio-iodine onto tyrosine residues. One hundred microlitres 
lodogen (1 mg/ml in methylene chloride) is added to a 1.5 ml eppendorf tube and 
allowed to dry completely. Parasites are transferred to the tube in PBS together 
with 500jiCi sodium 121  Iodine (IMS 30, Amersham, UK) and incubated at room 
temperature for 10 minutes with occasional agitation. Ten microlitres of saturated 
tyrosine solution is then added to quench the reaction. The parasite are removed 
from the tube and washed extensively in PBS. 
2.26 Immunoprecipitation 
Immunoprecipitations were carried out on SOOil of culture supernatant pre-
cleared by incubation with SOtl formalin-fixed Staphylococcus aureus (Panasorb, 
Calbiochem, Nottingham, UK) for 15 minutes. After removal of Panasorb by 
centrifugation at 12,000g the cleared supernatant was incubated with 20il antisera 
overnight at 4°C. Immune complexes were absorbed onto Protein G-Sepharose 
(Pharmacia) by rotating for 2 hours at 4 °C. The complexes were then washed in 
phosphate buffered saline containing 0.5% Triton X-100 and released by boiling in 
SDS-PAGE sample buffer. Proteins were analyzed by SDS-PAGE on 17.5% 
polyacrylamide gels. 
2.27 Phylogenetic Analysis 
Cystatin sequences, omitting their signal peptides, were aligned with the aid 
of the ClustalW function of MacVector with final manual adjustment. Using two 
stefin sequences as the outgroup, phylogenetic analyses using maximum parsimony 
were performed using PAUP 3.1.1, written by David L. Swofford. Bootstrap 
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Plasmids used in this study 
Name (company) 	 Brief description 
pBluescript II KS(Stratagene) 	Amp. Resistant. Blue/white screen 
pGEM-T(Promega) 	 cloning of PCR products Amp. Resistant. Blue/white screen 
pET-29-T(Novagen) direct cloning and high level expression of PCR products. 
Fusions contain N-terminal S'Tag and C-terminal His-Tag. 
Kan. Resistant. 
pET-22(Novagen) 	 High level expression of proteins fused to the pelB signal 
sequence for potential periplasmic localisation. C-terminal 
His-Tag. Amp. Resistant. 
























BstZ I 	43 
Not I 43 
Sac II 	49 
EcoR I 52 
Spel 	64 
EcoR I 70 
Not 	77 
BstZ 1 77 
Psi I 	88 
Sa/l 90 
NdeI 	97 
Sad 1 109 
BstXl 	118 
NsiI 1 127 
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Tthlll 1(2960) ~ftpl 427,11) 
A. pBluescript II KS(+). Not I and Barn HI sites were used to clone abundant transcripts. B. 
pGEM-T. A commercially derivative of pGEM 5Z f(+) prepared by restriction digesting with 
EcoR V and adding 3 -T overhangs to allow the direct cloning of PCR products produced by Taq 
polymerases. C. pET-29-T. A T-ended expression vector also produced by digesting with EcoR 
V and T-tailing. Allows the production of recombinant proteins fused to a C-terminal S'Tag and 
N-terminal hexahistidine tag. D. pET-22. Allows the production of recombinant proteins fused to 
an N-terminal pelB signal sequence for potential periplasmic localisation plus a C-terminal 
hexahistidine tag. Inserts are introduced into both pET plasmids in a region transcribed by T7 






E. coli strains used in this study. 
Strain(company) Genotype Brief description 
XL-1 Blue(Stratagene) 4(mcrA)183 zl(mcrCB-hsdSMR-mrr)1 73 Tet resistant 
endAl supE44 thi-1 recAl gyrA96 relAl Lac 
[F'proAB lacIqlacZiM15Tn1O(tet')] 
JM109(Promega) endAl, recAl, gyrA96, thi, hsdRl7 (rb, mk), No antibiotic resistance 
relAl,supE44, iX(lac-proAB), [F traD36, 
proAB, laqlZz\M15] 





Appendix 3 - Primers used in this study. Sequences underlined indicate 
restriction sites used for cloning. Extra nucleotides used for cloning into pET-29-T 
are bolded 
Primer Pairs for expression cloning 
Name (restriction site) Location 
4.1 pET For AGATGACGAATTCGACGACGAATCCTCA 100-127 
4.1 pET Rev ACGAGCATTGCCAACTTTCTTGAGGCGC 380-403 
061 pET For ATACGATTAAGCAGAGCTACATATAAT 86-112 
061 pET Rev TTGTCAAAGTGACTTTGAATGTGTTTTG 377-403 
CPI-1 pET22For (Msc I) GGCGATGGtCATGAGGGAA.ATACGATTAAGCAGAGCT 80-103 
CPI-1 pET REV (Xho I) 377-403 
038 pET For TTGATTCATCGACGAGAAATTCCTCAT 131-157 
038 pET Rev GAGAGTACCTTTGTCTCCAAAATATTC 505-53 1 
CPI-2 pET22For (Barn HI) CGGATCCCTTGATTCATCGACGAGAAATTCCTCAT 131-157 
CPI-2 pET22Rev (Xho I) CACCrCGAGTACTGACGAGTACCTTTGTCTcCAA 5 12-535 
A033 pET For 	 ATTTGGTTGGGGATACTCATATTACGGT 	 107-133 
A033 pET Rev TTTTCTTCTTGCCCAGTACAGCACCAGCGAT 	 185-214 
TPH pET For 	 AATGTTGATCTTCAAGGATGCATTCACA 	 63-89 
TCTP pET Rev TTTGTTTTTCTTCAATGAGTGCCTCCTT 579-603 
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Primer Pairs for RT-PCR and library PCR 
Location 
4.1 3 IJTR TTGTTTTGCTTGCTTTGTAAGCATTTA 407-432 
(Used with 4.1 pET For) 
alt-2 For GACGAAGAGTTCGATGACTCCGCAGCC 102-128 
alt-2 3 UTR GTAGTATCAAAGACTGATTCATTCCTA 417-443 
0613' CACAATCTGTTATTTATGAATTATCG 461-486 
061 5' ATGTTCTTCCCGATTGTATGG 23-43 
038-5 ACCAACTGTGTAAACAAAATAAGC 23-46 
038-3 ' ACCAAATCCAAATATTTATGCACCA 670-693 
A033 3' UTR CGTATGACCTTTTCAACACTTAAIAT 282-308 
(Used with A033 Pet For) 
Tubulin A AATATGTGCCACGAGCAGTC 121-140 
Tubulin B CGGATACTCCTCACGAATTT 409-428 
Ce-alt For 	 GGAATGCCTTGCGAAACAGACCAAGAT 	 1-27 
Ce-alt Rev ATGTTTTGGTGGTGAGCAATGGTCCAA 211-237 
Primers for genomic sequencing 
Location 
g061-1 For 	 TGCACCGACCACCTGTAGAAA 	 362-382 
g061-2 Rev GTCGGTTTACTGCTGTCGATA 687-707 
g038-1 Rev CTGCAAAAAATCTTCCCATGG 1469-1489 
g038-1 For GGACAAATGCAGCGTGGCCAA 148-168 
g038-E2 For ATGCCAATCAAATTGCTAAAAGTTTCA 588-614 
g038-3' ACCAAATCCAAATATTTATGCACC 1657-1679 
alt-2g Rev 	 GTTCTTTCGATGACGCACGAATGCAAC 	 990-964 
alt-2E2 For GCTCTTCGCACGAAGCTTGCTACGATC 530-556 
Miscellaneous primers 
(Restriction enzyme site) 
SL-1 GCTCTAGAGCGGCCGCGGTTTAGTTACCCAAGTTTGAG 	(Not 1) 




Ml 3R AGCGGATAACAATTTCACACAGGA 
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CHAPTER 3 
Cloning of abundant trans-spliced cDNAs from L3 and L4 larvae 
3.1 Introduction. 
3.2 Results 
3.2.1 Abundant PCR Products from vL3 and L4 eDNA 
3.2.2 550 bp vL3 Products: Bm-alt-1, cpi-1, rbp-1 and a ribosomal protein. 
3.2.3 500 bp vL3 Products: glt-1 and ribosomal proteins 
3.2.4 300 bp vL3 and L4 products: Bm-col-3 and sit-i 
3.2.5 750 bp vL3 band: Bm-tph-1 
3.2.6 250 bp vL3 band: Bm-efa-i 
3.2.7 150 bp vL3 band: Bm-rps-19 
3.2.8 L4 abundant bands: 525 bp is Bm-cdd-1 




Experimental studies have shown that the transmission of filarial third-stage 
infective larvae (L3) from mosquitoes to their mammalian host and their 
subsequent development are promising targets for control of filarial infections. 
Entry into the mammalian host initiates recovery from an arrested state entered 
during the final stages of development in the vector. After transfer the larvae must 
quickly adapt to their new environment and prepare for the fourth moult 8-9 days 
later (Schacher, 1962). Besides moulting, the vertebrate-derived larvae undergo 
several changes in the definitive host to adapt to the new environment and evade 
immune responses, processes that require induction or down regulation of genes 
essential for their survival and development. Attempts have been made to define 
stage-specific proteins by comparing the total protein of polypeptides expressed by 
different life cycle stages. For example, this approach has been used to compare 
protein expression in filarial larvae as they re-initiate their development after 
transmission to the vertebrate host. These studies have concentrated on both 
surface (Apfel et al., 1992; Lal and Ottesen, 1988; Scott et al., 1990; Storey and 
Philipp, 1992)and secreted molecules (Bianco et al., 1990; Bianco et al., 1995; 
Frank and Grieve, 1991; Hong et al., 1993; Pogonoka et al., 1999; Richer et al., 
1992). Information on these and other larval products will not only add to our 
understanding of the biology of infective larvae but may also identify potential 
targets for drug or vaccine-induced control of infection. 
Despite this, few proteins have been cloned and characterised from the 
infective larval stage. In order to identify abundant, stage-specific transcripts in 
infective larvae, reverse transcriptase-polymerase chain reaction (RT-PCR) has 
been used to amplify total larval RNA using the conserved nematode spliced leader 
(SL1) and oligo(d)T. This technique has been used recently to identify abundant 
transcripts in B. malayi (Scott et al., 1995; Yenbutr and Scott, 1995) and Toxocara 
canis (Gems et al., 1994; Gems and Maizels, 1996). These studies have utilised the 
presence of SL1, a conserved 22 nt sequence trans-spliced onto the 5' end of many 
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nematode mRNAs, to amplify full length cDNAs in combination with a 3' oligo-dT 
primer (Blaxter and Liu, 1996; Nilsen, 1993). In both species several abundant 
bands were apparent when total SL/dT RT-PCR products were resolved on an 
agarose gel. With the assumption that highly expressed genes may play important 
roles in the development of larvae and their establishment in the mammalian host 
this technique has been used to identify abundant transcripts produced by infective 
third stage larvae harvested from the vector mosquito (vL3) 12 days after mosquito 
infection and fourth-stage larvae (L4) recovered 9 days after intraperitoneal 
infection of gerbils, immediately after the third moult. This chapter describes the 




3.2.1 Abundant PCR Products from vL3 and L4 eDNA 
Amplification of vL3 first-strand cDNA with SL and DGDT primers 
produced six distinct bands of 750, 550, 500, 300, 250 and 150 bp super-imposed 
on a smear of less abundant cDNAs on agarose gel electrophoresis (Figure 3.1). 
Parallel PCR of L4 cDNA produced only three visible bands of 300, 525 and 1.1 
kb. Abundant bands were excised from the gel, amplified with a second round of 
PCR with the same primers and directionally cloned into pBluescript using Barn H I 
and Not I restriction sites present on the primers. The 1.1 kb band from day 9 
larvae failed to re-amplify and thus was not analysed further. Multiple clones 
derived from each band were sequenced. A summary of the sequence analysis of 
clones produced by each abundant band is presented in Table 3.1. 
3.2.2 550 bp vL3 Products : Bm-alt-1, cpi-1, rbp-1 and a ribosomal protein. 
Seventeen clones derived from the intense 550 bp vL3 band were analysed 
and found to contain 4 distinct transcripts. Twelve clones represented one 
transcript, have been named Bm-alt-1 (for abundant larvaltranscript-1). A detailed 
analysis of this gene and its protein product is presented in Chapter 5. 
Three additional clones derived from the 550 bp band were found to encode 
a homologue of the cystatin family of cysteine proteinase inhibitors, which has 
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Figure 3.1: Autoradiograph of total SL/oligo-dT RT-PCR products from mosquito-derived larvae 
(vL3) and larvae nine days after infection of jirds. Four microlitres of RT-PCR products were re-
amplified using identical primer and cycling conditions in the presence of 40Ci [32P]dATP. 
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Genbank 	 Relative 	EST abundancet 
Size of band Name 	accession Identification 	 Ab undance* L3 	LA 
Day 0 L3 Bands 
750bp Bm-tph-1 U80971 Translationally controlled tumour 
protein/Histamine releasing factor 8/8 0.20(6) 0.99 (16) 
550bp Bm-alt-1 U57547 D. immitis larval 20/22 kDa protein homologue 12/17 1.39 (33) 0 
Bm-cpi-1 U80972 Cystatin-type cysteine proteinase inhibitor 3/17 0.38(8) 0 
Bm-rbp-1 U80973 Polyadenylation factor/RNA binding protein 1/17 0.39 (12) 1.79 (29) 
Bm-rps-12 U81008 40S ribosomal protein S12 1/17 0.07(2) 0.93 (15) 
500bp Bm-glt-1 ' U80974 6 kDa Gly/Tyr-rich protein 8/11 0.7(13) 0 
Bm-rpp-2 U80977 60S ribosomal protein P2 1/11 0.05(l) 0.86 (14) 
Bm-rpl-44 U80976 60S ribosomal protein L44 1/11 0.05(l) 0.74 (12) 
alt-1(truncated) 1/11 
300bp Bm-col-3 U80975 Collagen 11/12 0.49 (15) 0.19(3) 
Bm-slt-1 U80978 Novel 1/12 0.29 (9) 0.06(l) 
250bp Bm-efa-1 U84736 Elongation factor 1-a 15115 0.26(8) 0 
150bp Bm-rps-19 U80979 40S ribosomal protein S19 ND 0.13(4) 0.25(4) 
Day 9 L4 Bands 
525bp Bm-cdd-1 U80980 Cytidine deaminase 8/8 0 5.9(96) 
300bp Bm-col-3 U80975 Collagen 7/7 0.49 (15) 0.19(3) 
Table 3.1. Summary of clones obtained from abundant bands. * Relative abundance refers to the 
number of clones identified by sequence analysis or hybridisation compared to the total number of clones 
analysed. Number of matches with dbEST as a percentage of 3053 L3 and 1619 IA EST's deposited 
into Genbank by the Filarial Genome Project as of 5.1.00. Total numbers of identical sequences are 
given in brackets. ' Originally termed Bm-alt-3, this sequence have been renamed glt-1 for glycine-
Lyrosine rich protein. 
Gene abbreviations are as follows: 
iph, tumour protein homologue 
alt, abundant larval transcript 
cpi, cysteine proteinase inhibitor 
rbp, RNA-binding protein 
rps-12, ribosomal protein S12 
pp-2, ribosomal protein P2 
rpl-44, ribosomal protein L44 
col, collagen 
sit, small larval transcript 
efa, elongation factor-la 
rps-19, ribosomal protein S19 
cdd, cytidine deaminase 
git, glycine/tyrosine rich 
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Bm-rbp- I 
C. elegans R0983.2 
C. elegans R0983.3 
C. elegans R06CI.4 
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Figure 3.2: Panel A: Alignment of B. malayi RNA binding protein, rbp-1 with members of the cleavage 
stimulation factor/polyadenylation factor families. GenBank accession numbers are as follows: Bm-rbp-
1, U80973; C. elegans cosmid R09B3, Z81108; C. elegans cosmid ROC, Z81106; Drosophilia CSF, 
AF] 70082; Xenopus leavis CSF, UI7394; Human CSF, Z78021. The RNA recognition motif (RNP) is 
boxed in red. Note that only the N-terminal 99 residues of the Drosophilia, Xenopus and human sequences 
are shown in the alignment. Panel B shows that members of the cleavage stimulation 
factor/polyadenylationfactorfamilies are considerably longer and contain auxiliary motifs. 
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10 	20 	 30 	 40 
RS23_BRUMA 	M C K P K G I R A A R K L K T H K Q A  Q R 	D K G Y K K A H L C I R W K A 
RS23_FRAAN M GK TR G MGAA RKL KN HR RRQRHADKS YKK SHL G NE W K- 
RS23_YEAST M C K C K P R G L N S A R K L R V H K R N N R HA  E N N Y KK RLL GT AF K S 
RS23_HUMAN 	M C K C R G L R TA R K L R S H K R DQ K WHDKQ Y KK AHL GT ALKA 
RS23_CAEEL M G K P K G L C T A R K L K T H R Q E Q R WjN D K R Y KK AH I G T RW K S 
50 	 60 	 70 	 80 
RS23_BRUMA NPFGTASHAKCIVLEKVGVEA'KQPNSAIRKCVRVQL IKNG 
RS23_FRAAN KPFAGSSHAKGIVLEKIGI EAKQI'NSAIRKCARVQLIKNG 
RS23_YE4ST S P F G G S SHAKGIVLEKLGI ES KQ}'NSAIRKCVRVQL IKNG 
RS23HUMAN NPFGGASHAKGIVLEKVGVEAKQPNSAIRKCVRVQL IKNG 
RS23_CAEEL NPFGGASHAKGIVLEKIGVEAKQPNSAIRKCVRVQL I K N G 
RS12 SIGNATURE 
90 	 100 	 110 	 120 
RS23_BRUMA KKITAF VP NDGCL NF I  ENDE VL. VA GE CR KGHA VGD IPGV 
RS23_FRAAN KKI AAFVPNDGCLNY I EENDEVL IAGFGRKGHAVGDIPGV 
RS23_YEAST KKVTAFVPNDGCLNFVDENDEVLLAGEGRKGKAKGDIPGV 
RS23_HUMANKKITAFVPNDGCLNFIEENDEVLVAGEGRKGHAVGDIPGV 
RS23_CAEEL KKI TAFVPNDGCLNFVEENDEVLVSGFGRSGHAVGDIPGV 
130 	 140 	 150 	 160 
RS23_BRUMA R F K I V K V A N T S L IALFKGKKERPRS 
RS23_FRAAN RFKVVKVSGVSLLALFKEKKEKPRS 
RS23_YEAST RFKVVKVS G V S L L A L W K E K K E K P R S 
RS23_HUMAN RFKVVKVANV S L L A L Y K G K K E R P R S 
RS23_CAEEL RFKIVKVANTSLIALFKGKKERPRS 
Figure 3.3: Alignment of Bm-RPS-12 (RS23BRUMA) with members of the S12123 family of 
ribosomal proteins. Accession numbers are as follows: RS23_BRUMA, Swiss-Prot P907076; 
RS23_FRAAN, Swiss-Prot P46297; RS23_YEAST, Swiss-Prot P32827; RS23_HUMAN, Swiss-Prot 
P39028; RS23_CA EEL, Swiss-Prot Q19877. The RS12 signature is boxed in red. 
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Of the two remaining 550 bp clones analysed, one is homologous to a 
partial cDNA recently identified in B. pahangi, and encodes a predicted protein 
with extensive similarity to a large family of RNA-binding proteins containing the 
ribonucleoprotein 1 and 2 consensus sequences (RNP- 1 and RNP-2) Which appear 
to be directly responsible for the interaction of the protein with RNA. This 
transcript is therefore termed Bm-rbp-1 ( for RNA-bindingprotein-1). The 
predicted protein shares the greatest similarity to the RNA binding segment of 
cleavage stimulation factors (CSF)/polyadenylation factors (Figure 3.2A). These 
are proteins of around 64kDa and are among the factors required for 
polyadenylation and 3' cleavage of pre-RNAs. In addition to CSFs these RNPs are 
found in more than 1000 proteins catalogued by SwissProt and consist of single or 
multiple N-terminal RNA recognition motifs in combination with other domains 
thought to direct other interactions (Takagaki et al., 1992). Other CSF domains 
include regions rich in one or two amino acids (predominantly Gly and Glu or 
Arg/Ser, Gly/Pro). Additionally, a feature of human CSF is a repeat sequence of 5 
amino acids (MEARA/G) possibly mediating protein-protein interactions. CSFs are 
typically 400-600 residues in length, considerably longer than Bm-RBP-1 which 
has a calculated molecular weight of 9.2 kDa and contains a single RNA 
recognition motif with few additional residues, which are unlikely to contain 
auxiliary motifs (Figure 3.213). Of the homologues found in the database three 
predicted genes from C. elegans are small and contain only the RNP motifs as the 
B. malayi gene. (Figure 3.2B). Bm-rpb-1 encodes an in frame stop codon at bases 
322 - 324. The codon is conserved amongst the ESTs representing this gene. The 
EST sequences do not extend into the poly A tail, it is therefore difficult to assess 
whether Bm-RBP- 1 represents the full length sequence, however the presence of 
the three C. elegans genes also containing a single RNA binding motif would 
suggest that this represents the full length of a novel group of nematode proteins. 
Although the function of these nematode genes is not yet known, their similarity to 
eukaryotic and plant proteins suggests that they play a role in RNA processing and 
gene expression (Heintzen et al., 1994; Nishiyama et al., 1997; Sturm, 1992; 
Takagaki et al., 1992). 
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The second 550 bp sequence is homologous to genes encoding the 40S 
ribosomal proteins S12/23 and is designated Bm-rps-12. One characteristic of this 
group of proteins from the small ribosomal is their high content of basic amino 
acids. Bm-rps-12 has a calculated P1 of 11.0 and contains the ribosomal protein 
Si 2 signature: [RK] -x-P-N-S- [AR] -x-R (Figure 3.3). 
3.2.3 500 bp vL3 Products: g1t-1 and 60S ribosomal proteins P2 and L44 
Of 11 clones obtained from the vL3 500 bp abundant band, 8 represented a 
novel transcript with an unusually long 3' untranslated region, which has been 
termed Bm-glt-1. This gene is further characterised in Chapter 6. 
The remaining clones analysed from the 500 bp vL3 band encoded 
ribosomal proteins L44 (Bm-rpl-44, Fig. 3.4) and P2 (Bm-rpp-2, Fig. 3.5), and a 
truncated form of alt-1 terminating at an A-rich stretch of sequence in which 11/18 
bases are As. It appears that mis-priming of the oligo-dT primer produced this 
clone. 
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C. elegans C37A2.7 H KY L GA T L G AIS P S ADL 
K V L EG L DC D MNA
P. olivaceus RPP -2 	R Y V A A V L G TIS P~AK KA I L G S V G I EA D DR L 
RLA2_HUMAN 	RYVAS ALGS(P KKLLDSVGIEADDDRL 
RLA2_RAT R Y V A S 	 A L GS ]P K K I L D_S V G I EA D DR L 
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RLA2_BRUMA 	
MKV 
 VA L S C K S I D E V I T A C L A K V S S V P S -DmA V S A I A P V V 
C. e!egansC37A2.7 	 V D A L K C K T I S E V I A Q G K V K L S S V P 5 G GA P A A A A P S G 
P. olivaceus RPP -2 	I II1E L N C K D L N E V M N S C L S K L A S V P A C C A TAAP A A A AA 
RLA2HUMAN 	 I SELNCKNIEDVIAQGI GKLASVPAGGAVAVSAAPGS 
RLA2_RAT ISELNGKNIEDVIAQGVGKLASVPAGGAVAVSAAPGS 
90 	 100 	 110 	 120 
RLA2_BRUMA 	S A T P - - - - - - - - - - - - TDALQAGS --------  FK  KGETK- 
C.elegansC37A2.7 G A A P K G K F C F T N Y D P H L K I IHCGARFKISKQYRWPEEKKK 
P.olivaceusRPP-2 A A A G - - - - - - - - - - - - - - AAGAGAAPAAAEE - KE EKK- - 
RLA2_HUMAN 	AAP ----------------- AAGSAPAAAEE-DK
RLA2_RAT AAP - - - - - - - - - - - - - - - - -  AAGSAPAAAEE -DEKK- - 
130 	 140 	 150 	 160 
RLA2_BRUMA 	EGPKEESDEDMGFCLFD 
C. elegans C37A2.7 E
N
P K E E S D D D M G F C L F D 
P. olivaceus RPP -2 - E S E E S D E D M C F C L F D 
RLA2_HUMAN 	- ESEESDDDMGFGLFD 
RLA2_RAT -ESEESDDDMGFGLFD 
Figure 3.4 Alignment of Bm-RPP-2 (RLA2_BRUMA) with members of the P2 family of ribosomal 
proteins. Accession numbers are as follows: RL/t2 BRUMA, Swiss-Prot P90703 ;C. elegans C37A2.7, 
TrEMBL 001504; Paralichthys olivaceus RPP-2; RLA2_HUMAN, Swiss-Prot P05387; RLA2_RAT, Swiss-
Prot P02401. 
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10 	 20 	 30 	 40 
RL44_BRUMA M V N V P KT R R I F TD G K - C R R H I M H K V T Q Y K K G K E S RJJA Q G R 
RL44_CAEEL 	V N V P KR R T F C D G K - C R K H T NHKVT Q Y KK G K E S KIF Q G R 
RL44_YEAST VNVPKTRTYCKGKTCRKHTQHKVTQYKAGKASL FAQGK 
RL44_PICJA 	VNVPKTRRTYCKGKECRKHTQHKVTQYKAGKASL FAQGK 
RL44_PHARH VNVPKTRRTYCKGKACKKHTP HKVTQYKKGKDS I FAQGK 
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RL44_BRUMA RRYDSKQKGFGGQTKP I FRKKAKTTKKI VLRMECTECKHR 




90 	 100 	 110 	 120 
RL44_BRUMA K Q L P IKRCKHFELGGQKKTRGQVIQF 




Figure 3.5: Alignment of Bm-RPP-44 (RL44_BRUMA) with members of the L44 family of ribosomal 
proteins. Swiss-Prot accession numbers are as follows: RL44_BRUMA; P90702, RL44_CAEEL; 
P48166, RL44_YEAST; P02405, RL44_PICJA; P52809, RL44_PHARHA; 059870. 
3.2.4 300 bp vL3 and L4 products: Bm-col-3 and sit-i 
Clones derived from the 300 bp bands from both vL3 and L4 represent a 
transcript with similarity to the signal peptide and part of domain I of the C. 
elegans collagens COL-12 and COL-13 (Johnstone, 1994). Based on this similarity 
this transcript is designated Bm-col-3 (Fig. 3.6). Bm-col-1 and col-2, which 
represent distinct collagen genes, have recently been described. The small size of 
this cDNA compared to other members of the family, the absence of an in-frame 
termination codon and the absence of (Gly-X-Y) n  motifs, typical of collagens, 
suggest that the clone may have been truncated by mis-priming of the oligo-dT 
primer. Seven ESTs identical to Bm-col-3 can be found in dbEST, a consensus of 
which extends the sequence by 81 nucleotides. This extended sequence reveals that 
the SL/dT amplified 300 bp clone is truncated at an A-rich stretch (14/18 bases are 
A), and that the overlap region is identical at the amino acid level to the recently 
described B. pahangi collagen gene Bp-col-1 (Bisoffi and Betschart, 1996). Bp-col- 
. uiv-i 
'Li 
cz'I 	 Page 51 
I appears to be 5' truncated as the start of its translated sequence aligns with 
residue 72 of the Bm-col-3 protein 
A single clone was also isolated from the L3 300 bp band for which no 
identity can yet be given. The longest open reading frame in this sequence is only 
26 amino acids and the sequence is therefore designated Bm-slt-1 (for small larval 
transcript-1) (Fig. 3.7). No database similarities were found other than with a 
family of highly similar ESTs from Brugia Us. The nucleotide composition is 
heavily A/T biased - 74.5% of nucleotides are A or T, a percentage more typical of 
introns in C. elegans (Blumenthal and Steward, 1997) and Brugia (Hammond, 
1994). The EST sequences support the sequence of Bm-slt-1 as many show the 
presence of the SL sequence at the 5' end and also confirm the site of addition of 
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Figure 3.6. Alignment of Bm-COL-3 with its closest collagen homologues. GenBank accession numbers are 
as follows: Bm-COL-3, U80957; B. pahangi, X92099; A. suum Col-6, AF035410; A. suum col C, AJ243805; 
C. elegans cosmid FJIGJJ, U80451; C. elegans cosmid F57B1, Z78064; CCI2_CAEEL, Swiss-Prot P20630. 
Collagen domains are boxed: Gly-X- Y domains in blue, others in red. Conserved cysteines are boxed in green. 
The col-3 consensus sequence was generated from 7 B. malayi ESTs (accession numbers) A1574499, 
AW159925, AWl 79743, AW225450, AW257696, AW043521 and AW 179891). 
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the poly A tail. Taken together these data suggest that sit-i is a real gene and not 
an artifact of the PCR amplification, although identification of the native protein 
will be required to provide conclusive evidence of this. 
	
10 	 20 	 30 	 40 	 50 	 60 
I GGTTTAGTTACCCAAGTTTGA4ATTTTTCGATTAAATTCTTGAACTTGCTGGTAAAAAAAA ATG AAA 
70 	 80 	 90 	 100 	 110 	 120 
APT GAT TGC TTT ATA ATG GAT ATC CAT CAA TTT GPC ATC AAG TTA ACG AAA AAA 
I D C F I H D I H Q F V I K L T K K 
130 	 140 	 150 	160 	170 	180 
AAA AAT TAT GAA AAT TAT TAG CAACTAATCATTATTATTATTGTCGGCTATCGATATTTTGATC 
K N Y E N Y * 
190 	200 	210 	220 	230 	240 	250 
TGTCTCATGCCAATACTAATTAAAATTATGTTCAAAATGCGCCGCTATATTTAATGCTTTTCAAATATACA 
260 	270 	280 
TGAACCAGTGAAAAGAAAAAAAAAAAAAA 
Figure 3.7: Nucleotide and deduced amino acid sequence of Bm-slt-1. The nematode trans-
spliced leader sequence is boxed. 
3.2.5 750 bp vL3 band: Bm-tph-1 
Clones produced from the vL3 750 bp band all appear to derive from the 
same gene. Database searches revealed extensive similarity to translationally 
controlled tumour protein (TCTP), the sequence of which has recently been 
identified as an IgE-dependent histamine releasing factor (MacDonald et al., 1995). 
Characterisation of this gene and its protein product, termed Bm-tph-1 for rumour 
protein homologue), are presented in Chapter 7. 
3.2.6 250 bp vL3 band: Bm-efa-1 
The majority of clones derived from the vL3 250 bp band encoded a protein 
with similarity to elongation factor-la (EF-lct) from a wide range of organisms. 
Comparison of this sequence with its homologue from 0. volvulus (Alarcon and 
Donelson, 1991) shows that this is a truncated product containing only the 5' end. 
(Fig. 3.2.8). EF-la catalyses the GTP-dependent binding of aminoacyl-transfer 
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RNA to ribosomes and in eukaryotes it is the second most abundant protein after 
actin. It is the subject of recent interest because although EF-hxmRNA levels 
correlate with levels of cellular proliferation, it is found in vast molar excess to the 
other essential components of the translation machinery. This has prompted the 
suggestion that EF-la may serve other purposes within the cell such as interaction 
with the cytoskeleton via its binding to actin (Condeelis, 1995). 
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tO 	 20 	 30 	 40 	 50 	 60 
Bm-efa-1 MG KR K T H I N I V V I C H V D S C K S T T T G H L I Y K C G G I D KR T II  
EFI&ac60 M G K E K T H I N I V V I G H V D S G K S T T T G H L I Y K C G G I D K R T IEKFEKEAQEMGKGSFKYAWVL 
EFI&C4.EEL MG K E KJH I N I V V I G H V 19 S G K S T T T G H L I V K C G G I 19 K R T I E K F E K E A Q EM G KG S F K Y A WV L 
EFI&Cd-IICK M G K E K T H I N I V V I G H V D S G K S T T T G H L IYKCGGIDKRTIEKFEKEAAEMGKGSFKYAWVL 
EFIO_XENLA M G K E K T H I N I V V I G H V D S G K S T T T G H L I Y K C G G I D K R T IEKFEKEAAEMGKGSFKYAWVL 
EFII_HUMAN M G K E K T H I N I V V I G H V D S G K S T T T G H L I Y K C G G I D K R T IEKFEKEAAEMGKGSFKYAWVL 
EFI2_MOUSE M G K E K T H I N I V V I G H V D S G K S T T T G H L I Y K C G G I D K R T IEKFEKEAAEMGKGSFKYAWVL 
70 	 80 	 90 	 tOO 	 110 	 120 
Bm-efo- I  
EFlA_Q'CO DKLKAERERGIQ IDIALWKFETPKYYI fl IDAFGHRDF IKNMITGTSQAUCAVLV[ACGT 
EFI&CAEEL 0 K L K A E R E R G I I I 0 I A LW K F K I A K Y Y I T I I 0 A P G H R 19 F I K NM I I C T S Q A D C A V L VV A C G T 
EFI&CMICK DKLKAERERGIT lOIS LWKFETSKYYVTI IDAFGHRDF I K N M I T G T S Q A D C A V L IIVAAGV 
EFIO_XENLA 0 K L K A E R K R G I I I 0 I S LW K F E T S K Y V V T I I D A F G H R 19 F I K N M I T G T S QA D C A V L liv  A A G V 
EFII_I-IUMAN 0 K L K A E R E R G I T I D I S LW K F R T S KY V V T I I 19 A F C HR D F I K NM I T C I S Q A 0 CA V L liv  A AG V 
EFI2_MOUSE DKLKAERERGIT lOIS LWKFETTKYYITI IOAPGHRDFIKNMITGTSQAOCAVLIbLAAGV 






EFIA_CI-IICK PEAGISICNGQTREHALLAYTLGVKQL IVGVNICMDSTEJ'PYSQKRYEEI VKEVSTY IKK
EFIO_XENLA 	 FEAGIS KNGQTREHALLAYTLGVKQL IVO I NKMOSTEFPYSQKRYEEIVKEVSTYIKK
EFII_HUMAN 	 FEAG IS KNGQTREHALLAYTLGVKQL IVGVNKMDS TEPPYSQKRYEE I VKEVSTY IKK
EFI2_MOUSE 	 FEAGIS KNGQTREHALLAYTLGVKOL IVGVNKMDSTEFAYSEKRYDEIVKEVSAY IKK 
190 	 200 	 210 	 220 	 230 	 240 
Bm - ela - I 	_ _ 	_ ___ _____________ 	_________________ 	 ____________ 
EFIA_GrICO IGVNPKS I PFVP ISGFNGDNMLEP SANMFWFKGWSVERKEGTMTGKTLLEALDSVVPPQR 
EFI&CAEEL IGYNFKAV PIP VP ISGFNGDNMLEVS  SIN MPWF KGWAVERKEGNA SGKTLLEALDS II PPQR 
EFIA_CI-IICK IGYNFDTVAFVP ISGWNGDNMLEPS  IN MPWFKGWKVTR KID GNASGTTLLEALDCI LPPTR 
EFIO_XENLA IGYNPDTVAFVP ISGWNGDNMLEPS  PIN MPWFKGWKITRKEGSGSGTTLLEALDCI LPFSR 
EFII_HUMAN I G Y N P C T V A F V P I S C W N C 0 N M L K P S A N M F W F K G W K V T R K D G N A S C T T L L E A L D C I L F P 1 R 
EFI2_MOUSE IGYNPATVPFVP_ISGWHGDNMLEP SPNMFWF_KGWKVERKEGNA SCVS 
LL 
 EALDT I LPPTR 
250 	 260 	 270 	 200 	 200 	 300 
Bm-efa- I __ _  
EFIA_ONO PTDKPLRLFLQDVYKIGGIGTVPVGRVETGI LKPGMIVTFAFQNLTTEVKSVEMHHEALQ 
EFIA_CAEEL LPT RPLRLPLQDVYKIGGIGTVPVGRVETGI I KPCMVVTFAPQNVTTEVKSVEMHHESLP 
EFIA_CI-IICK KPLRLPLQDVYKIGG IGTVFVGRVETGVLKPGMVVTFAPVNVTTEVKSVEMHHEALS 
EFIO_XENLA 	 KPLRLPLQDVYKIGGIGTVPVGRVETCV IKPGMVVTFAPVNVTTEVKSVEMHREALT 
EFII_HUMAN 	 KPLRLPLQDVYKIGG IGTVPVGRVETGV LKPGMVVTFAPVNVTTEVKSVEMHHEALS 
EFI2MOUSE 	 KPLRLPLQDVYKIGGIGTVPVGRVETGI LRFGMVVTFAPVNI TTEVKSVEMHHEALS 
310 	 320 	 330 	 340 	 350 	 360 
Bm-efa- I 	 ________ ____________ 
EFIA_a\YJVO EALPGDNVGFNVKNI S IKDI RRGSVASDSKNDPAKETKMFTAQVI IMNHFGQISAGYTPV 
EFI&CAEEL KAVPGDNVGFNVKNVSVKDIRRGSVC SID SKQO PIA KEARTFHAQVI IMNHPGQISNGYTPV 
EFIA_CHICK EALFGDNVGFNVKNVSVKDVRRGNVAGDS KNDPPMEAAGFTAQVI ILO6HPGQISAGYAPV 
EFIO_XENLA EAVPGONVGFNVKNVSVKDVRRGNVAGDS KNDPI'MEAGSFTAQVI ILNHPGQIGAGYAFV 
EFII_HUMAN EALPGDNVGFNVKNVSVKDVRRGNVAGDS KNDFPMEAAGFTAQV I ILNHPGQIS AGYAPV 
FF12_MOUSE RALPGDNVGFNVKNVSVKDI RRGNVCGDSKADPPQEAAQFTSQVI_ILNHPGQISAGYS PV 
370 	 380 	 390 	 400 	 410 	 420 
Bm-efa- I 	_ __ 
EFIA_O'tCVO LDCHTAHIACKFARLKEKVM
DR
SGKKVEDNPKSLKSGDAI3I lOLl PTKFLCVETFTEYPP 
EFIA_CAEEL LDCHTAHIACKFNELKEKV TGKKVEDPPKF LKSGDAGIVEL I PTKPLCVES FTDYAP 
EFIA_CHICK LDCHTAHIACKFAELKEKI SGKKLEOGPKF LKSGDAAIVDMI PGKPMCVES FSDYP
EFIO_XENLA LDCHTAHIACKFARLKRKI SGKKLEDNFKF LKSGDAAIVDMI FGKPMCVES FSDYP
EFII_HUMAN LDCHTAHIACKFAELKEKI SGKKLEDGPKF LKSGDAAIVDMVFGKPMCVES FSDYP
EFI2_MOUSEI DCHTAHIACKFAELKEKI SGKKLEDNPKS LKSGDAAIVEMVPGKPMCVES FSQYP P 




EFIA_CI.CVO 	 RFAVRDMRQTVAVGVIKNVDKS KG -VGKVQKAAQKAGVGGKKK 
EFIA_GAEEL RFAVRDMRQTVAVGVIKSVEKSDGSSGKVTKSAQKAAP - - KKK 
EFIA_CHICK 	 RFAVRDMRQTVAVGVIKAVOKKAGGAGKVTKSAQKAQKAK 
EFIO_XENLA RFAVRDMRQTVAVGV I KAVEKKAAGSGKVTKSAQKAAKTK 
EFII_HUMAN 	 RFAVRDMRQTVAVGVIKAVDKKAAGAGKVTKSAQKAQKAK 
FF12MOUSE 	 RFAVRDMRQTVAVCVIKNVFKKSGGAGKVTKSAQKAQKAGK 
Figure 3.8: Alignment of Bm-EFA-1 with members of the elongation factor-alpha family. Accession 
numbers are as follows: Bm-EFA-1; U84736, EFIA_ONCVO;Swiss-Prot P27592, EFIA_CAEEL;Swiss-
Prot P27592, EFIA_CHJCK;Swiss-Prot Q90835, EFIO_XENLA;Swiss-Prot P13549, 
EFIA_HUMAN;Swiss-Prot P28347, EFI2_MOUSE;Swiss-Prot P10126. 
Page 56 
3.2.7 150 bp vL3 band: Bm-rps-19 
Clones produced from the 150 bp band were homologues of the small 
ribosomal subunit S19. The predicted protein aligned with the first 22 residues of 
the Ascaris suum S19 protein but was truncated by mis-priming of the oligo dT 
primer (Fig. 3.9). The corresponding section in A. suum gene is particularly A-rich 
at this point. The A. suum gene RS19G is one of the genes eliminated by 
chromosomal diminution, the discarding of genomic DNA from presomatic cells 
during embryonic development (Etter et al., 1991). A second slightly diverged 
gene, AS 19S, is retained in somatic cells (Etter et al., 1994). The elimination of 
DNA encoding genes from presomatic cells is thought to mediate a switch in which 
ribosomes are initially composed of the RS19G product but contain RS19S in 
somatic cells representing an alternate method of gene regulation. 
10 	 20 	 30 	 40 	 50 
Bm- rps - l 9 EMVKPITSVKDVDQUEMEJKH[FX1
HFLKK SG K RSI9_CAEEL 	 AlT S QJK U V U Q II K A T K S I A H     	V K V P K W S U L V K L G V N K£LAPVD 
RI9G_ASCSU 	 A(]S V K D V U Q H K I V Q H I A KL K K S G K V K V P E W S U V T KM G I S K K L A F L N 
RI9S_ASCSU 	 QPISVKUVDQIIE I VRY lAGLKKSGKVKVPEWSDLVKLGI TKELAFVD 
60 	 70 	 80 	 90 	 100 
Bm- rps-19 
RSI9_CAEEL PDWFYTRAASLARHLYFR- FAG IGAFKKVYGGNKKRGVAPNHFQTSAGNC 
R19G_ASCSU SDWYYVRTAS I ARK LYVRS PTGVDALR LVYGGS KRRGVV PP411FAKA SGS V 
RI9S_ASCSU SDwYYVRTASVARRLYIRS FTGVGALRRVYGGNKRRGVTFNI1FARASGS 
S19 SIGNATURE 
110 	 120 	 130 	 140 	 150 
Sm- rps-19 
MKA 
RSI9_CAEEL LVQQLEKIKWVEKHPDGKGRI E TIKQGRKDLDRJATSLItSSGQQA 
RI9G_ASCSU ILQT LEA IKWVQKUPDGNGRVKQGRKDLDR IASQMRQNDR PTA 
RI9S_ASCSU IL TLEAIKWVEKHPDGNGRITKQGRKULDRIASQMRQNTKI T L E P 
Figure 3.9: Alignment of Bm-RPS-19 with members of the ribosomal protein family S19. 
Accession numbers are as follows: Bm-RPS- 19, GenBank U80979; RSI 9_CA EEL, SwissProt 018650; 
RI9G_ASCSU, SwissProt P24494; RI9S_ASCSU, SwissProt P39698. The S19 signature is boxed. 
3.2.8 L4 abundant bands: 525 bp is Bm-cdd-1 
The major component of the abundant L4 525 bp band encodes a 
homologue of cytidine deaminase (cdd) and has been designated Bm-cdd- 1. The B. 
pahangi homologue of this gene has previously been cloned (Martin et al., 1996). 
The predicted protein product of this transcript contains conserved cysteine 
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residues thought to mediate binding to the catalytic zinc ion (Fig. 3.10). The B. 
malayi and B. pahangi sequences differ in only one reside out of 132. Asp-57, a 
common amino acid at this position in other organisms, is encoded by the B. malayi 
sequence, and serine in B. pahangi. To assess whether this is a position of natural 
variation in the Brugia sequences ESTs representing the B. malayi sequence were 
analysed: all ESTs encoded an asparagine at position 57. 
Cytosine delaminate was originally identified as part of the pyrimidine 
salvage pathway via its ability to convert cytidine to undine. However, recently it 
has been shown to be the enzyme responsible for producing an alternatively edited 
form of apolipoprotein B mRNA by converting a cytidine to uridine, thereby 
forming an in-frame stop codon. Given these functions, the stage-specificity of 
CDD expression in filariae (our data and (Martin et al., 1996)) is intriguing and 
may indicate a period of intense gene expression in post-parasitic larvae via its role 
in a salvage pathway. Recombinant CDD from B. pahangi has been shown to bind 
AU-rich RNA templates (Anant et al., 1997). It was additionally found to bind 
apolipoprotein B mRNA but failed to edit the transcript. Given the overall high AT 
content of the filarial genome (Hammond, 1994) this may indicate a general role in 
regulating the stability of mRNA rather than editing RNA templates. 
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Figure 3.2.10: Alignment of Bm-CDD-1 with cytidine dearninanses. Accession numbers are as follows: 
Bm-CDD- 1, TrEMBL P90706,- Bp-CDD-1, TrEMBL Q93143; Thermotoga ,nariti,na, GenBank AE001751; 
C. elegans cosmid F49E8, U61949, C. elegans cosinid C47D2, U64861; CDD_BACSU, Swiss-Prot 
P19079; CDD_HUMAN, Swiss-Prot P32320. The zinc-binding region is underlined in blue and the 
potential coordinating cysteines are marked with an asterix. The potential N-glycosylation site in the B. 
nzalayi sequence is arrowed. In the B. pahangi sequence the site is absent as asparagine is replaced with a 
serine. 
3.2.9 Stage-Speci fic Expression of Abundant Transcripts 
The assignation of alt-1, gil- 1, cpi-i and cdd-1 as stage-specific abundant 
transcripts was confirmed by PCR amplification of these genes from cDNA 
libraries taken from each stage of the B. malayi life cycle. Gene-specific primer 
pairs were designed to amplify the region of cDNA predicted to encode the mature 
protein. Each primer pair was used to amplify genomic DNA and cDNA. In each 
case the genomic product was larger suggesting the presence of introns within each 
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cdd- 1  
tph-1 
mf 	L3 	L4 Adult 
Figure 3.11: A survey of the stage-specificity of the abundant transcripts using cDNA libraries 
from niicrofilariae (mf), infective larvae (L3), day 10 larvae (LA) and adult male (Adult) as 
templates. 
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Using cDNA libraries donated by the Filarial Genome Project as templates, 
expression of alt- 1, glt-I and cpi-2 is shown to be restricted to the L3 stage 
(Fig.3.11). In contrast tph-1 is expressed at comparable levels in all stages, as 
represented by their cDNA libraries. Identical results were obtained using the same 
tph primers to amplify poly-A primed first strand cDNA from Mf, L3 and mixed-
stage adults (Zang et al., 1999). RT-PCR analysis of RNA extracted from L3 
harvested from jirds at daily intervals post infection shows that as early as 24 hours 
after infection RNA levels of alt-i and cpi-2 have fallen below the detection limit 
of the assay (see Chapters 5 and 4 respectively) indicating tight control of 
expression, possibly under the influence of mammalian host factors. Although 
cytidine deaminase appears highly represented in the L4 library, weaker cdd-1 
products are present in all the other libraries. 
Some indication of stage-specificity for related transcripts has previously 
been reported in other filarial species. For example, the alt-1 homologue in D. 
iinmitis is expressed only by vector-borne L3 and during the early part of L3 
development in mammalian culture conditions (Frank et al., 1996). In B. pahangi, 
cdd was identified in a screen designed to select transcripts up regulated in post-
parasitic Ds after entry into the mammalian host (Martin et al., 1996). More 
broadly, the Filarial Genome Project provides data on clone frequency in libraries 
from each stage of B. inalayi, which are fully consistent with the results reported 
here. Thus, alt-1 has been identified 33 times in randomly picked clones from L3 
libraries, but not once from other life cycle stages. Similarly cpi-i and glt-i have 
only been identified as ESTs in L3, and Bm-cdd-I only in the L4 library, from 
which it has been sequenced 96 times. 
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Mosquito-stage larvae of lymphatic filariae develop primarily within the 
fight muscles of their vector species becoming infective to the mammalian host at 
around 8 - 10 days post infection. At this point larvae (vL3) are large, measuring 
1.4 - 1.9 mm in length and must reside within the mosquito until the next blood 
feed without harming its host. Because transmission to the mammalian host cannot 
be predicted the larvae must also be ready to respond to a sudden and dramatic 
change in environment. The thirteen genes identified here may offer clues to this 
success. Within this small sample of genes are a number of stage-specific 
transcripts, many of which contain secretory leader peptides and are therefore likely 
to be localised the cuticle or secreted by the parasite. 
The presence of an abundant collagen transcript in vL3s is noteworthy since 
cuticle synthesis was not thought to occur in the developmentally-arrested L3 stage 
present in the vector mosquito. Collagen synthesis is also unexpected in day 9 L4s 
and in day 25 adults, as these parasites have completed the third and fourth moults 
respectively. Although Howells and Blainey (Howells and Blainey, 1983) have 
suggested that growth between moults is accomplished largely by stretching a pre-
formed, highly annulated cuticle, the abundance of collagen at these time points 
does suggest a role in growth or thickening of the cuticle between moults. In C. 
elegans it has been demonstrated that collagen genes are transcribed in a carefully 
controlled temporal cycle, which repeats within each intermoult period. The timing 
of the B. nialayi moult is obviously longer (8-9 days between moults rather than 6-
10 hours) but expression of specific collagen genes at this early intermoult time 
may indicate a similar extended patterning in B. malayi collagen gene transcription. 
In addition ESTs representing the Bm-col-3 gene have been sequenced from day 10 
and day 25 post-infection libraries in addition to vector-derived Us. Larvae at 
day 10 and day 25 post-infection have largely completed the third and fourth moults 
respectively, further suggesting that significant collagen synthesis occurs after 
moults, and, that in day 25 parasites this synthesis is not contributing to synthesis of 
completely new cuticle. 
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Using small quantities of parasite RNA it has been demonstrated that 
developmentally regulated larval transcripts can be cloned simply by ligation of 
gel-purified abundant SL/dT amplified RT-PCR bands from agarose gels. A 
similar approach has been reported by Yenbutr and Scott (Yenbutr and Scott, 
1995), who by isolating a 1.4 kb abundant SL RTIPCR band from vL3 cloned a 
mixture of transcripts. Two technical points seem worthy of comment. First, in 
this study less variety was observed within each gel-isolated abundant band when 
compared with Yenbutr and Scott. This is most likely due to the re-amplification of 
isolated bands prior to restriction digestion and ligation in our protocol. Secondly, 
truncated transcripts have been identified due to mis-priming of the oligo-dT primer 
to A-rich stretches. This is likely to remain a minor limitation to the technique. On 
the other hand, there appears to be little mis-priming of the SL primer, as the 5' 
ends of each newly determined sequence showed good alignment with the 5' ends 
of the homologues deposited in various databases. 
It is noteworthy that several transcripts identified repeatedly by EST 
sequencing of the B. malayi L3 library (Williams et al 2000) were not identified in 
this study. Such transcripts may lack a transpliced leader sequence or be obscured 
by abundant bands of similar size. Bm-tpx-2 is a member of the thioredoxin 
peroxidase family of antioxidant proteins (Ghosh et al, 1998) and represents 0.85% 
of ESTs from the L3 library, much lower than those representing alt-i or alt-2 
(Williams et al, 2000). None of the clones sequenced represented tpx-2, which may 
be due to the tpx-2 (714bp) band being obscured by the tph-1 (728) band when 
resolving the SL-dT produced on a gel. Although all clones generated from this 
band were not sequenced all were positive when screened by PCR using tph-
specific primers. Resolving the SL-dT products on a larger, higher resolution gel 
will no doubt allow the identification of more transcripts. Another abundant 
transcript identified by EST analysis is a member of the ancylostoma secreted 
protein (asp) family (Hawdon et al, 1996). This transcript is not transpliced and 
would therefore not be identified in SL-dT products. 
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A highly abundant member of the alt family, alt-2, was not identified in this 
study despite being EST sequenced many more time than alt-i. The alt-i and alt-2 
transcripts are similar enough in size that they would not be distinguished by the 
agarose gel electrophoresis used in this study. It is possible that there were alt-2 
transcripts in the 550bp band but were not cloned and sequenced because they were 
hybridisation positive for alt-i due to their high level of homology to each other at 
the nucleotide level. To avoid this situation more clones generated from each 
excised band should be sequenced, ensuring variant transcripts of similar size are 
identified. 
The gene-first approach of this study is an important component in 
identifying proteins of significance in parasitic infections, especially where limited 
access to parasite material precludes comprehensive developmental and 
biochemical studies. The data presented here suggest that by using this approach 
genes of importance in development can be identified, and that there may be an 
important bias towards these. Of the 7 most abundant transcripts reported here, 4 
contain potential hydrophobic signal sequences and 5 are developmentally 
regulated. As the Filarial Genome Network rapidly expands our inventory of 
parasite genes, analysis of developmental expression patterns will be an 
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The human filarial nematodes B. malayi and W. bancrofti together account 
for the majority of human filarial infections (Michael et al., 1996). They are 
complex multicellular parasites capable of surviving for 10 years or more in their 
definitive host. During most of this time they reside in the host lymphatic system 
provoking a vigorous immune response characterised by extraordinarily high levels 
of IgG4 and IgE antibodies and the presence of specific, cytokine secreting, T cells 
incapable of proliferation (Maizels et al., 1995). It has been suggested that these 
parasites must not only protect themselves from attack from the immune system but 
probably manipulate the immune system in order to survive (Maizels et al., 1993). 
The cystatin family of cysteine protease inhibitors are candidate molecules with 
potential for interfering with the immune system. As broad inhibitors of cysteine 
proteases that have the capacity to bias the antigen processing capacity of antigen 
presenting cells (APCs). With the identification of a cystatin-type cysteine protease 
inhibitor among the abundant infective larval cDNAs we sought to characterise its 
protein product along with a second distinct cystatin identified through EST 
sequencing. 
The cystatin superfamily constitutes a large and diverse group of cysteine 
protease inhibitors found in the tissues and body fluids of mammals as well as 
insects, reptiles, plants, fish, and helminths (Barrett, 1987; Barrett et al., 1986; Turk 
et al., 1997; Turk and Bode, 1991). They can be grouped into three distinct families 
thought to have evolved from a common ancestor. Stefins or family 1 cystatins are 
about 100 amino acids in length and lack carbohydrates and disulphide bonds. 
Cystatins, or family 2 cystatins are slightly larger, disulphide-bonded, secreted 
molecules. Kininogens are much more complex plasma glycoproteins containing 
two or three contiguous cystatin domains followed by an additional domain that 
contains the bradykinin sequence. The precursor molecule is processed releasing the 
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Figure 4.1. Schematic representation of the cystatin superfamily. Cystatins and the homologous 
cystatin domains within kininogens are shown in blue. Alternate splicing of the same gene forms 
the high (HK) and low (LK) molecular weight kininogens. The C-terminal segment (in orange and 
not shown to scale) contains the kin in segment (in red). Intrwnolecular disulphide bonds are also 
shown. 
Possible Roles for Family 1 and 2 Cystatins 
The cystatins are well-characterised inhibitors of the papain-like (Cl) 
family of cysteine proteases that includes the lysosomal cathepsins B, C, H, L, S 
and K that are important mediators of intracellular proteolysis. Recently some 
cystatins have also been shown to inhibit legumain, a member of the unrelated 
C13 family of cysteine proteases (Chen et al., 1997). Legumain is an asparaginyl 
endopeptidase with a strict specificity for the hydrolysis of bonds on the carboxy 
side of some, but not all, asparagine residues in a protein (Dando et al., 1999), 
quite different from the bonds hydrolysed by cathepsins. This enzyme has 
previously been described only in plants and Schistosoma mansoni. In S. 
mansoni it is involved in the degradation of host haemoglobin, probably by 
activating enzymes involved in the proteolysis (Dalton et al., 1995). 
A number of physiological functions have been proposed for cystatins. 
Their role in metastasis has been extensively studied. Some reports have 
Page 67 
described increased levels of cystatins in metastatic tumours (Kos et al., 1998; 
Kuopio et al., 1998). Cystatin genes have also been identified as transcripts down 
regulated in tumours in comparisons with their normal, matched tissue (Shiraishi 
et al., 1998; Sotiropoulou et al., 1997). Stable transfection of cystatin C cDNA in 
melanoma cells led to decreased invasiveness in vitro (Coulibaly et al., 1999; Cox 
et al., 1999). These studies indicate that some tumours use cysteine proteases to 
invade tissues and that this activity is regulated by cystatins. In perhaps an 
analogous situation, cystatin C appears to have a critical role in regulation of 
cathepsins B and L secreted by trophoblast giant cells during invasion of the 
uterine stroma (Afonso et al., 1997). 
Cystatins have been shown to be involved in other protease-dependant 
processes such as inhibition of viral replication (Aoki et al., 1995; Cimerman et 
al., 1996; Collins and Grubb, 1998; Garcia et al., 1993; Korant et al., 1985), and 
bacterial replication (Naito et al., 1995) and resorption of bone by osteoblasts 
(Lerner et al., 1997). They are also insolubly cross-linked into cornified 
envelopes, specialised structures cross-linked by transglutaminases that form a 
rigid barrier over epithelial cells producing a vital barrier for the tissue below 
(Steinert and Marekov, 1997; Takahashi et al., 1996). 
Interestingly, mutations in the two human cystatin genes associated with 
disease cause specific neuropathologies. One of a number of single point 
mutations in the stefin B gene is associated with a rare form of inherited epilepsy, 
known as progressive myoclonic epilepsy of the Unverricht Lundborg type 
(Pennacchio et al., 1996). Cystatin C deposited in the small blood vessels is 
found in the brains of Icelanders affected by a genetic disease that leads to fatal 
cerebral haemorrhages. As well as being truncated at the N terminus by 10 
residues the precipitated protein was found to contain a G1n 68 -* Leu substitution 
(Ghiso et al., 1986). 
Roles for cystatins in the immune system have also been described. 
Native, full length, cystatin C has been shown to inhibit phagocytosis by human 
polymorphonuclear neutrophils (Barna and Kew, 1995). Incubation of mouse 
Page 68 
peritoneal macrophage with cystatins, stefins and kininogens has been shown to 
cause the release of nitric oxide (Verdot et al., 1996). 
Functions of Cystatins and Cysteine Proteases in the Immune System 
Cysteine proteases participate in the generation of class 11-peptide 
complexes in antigen presenting cells (APCs) at two critical points and it is 
probable that cystatins contribute to the regulation of this proteolysis. Firstly, the 
majority of antigens taken up via the endocytic pathway must be degraded in 
compartments of the endosome/lysosome system before being complexed with 
MHC class II c4 heterodimers (Watts, 1997). The lysosomal cysteine proteases 
have been implicated in this degradation on the basis of their localisation in the 
lysosomes of antigen presenting cells and use of cysteine protease inhibitors 
(Chapman, 1998; Watts, 1997). Control of this proteolysis may also be important 
to the outcome of an immune response because cathepsins are also capable of 
destroying T cell determinants leading to a decreased response to the epitope 
(Deussing et al., 1998; Vidard et al., 1991). There appears to be considerable 
redundancy of the proteases generating peptides as APCs from mice lacking 
either cathepsin B or the aspartyl protease cathepsin D show no impairment in the 
presentation of several model antigens (Deussing et al., 1998). 
Legumain/aspariginyl endopeptidase is also capable of digesting antigens for 
class II presentation (Manoury et al., 1998). 
Secondly, loading of class II molecules with foreign peptides cannot take 
place unless the invariant chain (Ii) is first removed from its peptide binding 
groove. Ii forms a complex with class II molecules and targets them to the 
endocytic pathway preventing them from binding to endogenous peptides. 
However when the complex reaches the endosomes, which are rich in processed 
exogenous antigens, Ii is sequentially degraded. Several cathepsins have been 
implicated in this processing with cathepsin S playing a key role, as it is the only 
protease identified so far capable of fully degrading Ii. LHVS, a specific 
inhibitor of cathepsin S prevents the complete degradation of Ii resulting in the 
down regulation of cell-surface class II (Riese et al., 1996). Recently it has been 
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shown that the developmentally regulated ability of dendritic cells to present 
class-IT peptide complexes on their surface is related to their inability to process 
the invariant chain. Alterations in expression and localisation of cystatin C 
probably regulate cathepsin S activity and thus ultimately control the fate of class 
II molecules (Pierre and Mellman, 1998). 
The outcome of an immune response is also affected when cathepsin S is 
inhibited. Mice treated with LHVS were immunised with either ovalbumin or the 
T cell independent antigen TNP-ficoll. Antibody levels to ovalbumin, but not 
TNP-ficol, were decreased in LHVS-treated animals. In a mouse model of 
pulmonary hypersensitivity, treatment ablated a rise in IgE titres and profoundly 
blocked eosinophil recruitment to the lung (Riese et al., 1998) and mice 
genetically deficient in cathepsin S are protected against collagen-induced 
arthritis (Nakagawa et al., 1999). 
The blocking of cathepsin B activity in mice infected with Leishmania 
major has profound effects on the immune response. Susceptible BALB/c mice 
completely controlled the infection when treated with the inhibitor. The immune 
response towards the parasite paralleled resistant strains of mice by mounting a 
Th-1 type response although untreated, susceptible BALB/c mice mount a Th-2 
type response to the infection (Maekawa et al., 1998). 
Structural Studies 
Structurally cystatins and stefins are well-characterised proteins consisting 
of five anti-parallel n-pleated sheets, which are wrapped around a central (X-helix. 
Three regions of high amino acid conservation are brought together creating . a 
three-point interaction between inhibitor and protease active site cleft (Bode et 
al., 1985; Stubbs et al., 1990). The contact points correspond to the extremity of 
the N-terminal region, a central hairpin loop and a further C-terminal loop. The 
N-terminal section adopts no regular conformation in solution but is thought to 
interact with residues just outside the active site cleft of target protease after 
binding (Lindahl et al., 1994). Mutagenesis and deletion of these residues have 
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demonstrated that this region makes a strong positive contribution to protease 
binding affinity. The N-terminal 10-12 residues are not only necessary for high 
binding affinity but can also determine the specificity of interaction with a range 
of cysteine proteases (Estrada et al., 1998; Hall et al., 1993; Hall et al., 1995; 
Mason et al., 1998; Shibuya et al., 1995). These studies have demonstrated an 
important role for the wholly conserved g!ycine positioned 10-12 residues from 
the N-terminus. This is thought to confer structural flexible to the N-terminal 
residues due to its lack of any side chain. 
Inhibitory site for 
	
papain-like endopeptid ses 	 PWLN 
QLVSCJ 
GIy-9 	 / 




(analogous to K/N-89 polymorphic 
residue in Bm-CPI-2) 
Figure 4.2. Notable features of cyatatin family members:. Image created in MolScript using co-
ordinates for the X-ray crystal structure of chicken cystatin (JCEW,). Regions involved in the 
inhibition of papa in-like cysteine endoproteases and legunain are indicated. The proposed 
legunzain-binding motif is only found in a subset of cystarins. The polynorp/zic residue KIN-89 
found in Bin-CPI-2 and onchocystatin sequences aligns with Ser-49 using ClustalW multiple 
alignment. Polymorphism in the chicken Ser-49 has not been reported. The two chicken 
disulphide bonds are shown in purple 
The central conserved region which form part of the protease-binding site 
adopts a hairpin loop structure. The most common sequence at this point is Glu-Val-
Val-Ala-Gly although the end residues are the only ones strictly conserved in all 
members of the superfamily. Mutational studies on this loop have shown that Ki 
values can be reduced 10 —1000 fold by changing the conserved glycine residue. The 
largest decreases in affinity are seen with cathepsin B with inhibition of papain being 
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similar to the wild type protein and cathepsin L being insensitive to these mutations 
(Auerswald et al., 1992; Genenger et al., 1991). 
Cystatins from Parasites 
A wide range of cysteine proteases has been reported from parasitic 
nematodes (Tort et al., 1999) and it is possible that cystatins serve to control these 
activities. Specific functions for these proteases are not yet well defined but they can 
be expected to be involved in host invasion, migration, nutrition, development and 
perhaps immune evasion. 
Cystatins have been reported in other human-infecting filariae, 0. volvulus 
and in the rodent filariae A. viteae. In 0. volvulus it has been suggested that 
onchocystatin controls the activity of cysteine proteases known to be involved in the 
moulting process (Lustigman, 1993; Richer et al., 1993). The protein has been 
localised to 'lakes' formed between the old and new cuticles prior to ecdysis 
(Lustigman et al., 1992). In A. viteae the onchocystatin homologue is released by 
parasites maintained in culture which prompted Hartmann and colleagues to look at 
the effect of the protein on host cells. They found that the recombinant protein 
suppressed both polyclonal and antigen-specific proliferation of mouse splenocytes 
and T cells. The recombinant also induced the release of IL-10, but not IL-4 or IFN-
y from splenocytes (Hartmann et al., 1997b). IL-10 produced by Th-2-like cells in 
response to B. malayi antigen has been shown to have a down-regulatory effect on 
Th-1-like responses (Mahanty et al., 1997). Sequences of cystatins have also been 
reported from the sheep parasite, Haemonchus contortus (Newlands. and Skuce, 
unpublished, accession number AF035945) and the free-living nematode C. elegans 
that contains two related cystatin homologues (WormPep R01B 10.1 and K08B4.6). 
With the identification of one B. malayi cystatin gene as a stage-specific 
gene along with a second distinct cystatin discovered through EST sequencing 
(Blaxter et al., 1996) we set out to characterise these gene products with the 
speculation that these proteins are candidate parasite molecules capable of 
modulating APC and T cell function. 
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RESULTS 
4.2.1 Isolation and Sequence Analysis of Bm-cpi-1 and Bm-cpi-2. 
The cystatin gene Bm-cpi-1 was originally identified by its high level of 
expression amongst mRNA transcripts from the infective, mosquito-borne B. 
malayi larvae (Chapter 2 and in (Gregory et al., 1997)). This cDNA consists of 
526 bp encoding a predicted protein of 127 aa (Fig 4.3). The 5' end of the gene is 
trans-spliced with the 22-nt nematode spliced leader sequence (SL-1). The SL-1 
sequence is followed immediately by a start codon and a region of 19 aa predicted 
to form a signal peptide (von Heijne, 1986). The calculated molecular weight of 
the mature protein is 12.1 kDa and it has an estimated p1 of 9.34. 
A search of the Filarial Genome Project EST dataset in dbEST 
confirmed the abundance of cpi-1 (8/3,051 L3 ESTs, 0.3%). This search also 
identified 13 related cystatin ESTs representing a gene with homology to 
onchocystatin, which was designated Bm-cpi-2. In contrast to the cpi-1 ESTs 
which were derived solely from libraries constructed from vector-derived L3 
mRNA, the cpi-2 ESTs were obtained from libraries constructed from post-
parasitic (day 6) U's, adult male and female libraries as well as the L3 library. 
Brugia ESTs representing either cpi-1 or cpi-2 were the only sequences with 
cystatin homology found in the database. One clone, (SW3ICA038, GenBank 
accession number R47534) containing a 5 'spliced leader sequence and a 3 'poly A 
tail and presumed to represent the full-length cpi-2, was obtained from the Filarial 
Genome Consortium as a PCR product generated from amplifying the clone using 
T7 and T3 vector primers. This was ligated into the T-ended vector pMOS blue 
(Amersham). Three clones were selected for sequencing and were found to be 
identical. The insert of 711 bp contained an open reading frame representing 161 
aa. The translated sequence is shown in Fig. 4.4. 
The cpi-2 eDNA is similarly trans-spliced with SL-1, contains a 
predicted signal peptide starting 34 bp downstream of the SL-1 sequence, and 
encodes a mature protein of 136 amino acids (Fig 4.4). The calculated molecular 
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weight of the mature protein is 15.6 kDa with an estimated p1 of 6.51 after 
removal of the 25 aa signal peptide. 
Homology searches using the BLAST algorithm identified both CPI-1 
and CPI-2 as most closely related to family 2 cystatins (Fig. 4.5). Mature CPI-1 
and -2 are 20% identical at the amino acid level and contain the highly conserved 
cystatin motif Q-X-V-X-G and the P-W pair (Fig. 4.3 and 4.4). Notably, CPI-2 
contains a SND motif, which has recently been implicated in the inhibition of 
legumains (asparaginyl endopeptidases), by chicken cystatin C (Alvarez-
Fernandez et al., 1999). This motif is absent from CPI-1. 
Excluding the reported nematode genes, the closest matches to CPI-1 at 
the protein level are cystatins from the common carp (31.5% identity) and the 
African puff adder (34% identity). The closest human cystatin homologue is 
cystatin ElM (31% identity). The closest matches to CPI-2 are the three human 
salivary cystatins S, SN and SA (28-30% identity). In common with other filarial 
cystatins (Hartmann et al., 1997b; Lustigman et al., 1991) both B. malayi CPI's 
contain only 2 cysteine residues capable of forming a disulphide bond and 
consequently lack the second C-terminal cysteine residue pair that spans the P-W 
residues in all non-filarial family 2 cystatin sequences identified so far (Fig. 4.5) 
A noticeable feature of Bm-CPI- 1 is the absence of an evolutionarily 
conserved glycine residue near the N-terminus. This was confirmed by 
sequencing multiple clones and by examining ESTs corresponding to Bm-CPI- 1. 
A search of the filarial EST dataset with CPI-1 identified 4 0. volvulus ESTs 
closely related to Bm-CPI-1 but distinct from onchocystatin. In common with 
Bm-cpi-1 these EST's were derived from a vector-derived L3 stage cDNA library. 
One clone, SWOvL3CA303 (GenBank accession number R84217), was obtained 
from the Filarial Genome Project, and the full sequence deposited in the GenBank 
database (accession number AF177 194). The predicted protein, termed Ov-CPI-1, 
is 70% identical to Bm-CPI-1 and both proteins have extremely basic P1's (9.3 for 
Bm-CPI-1 and 9.2 for Ov-CPI-1). Thus the genes appear to be orthologous. 
Significantly 0v-CPI-1 does encode a conserved N-terminal glycine. Alignment 
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of the two genes indicates that the divergence of Onchocerca and Brugia was 
accompanied by the conservative replacement of a glycine by a serine residue at 
position 25 in Bm-CPI-1 (Figs. 4.3 and 4.6). 
1 	 M F F P 	I V W L S 	9 
1 ggtttaattacccaagtttgag ATG TTC TTC CCG ATT GTA TGG TTG TCA 49 
cpi-1-5' No 
10 V 	L 	L 	I I S K S F A R E I R L 24 
50 GTG PTA CTA ATC ATA TCT AAA AGC TTT GCT AGG GAA ATA CGA TTA 94 
10 
25 S 	R 	A 	T Y N E D 0 E E I Q 
VAA 
V 39 
95 AGC AGA GCT ACA TAT AAT GAA GAT GAT GAA GAA ATA CAG GTA 139 
_cpi-1pET FOR 	No 
40 A 	E 	K 	A M E Q V N D Q T R Y R 54 
140 GCA GAA AAA GCG ATG GAA CAA GTG AAT GAC CAG ACT AGA TAT AGA 184 
55 N L Y K L V R V I S A Q T S 	 69 
185 AAT CTC TAC AAA TTG GTG AGA GTT ATC AGT GCT CAA ACT CAG GTG 229 
70 	 I K Y Y L T I L A A P T 	84 
230 GTG GCC GGA ATC AAA TAC TAC CTC ACA ATT CTT GCT GCA CCG ACC 274 
	
85 T C R K VG A V G M N P M K C T 	99 275 ACC TGT AGA AAG GGT GCT GTT GGA ATG AAT CCA ATG AAA TGT ACT 319 
100 I D S S K P T KVQ F K I E V W 	114 
320 ATC GAC AGC AGT AAA CCG ACA AAG CAA TTC AAA ATA GAA GTT TGG 364 
115 S A • IU T F K V T L T * 	 127 
365 TCA GCA CCA TGG CAA AAC ACA TTC AAA GTC ACT TTG ACA TGA gct 409 
cpi-1pET REV 
410 tcactgagtataattgccgtatgtgataattcataagtaacagatatcattcgataatt 468 
44 
469 cataaataacagattgtgaaaattaaaaaaaaatatatcaaaaaaaaaaaaaaaaaaa 	526 
cpi-1-3' 
Figure 4.3: Nucleotide and deduced amino acid sequence of Bm-cpi-1. The 5' nematode spliced leader 
sequence SL-1 is underlined. The putative signal sequence is double underlined. Residues thought to be 
involved in protease binding are solid boxed. Arrowheads indicate the position of introns within the genomic 
sequence. Primers used for genomic cloning and RT-PCR (5 and 3) and for expression in pET-29 (PET 
FOR and REV) are also indicated. 
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1 	ggtttaattacccaagtttgagaccaactgtgtaaaCaaaataagCaaCgattt 	55 
cpl-2-5' 	10 
1 M M S T M S I K E G L L V I L 15 
56 ATG ATG TCA ACG ATG TCA ATA AAA GAA GGA TTG TTG GTG ATA TTA 100 
16 L 	S L F L F D T T A L I H R R 30 
101 TTA TCA TTA TTT TTA TTT GAT ACG ACA GCA TTG ATT CAT CGA CGA 
No 
145 
31 E 	I P H M E S K G Q M Q R G Q 45 
146 GAA ATT CCT CAT ATG GAA TCA AAA GGA CAA ATG CAG CGT GGC CAA 190 
—cpi-2pET FOR-. 
46 V 	L L G W Q E R S P E D N E 60 
191 GTT TTA TTG GGA GGA TGG CAA GAA CGT AGT CCA GAA GAT AAC GAA 235 
61 I 	L V E L L P S V L T K V N Q Q 75 
236 ATA CTG GAG CTA TTG CCA AGT GTT TTA ACT AAA GTA AAT CAA CAA 280 
76 S 	N D E Y H L M P I K L LK/N! V 90 
281 TCA AAC GAT GAG TAC CAT TTG ATG CCA ATC AAA TTG CTA AAA GTT 325 
91 S 	S   K Y K M E V Q 105 
326 TCA TCT CAA GTT GTC GCC GGT GTG AAA TAT AAG ATG GAA GTA CAG 370 
106 V 	A R S E C K KVS A S 
E Q V N 120 
371 GTT GCT CGA TCA GAA TGC AAA AAA AGT GCA AGT GAG CAA GTT AAC 415 
121 L 	1< T C K K L E G H P D Q\ M 135 
416 TTG AAA ACA TGT AAA AAA TTG GAA GGA CAT CCG GAT CAG GTG ATG 460 
136 T L E V W E K • PF L Q V 150 
461 ACA TTG GAR GTA TGG GAG AAA CCA TGG GAA GAT TTT TTG CAG GTG 505 
151 N I L E T K V L S S V * 	 161 
506 AAT ATT TTG GAG ACA AAG GTA CTC TCG TCA GTA TGA ttg tcc ctg 550 
44 	cpi-2pET REV 
551 tgattatcagtcc tatttcatac ta tattttcagtgctttttagtacttttcgattta 609 
610 gtgttacgtc tttttttttt cgc tgcattttgtaattttataaaaattaatgttttaat 668 
669 tggtgcataaatatttggatttggtaaaaaaaaaaaaaaaaaa 	 711 
44 	cpi-2-3' 
Figure 4.4: Nucleotide and deduced amino acid sequence of Bm-cpi-2. The 5' nematode spliced 
leader sequence SL-1 is underlined. The putative signal sequence is double underlined. Residues 
thought to be involved in protease binding are solid boxed. Arrowheads indicate the position of introns 
within the genomic sequence. Primers used for genomic cloning and RT-PCR (5 'and 3') and for 
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Examination of EST sequences in dbEST corresponding to Bm-CPI-2 
revealed a significant dimorphism: 5/12 sequences code for a lysine at residue 89, 
with the remaining 7 coding for asparagine. This asparagine is a potential N-
glycosylation site as it forms part the consensus Asn-X-Ser/Thr sequence. 
Deglycosylation of larval extracts with glycopeptidase F did not produce a 
change in molecular weight of CPI-2 suggesting that the site is not glycosylated 
by the parasite (Fig, 4.18). An identical dimorphism is observed in ESTs 
representing onchocystatin from 0. volvulus. 15/38 sequences code for a lysine 
residue at the same position, while the remainder code for an asparagine. Bm-
CPI-1 does not contain potential N-glycosylation sites. In B. malayi the change in 
amino acid is achieved by a single nucleotide change (AAA, coding for lysine, 
and AAC coding for asparagine). Sequencing of CPI-2 inserts in expression 
vectors have not revealed additional substitutions in the sequence indicating 
selective pressure on this region in both B. malayi and 0. volvulus. 
Page 78 
M 	F Y L I I 	W F S A 	F A 12 
1 	CGGCAGAGAG ATG TTC TAC TTG ATC ATA TGG TTC TCA GCG TTT GCC 46 
13 	I 	I 	S 	K 	S F A R E 	I R L K L 27 
47 	ATC ATA TCT AAA AGC TTT GCT AGG GAA ATA CGA CTA GGC AAG CTT 91 
28 T N D N E D D E E I Q E V A E 	42 
92 ACA AAT GAT AAT GAG GAC GAT GAA GAA ATA CAG GAA GTA GCA GAA 136 
43 K A N I Q V N E K N K Y D N L 	57 
137 AAG GCG ATG ATA CAA GTG AAT GAA AAG ATG AAA TAT GAT AAT CTT 181 
58 Y K L V K V I N A R T 	 72 
182 TAT AAA TTG GTG AAA GTT ATC AAT GCT CGT ACT CAA GTG GTG GCC 226 
7 a M K Y Y L T I L T A P T T C 	87 
227 GGA ATG AAA TAT TAT CTT ACA ATT CTC ACT GCA CCG ACC ACC TGC 271 
88 R K N S G 	M S P A N C A I D H 102 
272 AGG AAG AAT TCT GGA ATG AGT CCA GCG AAT TGT GCT ATC GAC CAC 316 
103 S K P K K 	K V I L E V W S A M 117 
317 AGT AAA CCG AAA AAG AAA GTC ATT CTA GAA GTT TGG TCA GCA CCA 361 
118 I F 	K V T M A * 127 
362 TGG CAA AAT ATA TTC AAA GTT ACT ATG GCA TGA GTTTTGCTGAGAATAA 410 
450 
411 TTTGTGCTTGTCAGTCGTTCGATGATTCATAAATAACAAATTGTGAAAATTAAAGAAAAA 470 
471 AAAAAAAAAAAA 	 483 
Figure 4.6: Nucleotide and deduced amino acid sequence of Ov-cpi-1. The 5 nematode spliced leader 
sequence SL-1 is underlined. The putative signal sequence is double underlined. Residues thought to be 
involved in protease binding are solid boxed. 
4.2.2 Analysis of Genomic Structure 
A PCR-based strategy was employed to isolate genomic copies of each 
cpi using gene-specific primers situated at the 5' and 3' end of each cDNA 
sequence. PCR carried out using these primers generated products of 1090 bp for 
cpi-1 and 1679 bp for cpi-2 (Figs. 4.7 and 4.8). Both genes contain 3 introns 
varying in size from 120 bp to 480 bp, which are located at identical positions 
within the coding sequences (Fig. 4.9). The boundaries of one intron within cpi-1 
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did not match the consensus GT-AG splice donor-acceptor boundaries. The 
second intron of cpi-1 uses GC as the 5 '-donor site, a sequence known to be very 
rarely used in C. elegans (Blumenthal and Steward, 1997). In a recent survey of 
Brugia genes, a cytosine in the +2 position of the 5'-splice site was only 
encountered in 2% of B. malayi introns (Zang et al., 1999). 
4.2.3 Comparison with cystatin genes from C. elegans. 
Two family 2 cystatin genes have been predicted from the complete 
genome of the free-living nematode C. elegans. Both genes, designated 
RO1B 10.1 and K08134.6 by the C. elegans Genome Project, have been predicted 
by Genefinder, a program capable of identifying open reading frames and introns 
from genomic DNA sequence. The program's prediction of introns within the 
genes is confirmed by comparison with multiple ESTs derived from the genes. 
These ESTs also demonstrate that both genes are expressed. The two genes are 
located on different chromosomes: R011310.1 is found on chromosome 5 and 
K08B4.6 is on chromosome 4. The predicted proteins share 48% amino acid 
identity and have many features in common with cystatins from parasitic 
nematodes such as the presence of only one pair of cysteines and the exclusive 
use of QVVAG in the central conserved region. Despite these similarities, the 
structure of the two genes differs significantly from the B. malayi genes (Fig. 
4.9). The C. elegans genes are interrupted by two introns, only one of which is 
found in exactly the same position in the B. malayi genes. 
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I ATG TTC TTC CCG ATT GTA TGG]TTG TCA GTG TTA CTA ATC ATA TCT AAA AGC 
M F F P I V W L S V L L I I S K S 
TTT GCT AGG GAA ATA CGA TTA AGC AGA GCT ACA TAT AAT GAA GAT GAT GAA 
F A R E I R L S R A T Y N E D D E 
GAA ATA CAG gtatattatttcttatgaatatgcataaatttatattatCaatgatgagatagag 
E 	I Q 
aatatatcaaactgaaattaaaagaaaagtaaaggtagagatgttCaaCgtttCtttCCtgCag GAA 
E 
GTA GCA GAA AAA GCG ATG GAA CAA GTG AAT GAC CAG ACT AGA TAT AGA AAT 
V A E K A M E Q V N D Q T R Y R N 
CTC TAC AAA TTG GTG AGA GTT ATC AGT GCT CAA ACT CAG GTG GTG GCC GGA 
L Y K L V R V I S A Q T Q V V A G 
ATC AAA TAC TAC CTC ACA ATT CTT GCT GCA CCG ACC ACC TGT AGA AAG 
I K Y Y L T I L A A P T T C R K 
agtcttcacatttattcgaatattgCgtgaatatatgagtCttaCaaataCgaattCtgattttCttCaCtg 
agtagtattcccatgc tccatagaagtcc tcgttttcaagcacatgcaatgagaCatgagtCtaaaaagaag 
gtaatgaacttgaattacctgttcagatttatCaCatgtCaCCatCtCaCttatgagtgtaatgttCtgact 
catattttatcaactaaacatc taaagatcttcaaaaCCatttattC tgcag 
GGT GCT GTT GGA ATG AAT CCA ATG AAA TGT ACT ATC GAC AGC AGT AAA CCG 
G A V G M N P M K C T I D S S K P 




ctttagctatcgaaattacgaattttttCag CAA TTC AAA ATA GAA GTT TGG 
Q F K I E V W 
TCA GCA CCA TGG CAA AAC ACA TTC AAA GTC ACT TTG ACA TGA gcttcactgagt 
S A P W Q N T F K V T L T * 
ataattgccgtatgtgataattcataagtaacagatatcatJcgataattcataaataaCaattt I 
Figure 4.7. Partial genomic sequence of the Bm-cpi-1 gene. The nucleotides boxed indicated the gene-
specific oligos used to amplify genomic DNA. The Exons are accompanied by the predicted amino acid 
sequence. The rare GC 5 splice site is boxed in red. 
Page 81 
accacctgtgtaaacaaaataag4acgatttg ATG ATG TCA ACG ATG TCA ATA AAA GAA 
I 	 M M S T M S 	I 	K E 
GGA TTG TTG GTG ATA TTA PTA TCA TTA TTT TTA TTT GAT ACG ACA GCA TTG ATT 
G L L V I L L S L F L F D T T A L I 
CAT CGA CGA GAA ATT CCP CAT ATG GAA TCA AAA GGA CAA ATG CAG CGT GGC CAA 
H R R E I P H M E S K G Q M Q R G Q 
GTT PTA TTG GGA GGA TGG CAA GAA CGT AGT CCA GAA GAT AAC GAA ATA CTG gtt 





ttgctatctgcag GAG CTA TTG CCA AGT GTT TTA ACT AAA GPA AAT CAA CAA TCA 
E L L P 5 V L T K V N Q Q S 
AAC GAT GAG TAC CAT TTG ATG CCA ATC AAA TTG CPA AAA GTT TCA TCT CAA GTT 
N D K Y H L M P I K L L K V S S Q V 
GTC GCC GGT GTG AAA TAT AAG ATG GAA GTA CAG GTT GCT CGA TCA GAA TGC AAA 
V A G V K Y K M K V Q V A R S E C K 
AAA gtatgcttctagtggtaatttcggaatttataatattctctagctttcctgaatcctaatgagaaatga 
K 
c tgaaggtgacatt ttgccataggaaaatagagaaagtgatgaggaaaaaggagaagcaaaaaagaagaacaa 
tttctttgaaaacaaagtaatgaaacttgaaatattcatttagagcactttgcatatctcttgaaagttaaat 
tttcag AGT GCA AGT GAG CAA GTT AAC TTG AAA ACA TGT AAA AAA TTG GAA GGA 
S A S E Q V N L K P C K K L K G 
CAC CCG GAP CAG gtttgttgcatgtaatttcaagataaagtgaaactgttgacattgaaataatttga 






tatttagcatttattttacattttaattatgtattaactatttttctaatctttttcag GTG ATG ACA 
V M T 
TTG GAG GTA TGG GAG AAA CCA TGG GAA GAT TTT TTG CAG GTG AAT APT TTG GAG 
L E V W E K P W E D F L Q V N I L E 
ACA AAG GTA CPC PCG PCA GPA TGA ttgtccctgtgaattatcagtcctatttcatctattattt 
T K V L S S V * 
tcagtgctttttagtacttttcgatttagtgttacgtcttttttttttcgctgcattttgtaattttataaaa 
attaatgttttaattgtgcataaatatttggatttgg I 
Figure 4.8: Partial genomic sequence of the Bm-cpi-2 gene. The nucleotides boxed indicate 
the gene-specific oligos used to amplify genomic DNA. The exons are accompanied by the 
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Figure 4.9: Schematic representation of the gene structures of B. malayi and C. elegans cystatin 
genes. Identical box colouring indicates correspondence between exons. Lines represent introns, and 
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Figure 4.10: Rooted phylogram showing the relationship of nematode cystatins with members of 
the cystatin, stefin and kininogen families. Stefin sequences were designated the outgroup for this 
analysis. Numbers on top of the branch lines show the calculated bootstrap percentage values. 
GenBank or SwissProt accession numbers are as follows: B. malayi CPI-1; U80972, B. malayi CPI-2, 
AF015263; A. viteae Av17, L43053; onchocystatin, P22085;0v-CPI-, AF177194 Haemonchus 
contortus, AF 035945; C. elegans ROJB1O. 1, AF068718; C. elegans K08B4.6, AF100663; African 
puff adder, P08935; Carp, P35481; Chicken, P01038; Human C, P01034; Human S, P01036; Human 
D, P28325; Human M, Q15828; Human Leukocystatin, AF03 1824; Human kininogen segment 1 
(residues 144-207) and Human kininogen segment 2 (residues 266-355), P01042; Flesh fly  cystatin, 
P31727; RICE 1, oryzacystatin-1, P01040; RICE 2, oryzacystatin-2, P20907; Human A, P01040; 
Human B, P04080 
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4.2.4 Phylogenetic Analysis. 
Comparison of the available nematode cystatin sequences with 
representatives from cystatin families 1, 2 and 3 further demonstrated the divergent 
nature of the nematode cystatins (Fig. 4.6). In addition, Bm-CPI-1 and its 0. 
volvulus orthologue form a distinct group with no obvious counterparts as yet 
identified in the complete genome sequence of C. elegans (Fig. 4.10). 
4.2.5 Analysis of mRNA levels throughout the lifecycle. 
In order to gain information on the transcriptional regulation of the cystatin 
genes, RT-PCR was employed to detect gene expression throughout the parasites 
development in both mosquito and mammalian hosts. Gene-specific primer pairs 
located within exons 1 and 4 of the genes were chosen to ensure discrimination 
between cDNA and genomic amplification products. Bm-cpi-2 RNA was detected in 
all life cycle stages tested but cpi-1 was only detected in the late stages of parasite 
development in the vector mosquito (Fig 4.11A) and the very early stages of 
development in the mammal (Fig 4.11B). Twenty-four hours after entry into the 
mammalian host, cpi-1 expression fell below the detection limit of the assay, even 
after 35 rounds of amplification. Very faint bands could be seen at days 5 and 6 post 
infection and again at days 17, 21, 23 and 25. Control amplifications of the B. 
malayi -tubulin gene performed in parallel gave a detectable cDNA product at all 
time points. 
Analysis of the distribution of ESTs among the stage-specific libraries used 
for sequencing also highlights the restricted expression pattern of cpi-1 and shows 
that Ov-cpi-1 is similarly restricted. The distribution of ESTs representing cpi-2 
however indicates an increase in cpi-2 and onchocystatin expression occurs in the L3 
stage (Table 41). This variation around the life cycle is not evident in RT-PCR 
analysis of cpi-2 expression (Fig. 4.11A and B). 
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Day 6 Day 9 Adult Adult 
mf L2 	L3 
L3 L3 Female Male 
Bm-cpi-1 0 0 	 8(0.3%) 	0 0 0 0 
Bm-cpi-2 0 0 	 13(0.5%) 	1 (0.06%) 0 2(0.05%) 1 (0.02%) 
Moulting Adult Ault 
mf L2 	 L3 
L3 Female 'tale 
Ov-cpi-1 0 0 	 4(1.4%) 0 0 
Onchocystatin 0 0 	 42(1.4%) 5(0.2%) 2(0.1%) 
Table 4.1. The 'In silico' expression pattern of B. malayi and 0. volvulus cystatins as judged by 
EST abundance. Numbers of ESTs representing the cystatins are grouped according to their library 
of origin. The percentage of the total number of ESTs sequenced from each library is also shown. 
The 0. volvulus moulting library was constructed from RNA pooled from L3s after 1, 2 and 3 days of 
culture. ESTs from libraries generated by subtraction procedures are not included in the analysis. 
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A 	 Moult 	 Moult 
L3 	 I 	 L4 	 Adult 
CO- 1  
cpi-2 
Tubulin 
0 	2 	4 	6 	8 	10 12 1417212325 
Days Post Infection 
Moult 	 Moult 
B 	u 	Li 	 L2 	 L3 
cpi- 1  
cpi-2 
Tubulin 	
678910 11 12 
Days post blood feed 
Figure 4.11: Expression of cpi-1 and cpi-2 throughout the life cycle. The expression of cpi- 1 and 
cpi-2 during development in the mammalian host (A) and the first 25 days of infection of the mosquito 
(B). U represents RNA extracted from bloodfed mosquitoes fed on uninfected blood. Day 0 
represents RNA extracted from vector-derived infective larvae. 
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4.2.6. Expression of recombinant CPI-1 and CPI-2. 
CPI-1 and CPI-2 have been expressed in both pET-29 and pET-22 
expression plasmids. pET-29 (Stratagene) is a T-ended expression plasmid 
producing fusion proteins with an N-terminal S-Tag and a C-terminal Histidine tag 
(Fig. 4.12). Inserts are ligated directly into the EcoR V restriction site that has been 
T-tailed by the manufacturer. 
Recombinant CPI-2 produced in pET-29 was >80% insoluble without urea 
present in the sonication buffer. Two prominent bands were present in the urea 
soluble fraction. CPI-1 expressed in pET-29 was also largely insoluble producing a 
single band on SDS-PAGE. Both constructs produced sufficient soluble protein to 
purify recombinants from the Tris-soluble fraction. This allowed antisera to be 
raised against the recombinant and for enzyme inhibition studies to be carried out. 
In an attempt to produce larger quantities of both proteins and to reduce the 
length of fusion partners both genes were re-expressed in pET-22. This plasmid 
contains an N-terminal bacterial leader sequence (peiB) for potential periplasmic 
localisation and a C-terminal hexahistidine tag for rapid purification. This construct 
increases expression of soluble CPI-2 but little improvement was seen with CPI-l. 
Optimum cleavage of the leader sequence was assumed to occur if the cells were 
induced at room temperature overnight (Fig. 4.14B). This probably due to the slow 
rate of production of the fusion protein which allows the pelB signal peptidase to 
cleave more of its target. We have not, however, ruled out the possibility that the 
lower band is a partially degraded form of CPI-2 although the molecular weight shift 
is consistent with the removal of the signal sequence. 
As CPI-1 lacks the wholly conserved N-terminal glycine residue shown to 
be essential to the activity of many cystatins a second recombinant CPI-1 was 
produced in pET-22 lacking 7 amino acids at the N-terminal. The first amino acid of 
this construct aligns with the first amino acid after the double glycine residues in 
CPI-2. Fig. 4.13A shows that this construct produced levels of protein similar to the 
full length CPI-1. Studies using N-terminally truncated cystatins have demonstrated 
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that these constructs are structurally stable and are useful in assessing the 
contribution of the N-terminal to the overall cysteine protease affinity (Hall et al., 
1995). 
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Met Lys Glu Thr Ala Ala Ala Lys Phe Glu Are Gin His Met Aso Ser Pro Asp Leu Gly 
Thr Leu Val Pro Are Glv er Met Gly Tr----------- I 	 --------Ser Asp Pro Asn 
I hr ,ii 
Ser Ser Ser Vat Asp Lys Leu Ala Ala Ala Leu Glu His His His His His His End 
ffl 
CPI-IpIT-22 
Met Arg' Gin2 lie3 Arg4..........Va1 IOS  Thr'06 Leu'07 Thr108 ys  Glu His His His His His His End 
CPI-17pET-22 
Met kI98 Thr9 Tyr'° Asn . ........... Vai'°5 Thr'06 Leu'°7 Thr'° Lys Glu His His His His His His End 
CPI-2pET-22 
Met Asp Lie Gly lie Asn Ser Asp Pro eu' He2 His3 Arg4 ..........Leu'33 Ser' Ser' 35 VaP 4.ys Glu JjLj  
His His His His His End 
11TS I 
Fig. 4.12: Schematic representations of the recombinant CPI- I and -2 constructs. Panel A. Full length, 
mature CPI-I and —2 were ligated into the T-ended pET-22 vector. Panel B. CP!-I and -2 were both 
expressed in pET-22 as a full length mature proteins in addition a shortened version of CPI- I lacking 7 N-
terminal residues was produced. The first and last residues of the stretch of CPI-i and —2 expressed are 
boxed and in bold, other residue are derived from vector sequences. 
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A___ B 
kDa 	 kDa 1— 
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Total I 	 Total I 	I 
Extract Fractions 	 Extract Fractions 
Figure 4.13: Expression and purification of (A) CPI-1 and (B) CPI-2 in pET-29. Cells were 
sonicated in His-Bind resin binding buffer and purified over a His-Bind column. Lane 1: molecular 
weight markers, lane 2: total extracts, lanes 3-6: purified fractions elu ted from the column. 
	





2O 	 20_ 
- 4 
14— 
S 	 14 
With signal sequence 
Without signal sequence 
12 	1 	2 	12 	 1 	2 
CPI-1 
I bI-171GPI-2 I CPI-2 
Figure 4.14: Expression of CPI-1, CPI-2 and GPI-Th7 in pET 22. Panel A. Cells were induced for 
3 hours at room temperature and extracts were made by sonication in His-Bind resin binding buffer 
(20mM iris-H Cl, 500mM NaCl. 5mM imidazole, pH 7.9). Insoluble material was futher extracted into 
binding buffer containing 9M urea. Loading for each track represent 200d of induced culture. A 
Western blot of the extracts run on a 15% SDS-PAGE gel was probed with a monoclonal anti-hi stidine 
tag antibody (Boehringer Mannheim). Lane 1: binding buffer extract, Lane 2: urea extract. Panel B. 
CPI-2 extracts from cell induced at room temperature to increase the amount of recombinant with 
cleaved signal sequence. Extracts were prepared and blotted as in panel A. 
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4.2.7 	Inhibition of cysteine proteases. 
The ability of recombinant CPI-1 and CPI-2 to inhibit two distinct cysteine 
proteases, papain and cathepsin B, was assessed by incubation of the proteases with 
increasing concentrations of the inhibitors and assessment of the residual activity 
assayed in the presence of the fluorogenic substrate Z-Phe-Arg-AMC. Both 
recombinant proteins expressed in the pET-29 system showed significant inhibitory 
activity towards these proteases, however the inhibitory profiles were distinct for 
each recombinant protein; CPI-2 showed a preference for papain while CPI-1 was a 
stronger inhibitor of cathepsin B (Fig. 4.15). As a control, recombinant ALT-1, 
expressed with identical fusion partner and purified over His-Bind columns, failed to 
inhibit cleavage of Z-Phe-Arg-AMC by either cysteine protease (Fig. 4.15). 

















0 	 - 0' 
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Figure 4.15: Inhibition of (A) papain and (B) cathepsin B by recombinant CPI-1 and CPI-2. 
Initial rate of reactions were calculated by monitoring the increase in fluorescence emitted by the 
cleaved product of Z-Phe-Arg-AMC in the presence of increasing quantities of inhibitor or the 
control recombinant ALT-I. 
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4.2.8 	Surface localisation of the CPIs. 
Antibodies raised against recombinant CPIs were used to detect the native 
proteins in extracts of L3 and adults labelled with lodogen, a surface-specific 
iodination reagent. Antibodies raised against CPI-1 precipitated a protein of 14 kDa 
from infective larvae only (Fig. 4.16A), while antisera against CPI-2 precipitated a 
doublet of 16 and 18 kDa from all life cycle stages (Fig. 4.16B). Results 
corresponded well with the RT-PCR expression data: while cpi-1 mRNA and protein 
could only be detected in larval preparations, cpi-2 mRNA and protein could be 












1 4 - 
Figure 4.16. Surface localisation of CPI-1 and CPI-2. Surface componants if infective larvae 
(A) and adult (B) were iodinated with sodium iodide using IODOGEN as a catalyst. Proteins 
were solubilised in PBS/1.5% n-octyl glucoside and immunoprecipitated with anti-recombinant 
antisera. Panel A: Surface labelled L3 extracts (track 1) were immunoprecipitated with 
antisera raised against CP1-1 (track 2), CPI-2 (track 3) and normal mouse sera (track 4). Panel 
B: Surface labelled adult extracts (track i) were immunoprecipitated with antisera raised 
against CPI-2 (track 2) and CPI-i (track 3).normal mouse sera (track 4), 
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4.2.9 	Secretion of CPIs by parasites in culture. 
Polyclonal antibodies raised against recombinant CPI-2 were used to 
immunoprecipitate metabolically labelled proteins secreted by infective larvae and 
adult worms in culture. Anti-CPI--2 antiserum recognised two bands of 16 and 18 
kDa released from infective larvae cultured in RPMI 1640 medium at 37°C (Fig. 
4.17). Antibodies raised against recombinant CPI-1 also precipitated a 15 kDa 
protein (Fig. 4.17). 





Figure 4.17: Secretion of CPI-1 and CPI-2 by infective larvae maintained in culture. 
35S-labelled ES was collected over 3 days and irnnunoprecipitaed with antisera against CP!- I 
(track I), CPI-2 (track 2) and ALT I (track 3). 
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1 	2 	 1234 




Figure 4.18. CPI-2 resolves as a doublet under reducing conditions and does not contain Winked 
glycans. Panel A: Extracts of adult worms were resolved on a 15% polyacryla,nide gel in the 
presence, or absence, of 5% 2-niercaptoethanol in the sample buffer. Both samples were boiled 
before loading. The gel was transferred to nitrocellulose and probed with antisera to CPI-2. Panel 
B: Extracts of adult worms were degicosylated for 2 hrs with PNGase F (tracks I and 3). After 
separation on a 15% polyacrylamide gel and transfer to nitrocellulose the blot was probed with 
antisera to either the nematode polvprotein antigen (a gift from Dr. Judi Allen) tracks 1 and 2 or 
CPI-2 (tracks 3 and 4). Tracks 2 and 4 are negative controls incubated for 2 hrs in PNGase F buffer 
without enzyme. 
4.2.10 Characterisation of the CPI-2 doublet. 
Antisera against CPI-2 recognised a 16/18 kDa doublet in Western blots of 
adult and larval extracts produced in the presence of a cocktail of protease inhibitors. 
When these extracts were run in the absence of 2-mercaptoethanol in the sample 
buffer, only one band of l8kDa was visible (Fig. 14.18A). This result suggests that 
the cysteine residues in CPI-2 form a disulphide bond and that full denaturation of 
the protein does not occur under the standard reducing conditions employed. 
Altered migration under reducing and non-reducing conditions has been shown 
previously for onchocystatin (Lustigman et al., 1992). Deglycosylation of extracts 
prior to western blotting failed to alter the migration of the doublet demonstrating 
that the doublet is not caused by partial glycosylation of CPI-2 and thus the one 
potential N-glycosylation site is not used (Fig. 14.18B). 
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DISCUSSION 
The cystatins are an ancient and conserved family of cysteine protease 
inhibitors, and their expression among diverse nematode species is not unexpected. 
It is curious, however, that cystatins are such prominent gene products among 
parasitic nematodes, and that Bm-CPI-1 has no apparent orthologue in C. elegans, 
suggesting that cystatins play an essential role in transmission, invasion, and/or 
immune evasion (Hartmann et al., 1997b; Klager et al., 1999; Lustigman et al., 
1992). In B. malayi, for example, the cystatins cpi-] and cpi-2 appear to be among 
the most abundant transcripts from the infective larva, representing 0.5 and 0.3 % 
respectively of all ESTs sequenced to date. Filarial cystatins are therefore prime 
candidates for chemotherapeutic or immunological targeting. 
Developmental Expression of Cystatins 
The distinct developmental expression patterns of the two cpi genes may 
give some insight into their function. The restriction of cpi-1 to the mosquito stage 
indicates that its target protease is likely to be of insect origin rather than 
mammalian. Initiation of Bm-cpi-1 expression coincides with L2 moult and the 
migration of larvae from the muscle cells of the thorax to the mouthparts of the 
mosquito (Schacher, 1962a). This is also the time at which larvae become infective 
to the mammalian host. Expression of the gene is high in comparison with 13-tubulin 
and continues until larvae infect the mammalian host. Localisation of the protein at 
the surface of the larvae suggests that it may be involved in protection of this 
structure either while the larvae are resident within the head and mouthparts of the 
vector or during the early stages of mammalian infection. It is also possible that 
CPI-1 plays a regulatory role in the extensive cuticular changes that are initiated by 
the infection process. These changes include altered patterns of surface labelled 
proteins, biophysical properties and ultrastructural changes. 
In contrast, the continuing production and secretion of Bm-CPI-2 
throughout the mammalian part of the life cycle implies an active role in parasite 
maintenance. In the related parasite 0. volvulus, the homologous gene product is 
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highly expressed in the cuticle of moulting larvae, and indeed synthetic cysteine 
protease inhibitors are able to arrest moulting altogether (Lustigman, 1993; Richer et 
al., 1993). However, we saw no detectable increase in cpi-2 transcription around the 
moulting events, as for example observed with collagen genes involved in cuticle 
synthesis in C. elegans (Johnstone and Barry, 1996). In addition, the homologous 
protein from the rodent filarial parasite A. viteae has been shown to interfere with 
host T lymphocyte proliferation (Hartmann et al., 1997b), while in preliminary 
experiments we have shown that Bm-CPI-2 can interfere with MHC class II-
mediated antigen processing in human B cells, presumably by blocking host cysteine 
protease function (B. Manoury, C. Watts, W.F. Gregory, R.M. Maizels, manuscript 
in preparation). The probability remains therefore that CPI-2, at least, continues to 
be important in the host-parasite relationship after the final moult to the adult stage. 
Protein Structure 
Amino acid sequences of cystatin family members contain three features of 
high homology: (1) an invariant glycine residue within the first 10-15 residues of the 
mature protein, (2) the central Glu-X-Val-X-Gly motif and (3) a C-terminal Pro-Tip 
pair. Structural analysis has shown that these regions come together to form a 
protruding wedge which slots into the active site cleft of the protease (Bode et al., 
1988; Stubbs et al., 1990). Exchange of the glycine residue with other amino acids 
has demonstrated that this residue functions as a hinge between the flexible N-
terminal segment and the rest of the molecule. Replacement of the glycine with 
residues having small side chains results in dramatic reductions in affinity for a 
range of cysteine proteases. 
The replacement of the conserved N-terminal glycine with serine is 
therefore a notable feature of Bm-CPI-1. In mammalian cystatins, mutations in 
residues up to and including the glycine decrease or abolish the ability of the 
inhibitor to interact with a variety of substrates (Hall et al., 1993; Hall et al., 1995; 
Mason et al., 1998; Shibuya et al., 1995). Although serine has a small side chain, 
other studies have shown that replacement of glycine with serine leads to a 
significant decrease in inhibitory activity. However, the glycine residue of cystatin 
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C is not thought to be necessary for inhibition of the aminopeptidase cathepsin C 
(dipeptidyl peptidase I) (Hall et al., 1993). In addition, truncation of the N-terminal 
residues of cystatin C has no effect on cathepsin C or cathepsin H inhibition 
(Abrahamson et al., 1991; Abrahamson et al., 1987). These studies suggest that a 
cathepsin C-like enzyme may be the natural ligand for CPI-l. 
Recently, a second inhibitory site in chicken cystatin C has been proposed 
which may bind to legumain or asparaginyl endopeptidase enzymes (Alvarez-
Fernandez et al., 1999). It is interesting to note that there is sequence conservation 
between cystatin C and CPI-2 in this loop (SNDMYH and SNDEYH respectively). 
We have preliminary evidence that CPI-2 is able to block the activity of mammalian 
legumain and the related enzyme, asparaginyl endopeptidase in antigen-presenting 
cells (Manoury, B., Watts, C., Gregory, W.F. and Maizels, R.M., manuscript in 
preparation). This enzyme-inhibitor relationship may therefore be of ancient 
phylogenetic origin. 
Evolutionary Analysis 
The set of nematode cystatins now form a robust branch of the superfamily. 
Interestingly, all lack the second pair of cysteine residues found in family 2 
cystatins, residues that clamp the carboxy terminus to the p3-pleated sheet in all other 
family 2 cystatins. Members of the family 2 cystatins are considered to have 
evolved from family 1 stefins, which lack cysteine residues, acquiring four cysteine 
residues in the process (Brown and Dziegielewska, 1997; Muller-Esterl et al., 1985; 
Rawlings and Barrett, 1990). With the view that disulphide bonds are gained but 
seldom lost during evolution, nematode cystatins appear to be a fixed intermediate in 
this evolution. 
The arrangement of introns in the nematode cystatin genes is also worthy of 
comment. Most cystatin genes have two introns largely conserved between 
mammalian family-2 cystatins and cystatin-like segments of kininogens. To date 
only soyacystatin and leukocystatin genes are known to comprise of 4 exons (Halfon 
et al., 1998; Misaka et al., 1996) and their overall gene structures are highly 
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dissimilar to the Bm-cpi genes. Despite a relatively close evolutionary relationship 
and a high level of coding sequence conservation, only one intron position is shared 
between B. malayi and C. elegans. 
Overall, the Bm-cpi genes are atypical in containing three introns, and it is 
especially surprising that their positions are strictly conserved between two genes 
whose coding regions are only 25% identical. Thus, the genomic organisation 
implies a divergence between cpi-1 and cpi-2 subsequent to the separation of filarial 
and C. elegans lineages, while the sequence phylogeny suggests the reverse. This 
may indicate that Bm-CPI-1 has undergone rapid sequence evolution from a more 
recent time-point possibly as an adaptation to the parasitic life cycle. 
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5.3 	Discussion 
INTRODUCTION 
To date the only effective anti-nematode vaccines have been based upon the 
protective effects of immunisation with irradiated infective larvae. With low level 
irradiation larvae fail to undergo complete development dying within days or weeks 
of infection depending on the dose of radiation. During this period they continue to 
be metabolically active. In contrast immunisation with larval extracts fail to protect 
against a subsequent challenge infection. This implies that developing infective 
larvae are the source of parasite antigens capable of inducing protective immunity. It 
has been suggested that irradiated preparations are effective because they inhibit 
development and allow a degree of tissue penetration thus increasing the length of 
time the immune system is exposed to early larval stage antigens and perhaps by 
presenting protective antigens to a different subset of immune effector cells. 
Immunisation with material released by infective larvae during in vitro culture is also 
protective. Infections terminated with drug treatment are also capable of inducing 
significant levels of protection comparable with irradiated preparations. Analysis of 
the antibody responses of dogs protected against D. immitis by a drug-attenuated 
infection identified a 20/22 kDa doublet in parasite secretions recognised by 
protected dogs but not by a control cohort undergoing a normal infection. Protein 
sequencing of the doublet showed both bands to be almost identical and allowed the 
cloning of the gene. Database searches showed the gene to be novel, although a 
weak similarity with phospholipase A2 enzymes from honeybees was noted. To date 
homologues of this gene have only been described in filarial parasites. 
Products, such as the Dirofilaria 20/22 kDa proteins, which are associated 
with parasite invasion, which are tightly regulated and parasite-specific, are likely to 
be essential to the success of parasitism (Bianco et al., 1990; Bianco et al., 1995). In 
this chapter a family of related, stage-specific genes from B. malayi that are prime 
candidates for a new vaccine against filarial infection are described. These genes, 
identified by cloning of abundant L3 transcripts ((Gregory et al., 1997) and Chapter 
3) and through analysis of EST's (Blaxter et al., 1996) have been designated 
abundant larval transcripts (alt) are close relatives of the D. immitis 20/22 kDa 
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RESULTS 
5.2.1 Abundance of alt mRNA throughout the life cycle 
The alt-i gene (Figure 5.1) was originally identified as a prominent trans-
spliced mRNA from L3 larvae of B. malayi (Gregory et al., 1997), and alt-2 as a 
closely related expressed sequence tag (EST) from the same stage. Three 
representative alt-2 clones were obtained from the Filarial Genome Project and their 
inserts sequenced in full (Figure 5.2). Since then, the Filarial Genome Project has 
deposited over 16,000 expressed sequence tags from all stages of this parasite (The 
Filarial Genome Project, 1999). Analysis of this database reveals that alt-i is 
represented by 33/2378 ESTs (1.39%) from the L3, and alt-2 by 67/2378 (2.82%). 
The alt-2 and alt-i transcripts are, respectively, first and third in abundance among 
all L3-expressed cDNAs in the EST dataset (Williams et al., 2000). Remarkably, 
neither cDNA can be found among the 14,000-plus sequences derived from other 
points in the life cycle, implying that alt-11-2 are expressed at less than 0.01% of 
mRNAs in non-L3 stages. 
5.2.2 Other B. malayi alt sequences identified by EST sequencing 
The searching of over 21,000 B. malayi ESTs deposited in dbEST has 
allowed the identification of additional members of the alt family characterised by 
highly variable, acidic N-terminal regions with conserved central and C-terminal 
regions. Six further alt genes were tentatively identified and clones representing two 
of these genes were obtained from the Filarial Genome Project and sequenced in full. 
An alignment of the predicted protein sequences of these new ALT genes with ALT 
sequences from other filariae is shown in Fig. 5.5. 
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products. In addition members of the alt family have been recognised in other 
filariae. 
In 0. volvulus two highly similar genes have been described. Ov-ALT-1 was 
immunoscreened from a L3 expression library using a pool of sera from putatively 
immune individuals (Joeseph et al., 1998). A second gene was identified through 
EST sequencing: Ov-ALT-2 shares 85% amino acid identity with Ov-ALT-I. 
Sequence from an 18 kDa protein secreted by developing larvae was used to clone 
the A. viteae homologue. More recently, a gene encoding an A. viteae alt has been 
reported and its protein product shown to be secreted around the time of the L3 - L4 
moult (Pogonoka et at., 1999). 
This chapter describes the B. malayi alt-i and alt-2 genes in detail and report 
the presence further members of the family by analysis of ESTs. We have 
characterised the stage-specific transcription of alt-i and -2 and analysed the 
genomic structure of the genes. In addition we show that vaccination with 
recombinant ALT-1 can match the levels of protection achieved by irradiated larvae. 
The alt gene products represent attractive vaccine antigens for three reasons: (i) they 
are larval-specific in immunological terms; (ii) they are highly expressed, offering an 
abundant target; and (iii) they have no known homologue in the mammalian host. 
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10 	 20 	 30 	 40 	 50 	 60 
GTTTAGTTACCCAAGTTTGAGAAGAAAAA ATG AAC AAA PTG CTA ATA GCA TTT GGC TTA 
M N K L L I A F G L 
70 	 80 	 90 	 100 	ALT-ipETFORoligo 
ATT ATT CTT ACT GTG ACA CTG CCA TGT ATG TCA CAA TCA GAT GAC GAA TTC GAC 
I I L T V T L P C M S Q S D D E F D 
120 	 130 	 140 	 150 	 160 
GAC GAA TCC Tt GGT GCT GAT GAG GGA GGA GAT GGT AGT GAA GGA GGA GAT GAG 
D E S S G A D K G G D G S K G G D K 
170 	 180 	 190 	 200 	 210 	 220 
TAT GTC ACC AAG GGG GAA TTT GTT GAA ACT GAT GGC AAA AAG AAA GAA TGC ACT 
Y V T K G E F V E T D G K K K K C T 
230 	 240 	 250 	 260 	 270 
TCT CAC GAA GCG TGC TAC GAC CAG CGT GAA CCG CAA GCT TGG TGC AGA TTG GAC 
S H E A C Y D Q R E P Q A N C R L D 
280 	 290 	 300 	 310 	 320 	 330 
GAG AAT CAG TCG TGG ACA GAC AAA GGT TGC TTC TGT GAT GAT AAA TTG CAT TCA 
E N Q S N T D K G C F C D D K L H S 
340 	 350 	 360 	 370 	 380 
TGC GTT ATC GAA AGA AAG AAC AGT GGC AAG TTG GAA TAT TCG TAT TGT .Ct CCT 
C V I E R K N S G K L K Y S Y C A P 
ALT-1pETREV oligo 	 alt-1 3 UTR oligo 	 440 	450 
CAA GAA AGT TGG CAA TGC TCG TIAATGCTTACAAAGCAAGCAAAACAAGCTGTGATGCAAACTTT 
Q E S N Q C S 
460 	470 	480 	490 	500 	510 	520 
CAATTCTACCTTTCTATTTTAACTCCTTTTAGCAGCCJATTGATGCTTGTTGCTACTTTTATTTATGA 
530 	540 	550 	560 
AATATGAGAGATAAAAAATAJ JAAAA 
Figure 5.1: Nucleotide and deduced amino acid sequence of Bm-alt-1: The nematode 
spliced leader sequence SLI is boxed and the positions of primers used for expression (ALT-
IpETFOR and ALT-IpETREV), PCR of genomic DNA and RT-PCR (ALT-IpETFOR and alt-
13 VTR). 
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10 	 20 	 30 	 40 	 50 
rGTTTATTACCCCAAGTTTGAG AGGAGAAA ATG AAT AAA CTT TTA ATA GCA TTC GGT 
M N K L L I A F G 
60 	 70 	 80 	 90 	 100  
PTG GTA ATT CTT TTT GTG ACA CTC CCG TGT GTA TCA GAA TCA GAC GAA GAG TTC 
L V I L F V P L P C V S E S D E E F 
ALT-2pETFOR oligo 	 140 	 150 	 160 
GAT GAC TCC GCA GAT GAC ACC GAC GAC AGC GAG GCC GGA GGT GGT AGT GAA 
D D S A A D D T D D S E A G G G S E 
170 	 180 	 190 	 200 	 210 	 220 
GGA GGT GAT GAA TAT GTA ACC AAA GGG GAA TTT OTT GAA ACT GAT GGC AAA AAG 
G G D E Y V T K G E F V E T D G K K 
230 	 240 	 250 	 260 	 270 
AAA GAG TGC TCT TCG CAC GAA GCT TGC TAC GAT CAA CGT GAA CCA CAA GCG TGG 
K E C S S H E A C Y D Q R E P Q A H 
280 	 290 	 300 	 310 	 320 
TGC AGA CTG AGC GAG AAT CAG GCA TGG ACT GAC AGA GGC TGC TTC TGC GAA GAT 
C R L S E N Q A W P D R G C F C E D 
30 	 340 	 350 	 360 	 370 	 380 
AAG TTG CAT TCG TGC GTC ATC GAA AGA ACG AAC AAT GGT AAA TTG GAG TAT TCG 
K L H S C V I E R T N N G K L E Y S 
390 	 400 	 410 ALT-23'UTRoIigo 
TAC TGT GCA CCT GAA GCA GGT TGG CAA TGC GCA TAM GAATGAATCAGTCTTTGATACTA 
V C A P E A G W Q C A * 
- 450 	460 	470 	480 	490 	500 	510 
CCAACTTTCCATCCATTTCCTACACTTTTCAAATTTAATTCTTTCTAACAAATAACATTTAACTTTGGTTT 
520 	530 	540 	550 	560 	570 
TACCGTTATTTTATTAAATATTGGAAATATGTGCGACAAAAAAAAAAAAAAAAAAAAAA  
Figure 5.2: Nucleotide and deduced amino acid sequence of Bm-alt-2: The nematode 
spliced leader sequence SLJ is boxed and the positions of primers used for expression 
(ALT-2pETFOR and ALT-2pETREV), PCR of genomic DNA and RT-PCR (ALT-2pETFOR 
and alt-2 3 UTR). 
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50 
G GAG GAT GAA GAC GAG GAT GGT AGT GAA GAG AAA GAG GAT GAA GAT GAT GAT 
E 0 E D K 0 G S E E K E 0 E D D 0 
100 
GAT TAT CAA GAC GAC AGT GAT GAG AAA GAG GAG GAT GAA GAC GAG GAT GAT AGT 
D V Q 0 D S D K K E E 0 E 0 E 0 0 S 
150 
GAA GAG AAA GAG GAT GAA GAA GAA GAT AAG GAT GAT AGT GAA GAG AAA GAG GAT 
E E K E 0 K E E D K D D S E E K E 0 
200 
GAA GAA GAA GAT AAG GAT GAT AGT GAA GAG AGA GAA GAC GAA TAT ACT GCC AAA 
E K E 0 K 0 D S E E R E 0 E Y T A K 
250 
GGG GAA TTC GTT GAA ACA GAC GGC AAG AAG AAA CAA TGT GAC TCT CAC GTG GCT 
G E F V K T D G K K K Q C 0 S H V A 
300 
TGT TAT GAT CAA CGT GAA CCG CAA GCG TGG TGC ATA TTA AAG AGG AAT CAG TCT 
C V 0 Q R E P Q A W C I L K R N Q S 
350 
TGG ACA AAC AAA GGT TGT TTC TGC GAT GAA AAG AGA CAT TTA TGC GTT ATG GAA 
W T N K G C F C D K K R H L C V M E 
400 
CGG ATG AAC GGC GGT AAA TTG GAA TAT GCG TAT TGC GCG CCT GCA AAG AP.T TGG 
R M N G G K L E V A Y C A P A K N W 
450 
kAG TGT TCG TAT GAT TAA TAGTAACCTACGATATTCATCCATTTCCTATTTTTATTTC 
K C S V D * 





Figure 5.3: Nucleotide sequence and deduced amino acid sequence of Bm-alt-5. This 
represents the confirmed sequence of the expressed sequence tag SW3D9CA340SK (GenBank 
accession number AA585623) 
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50 
ATAAAAA ATG AAC AAA CTT PTA ATA GTT TTT GGC TTA ATA ATT CTT TTT GCC ACA 
M N K L L I V F G L I I L F A T 
100 
CCA CTT TAT GCA AAA CAA TCA AAT GAA GAG GAG GAT GAA GAC GAG GAT GGT GGT 
P L Y A K Q S N E E E D E D E D G G 
150 
GAA GAG GAT GAG GAT GAA AAA GAA AAC GAG GAT GAP AGT GAA GAG AGA GAA GAA 
E E D E D E K E N E D D S E E R E E 
200 
TAT ACG GCT AAA GGA GAA TTC GTT AAA ACT GAC GGC AAG AAG AAA CAA TGT GAT 
Y T A K G E F V K T D G K K K Q C D 
250 
TCT CAC GTA GCT TGC TAT GAT CAA CGT GAA CCA CAA GCG TGG TGC ATA TTA AAA 
S H V A C Y D Q R E P Q A W C I L K 
300 
GAG AAT CAG TCT TGG ACA GAC AAA GGT TGT TTC TGC GAT GAA AAG AGA CAT TTG 
E N Q S W T D K G C F C D K K R H L 
350 
PGC GTT ATG GAA CGG AAG AAT GGC GGT AAA TTG GAA TAT GCG TAT TGC GCG CCT 
C V H E R K N G G K L K Y A Y C A P 
400 
GCA AAG GAT TOG AAG TGT TCG TAC GAP TGATAATAACCTACGATATCCATTTTTTATTTTJ 
A K D W K C S Y D 





Figure 5.4: Nucleotide sequence and deduced amino acid sequence of Bm-alt-6. This 
represents the confirmed sequence of the expressed sequence tag MB3D6AA5G7T3 
(GenBank accession number AA841275) 
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Figure 5.5: Alignment of the predicted protein sequences of the filarial alt genes with the proposed homologue from C. 
elegans. Vertical red lines indicate introll position where known. The eight conserved cysseine residues are boxed in red 
GenBank accession numbers are a follows: Bin-ALT-1; 1157547, Bn-ALT-2; U84723, Wb-ALT-I; AF0845533, Av-ALT-1(Av-
18); U47545. Di-ALT-l(Di-20122); U29459, Ov-ALT-1; U96176, Ov-ALT-2; AF044952 and Bm-ALT-10; U29578. The Ls-
ALT-] sequence is generated from a consensus of 18 Litoinosoides sigmodontis ESTs (Allen et al manuscript submitted)- The 
elegans sequence is a translation of sequence from cosmid C08A9 with conformation of the predicted open reading frame by 
(-DNA sequencing. Bin-ALT-5 and -6 are full sequences of clones identifled by EST sequencing (SW3D9CAC340 and 
MB3D6AA5GO7 respectively). Bm-ALT-7is the full sequence of EST (-lone SWAMCACI4HO5 (David Guiliano. unpublished). 
Bin-ALT-8 is derived from consensus sequences from the following EST sequences SW3ICAI52ISK, AS3ISB330SL, 
SW3IcAI07SK, SW3IC'AII23SK, BSBmL3SZ44NIISK and BSBmL3SZ45B6SK). Bm- ALT-9 is a translation of EST 
MB3D6AAOH07T3- Note that Bin-ALT-5, -8, -9 are probably not full length sequences as the clones or clusters do not encode 
potential initiation niethionines- 
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One clone from a day 9 infective larvae library was chosen for sequencing, 
SW3139CA340SK (GenBank accession number AA585623). The gene differs 
significantly from alts-1 and -2 (46 and 43% amino acid identity respectively) and 
was therefore designated Bm-alt-5 (Figure 5.3). The gene has unusually long C-
terminal acidic region (in excess of 68 residues) but lacks both an initiation 
methionine and a signal sequence, probably due to truncation during preparation of 
the library. Two additional ESTs (BSBmL3SZ15H18SK and SWYACALO1C1 iS') 
appear to derive from this gene along with a partial genomic sequence (GenBank 
U29577, Wisnewski, N., Frank, G.R. and Grieve, R.B., unpublished). The genomic 
sequence reveals the conserved position of intron 2 in this and the alt-i and -2 genes. 
Clone SWYACALO1C1 iS' comes from a young adult library constructed is unusual 
as it is one of the few alt-family transcripts detected from stages other than L3. 
The full sequence of EST clone MB3D6AA5GO7 from the day 6 infective 
larvae library contains a complete open reading frame with 68% identity to the Bm-
alt-S protein sequence. The gene, designated Bm-alt-6 (Figure 5.4), also matched 3 
further ESTs (MB3D6VH7HOT3, MB3D6AA7Ei 1T3 and MB3D6V5A1OT3) all 
selected from the day 6 library. 
Nine other EST could be identified from a database search. One, from the 
adult male library did not group with any other ESTs. Full sequencing of the insert 
(D. Guilliano, unpublished) showed a predicted full length gene. In comparison with 
the other ALTs the predicted protein from this gene, designated Bm-alt-7, lacks an 
terminal acidic region although the central and C-terminal regions are conserved. 
A cluster of 7 ESTs from the infected larvae library defines a gene, 
designated Bm-alt-8. The protein sequence predicted from a consensus of the 7 
ESTs consists of approximately 20 amino acids similar to the ALT signal sequences 
and along with 70 predominantly acidic residues, however the sequences do not 
extend into a conserved central and C-terminal region. 
Two short sequences define two further ALT family members. A single EST 
from the day 6 library spanning only 152 nucleotides defines Bm-alt-9 and a short 
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genomic sequence (U29578, Wisnewski,N., Frank,G.R. and Grieve,R.B., 
unpublished) has been designated Bm-alt-10. 
As the B. malayi EST project proceeds further members of the alt family will 
undoubtedly be identified. The genes identified to date can to be broadly divided 
into 2 groups on the basis of the abundance (as assessed from EST data) and the 
timing of their expression. The first group, containing alt-1 and -2 are highly 
expressed in the vector derived L3, with lower expression following transmission. 
The second group are much less abundant, and are largely confined to libraries made 
from post-parasitic larvae and adult worms 
5.2.3 Analysis of alt-1 and -2 genomic structures 
Primer pairs designed to amplify the alt-i and -2 genes from the start of the 
predicted mature protein to the 3 'UTR were used to amplify genomic DNA. The 
products were cloned and sequenced which allowed a comparison of intronic 
structure. Both genes contained 2 introns, which show no similarity between the two 
genes, with intron/exon boundaries conforming closely to the consensus described 
for Brugia genes (Zang et al., 1999). However, two products were observed from 
genomic PCR for alt-2 (Figure 5.6), and this was found to be due to a dimorphism in 
the second intron of alt-2. Both alt-2 introns are unusual in consisting largely of 27 
or 46 bp repeat units (Figures 5.9 and 5.10). The dichotomy in alt-2 is due to the 
presence of either 6 or 9 copies of the 46 bp repeat (Figure 5.7). 
Page 111 
1075—* 
__.- 1212 bp (alt-2b) 
___ 1075 bp (alt-2a) 
alt-i 	alt-2 
Figure 5.6: Genomic PCR using gene-specific primers . Genomic DNA from mixed sex adults 
amplified with lane I alt-i-specific primers (alt-JFOR and alt-13 'UTR) and lane 2 alt-2-specific 






6 copies of the 27 bp 	6 or 9 copies of the 47 bp 
intron 1 repeat intron 2 repeat 
Figure 5.7: Schematic comparison of the partial But-alt and Ce-alt genomic sequences: Exons with significant 
homology are coloured identically. Each homologous repeat unit is represented by a identically coloured triangle. 
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I GAC GAA GAG TTC GAT GAC TCC GCA GCC AT GAC ACC GAC GAC AGC GAG GAC 
D E E F D D S A A D D T D D S E D 
GGA GGT GGT AGT GAA GGA GGT GAP GAA TAT GTA ACC AAA GGG GAA TTT GTT 
G G G S E G G D E Y V T K G E F V 
GAA ACT GAT GGC AA GTGAGTCGTTTGGTACTTTCAATAATTTGAATCCTTCAAAATATTTCT 
E T D G K> 
GAGGAATCGGTTCCCTTTCCATCTCACTTTTTATGGGTCCTTTTATTAAAAATGTGTTATTTGTATCGCTGC 
AATCTTTCATTTCGCTCTGAAATAGTTATTTCTTAAATTGACTCCAAAATGTCCCATATCA 




A AAG AAA GAG TGC TCT TCG CAC GAA GCT TGC TAC GAP CAA CGT GAA CCA 
K K E C S S H E A C Y D Q R E P 
CAA GCG TGG TGC AGA CTG AGC GAG AAT CAG GCA TGG AC GTAAGCCACTTCA 









T GAC AGA GGC TGC TTC TGC GAA GAT AAG TTG CAT TCG TGC GTC ATC GAA AGA 
< D R G C F C E D K L H S C V I E R 
ACG AAC AAT GGT AAA TTG GAG TAT TCG TAC TGT GCA CCT GAA GCA GGT TGG 
T N N G K L E Y S Y C A P E A G W 
CAG TGC GCA ITAG GAATGAATCAGTCTTTGATACTAC I 
Q C A 	* 
Figure 5.9. Partial genonzic sequence of Bm-alt-2a (lower band). The nucleotide sequence is 
accompanied by the amino acid translations of the 3 exons. Oligos used to amplify the fragment from 
genomic DNA are boxed. The repeated sequences within the introns are highlighted in red. Introit splice 
sites are indicated in bold. > indicates a split codon. This sequence has been deposited with Gen Bank under 
the accession number AF183573 
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IGAC GAA GAG TTC GAT GAC TCC GCA GCC AT GAC ACC GAC GAC AGC GAG GAC 
D E E F D D S A A D D T D D S E D 
GGA GGT GGT AGT GAA GGA GGT GAT GAA TAT GTA ACC AAA GGG GAA TTT GTT 
G G G S E G G D E Y V T K G E F V 
GAA ACT GAT GGC AA GTGAGTCGTTTGGTACTTTCAATAATTTGAATCCTTCAAAATATTT 
E T D G K> 
CTGAGGAATCGGTTCCCTTTCCATCTCACTTTTTATGGGTCCTTTTATTAAAAATGTGTTATTTGTAT 
CGCTGCAATCTTTCATTTCGCTCTGAAATAGTTATTTCTTAAATTGACTCCAAAATGTCCCATATCA 




A AAG AAA GAG TGC TCT TCG CAC GA.A GCT TGC TAC GAT CAA CGT GAA CCA 
K K E C S S H E A C Y D Q R E P 
CAA GCG TGG TGC AGA CTG AGC GAG AAT CAG GCA TGG AC > GTAAGCCACTT 












<T GAC AGA GGC TGC TTC TGC GAA GAT AAG TTG CAT TCG TGC GTC ATC GAA AGA 
D R G C F C E D K L H S C V I E R 
ACG AAC AAT GGT AAA TTG GAG TAT TCG TAC TGT GCA CCT GAA GCA GGT TGG 
T N N G K L E Y S Y C A P E A G W 
CAG TGC GCA ITAG GAATGAATCAGTCTTTGATACTA 
Q C A 
Figure 5.10. Partial geno?nic sequence of B,n-alt-2b (upper band). The nucleotide sequence is 
accompanied by the amino acid translations of the 3 exons. Gaps have been introduced in the repeat intron 2 
repeat unit to optimise the alignment. Nucleotides that differ in alt-2a and b are shown in green. Oligos used 
to amplify the fragment from genonhic DNA are boxed. The repeated sequences within the introns are 
highlighted in red intron splice sites are indicated in bold. > indicates a split codon. This sequence has been 
deposited with GenBank under the accession number AF183574. 
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5.2.4 Diversity within the alt-2 gene. 
The two alt-2 genomic PCR bands were obtained by amplifying DNA 
isolated from a large number of mixed sex adult worms. It was unclear whether the 
two alt-2 products were allelic variants of one gene or two distinct genes. Single 
worm PCRs were carried out to resolve this issue. Genomic DNA products from 
single adult males revealed a polymorphism within the alt-2 gene (Figure 5.11). Half 
of the single worm DNA produced the 1075 and 1212 bp bands produced by the 
mixed sex DNA. Three individuals appeared homozygous: 2 contained only the 
1212 bp alt-2b gene while one contained only the 1075 bp alt-2a gene. Additional 
bands were seen at approximately 1.4 and 1.5 kb in some individuals: one individual 
contained only this doublet while another produced bands at 1.0, 1.4 and 1.5 kb. A 
625 bp band was also present in most individuals. Sequencing of these additional 




Figure 5.11: Heterogeneity of the alt-2 gene. Lane 1, 100 bp ladder (Gibco-BRL). Lanes 2-9, single 
adult male worm genomic DNA amplified with alt-2-specific PCR primers (alt-2 FOR and alt-2 
3 UTR). Lane 10, Positive control: amplification of a plasmid containing an alt-2b insert with the 
same primer pair. 
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5.2.5 An alt-like gene in C. elegans 
alt-i and alt-2 cDNA sequences encode novel proteins each with signal 
sequences and N-terminal acidic tracts, which share 79% amino acid identity 
(Gregory et al., 1997) and similar proteins have been described in other filarial 
species (Frank et al., 1996; Joeseph et al., 1998; Pogonoka et al., 1999). Alignment 
of the filarial ALTs illustrates that the acidic tract is highly variable while the 
remainder of the protein is conserved (Figure 5.5). Among the predicted protein 
sequences from C. elegans deposited in Wormpep 
(http://www.sanger.ac.uk/Projects/C_elegans/wormpep),  only distant similarities 
could be found with low significance, including two genes annotated as 
phospholipase A2. However when the complete nucleic acid sequence of C. elegans 
was searched a more significant similarity (P>10 6) was found on cosmid C08A9. 
This cosmid contains a short tract corresponding to the second and third exons of 
Bm-alt-1 and -2 and encodes a predicted peptide sequence with 32% amino acid 
identity with Ce-ALT-1 (Fig. 5.5). Moreover, C08A9 shows exact alignment of all 
cysteine residues with ALT-1 and —2 and includes introns in identical positions to 
those determined for alt-i and —2. 
To confirm the predicted intron splice site and to assess whether sequence is 
transcribed primers designed to amplify across the two C. elegans exons to PCR 
amplify poly A-primed first strand cDNA. Figure 5.13 demonstrates that the gene is 
transcribed and sequencing of the PCR product confirmed that the splicing 
predictions are correct. The gene has therefore been designated Ce-alt-1. 
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2760 	2770 	2780 	2790 	2800 	 2810 
GAAGCATTTCTGGGAAATTTTATrAGAP TTATTCAGGTATTTT ATG TAT TCT AAA 
IM 	Y 	S 	K 
	
2820 	 2830 	 2840 	 2850 	 2860 	 2870 
GTT TG TTG CTT TTG GCC TGT ATA ATC GCC GTA ACC GAA CAA GCA A GTGAGATAG 
L L L L A C I I A V T E Q Al> 
2880 	2890 	2900 	2910 	2920 	2930 	2940 
TTTTACCTTTTTTTTTTTGAATATTGCATAAGCTTTAAAATTGTTGTCAAATTATCAAAAGTTTATTGTGAAA  
2950 	2960 	2970 	2980 	2990 	3000 	3010 
CAATGGTTTCAAGCTTTTTCCGAGACGAGAAAACTTTGAATTACCTCTTATTCATTGATGATGATTACATTTT 
3030 	3040 	3050 	 3060 	 3070 
TTCTATCGAATGAGTTGTGTAAAACACTPCAG GA GAT GTT CGA TGC TTT CCT CCA 
IR _DV R C F P P I 
3090 	 3100 	 3110 	 3120 	 3130 
GTG AAC TTC TAT TCA ACA CAT GGA TGT GTT CAA GAT AGT ACC AGC CAA AAT CCA 
Iv N F Y S T H G C V Q D S T S Q N 
3140 	 3150 	 3160 	 3170 	 3180 
AAC TAT GAC TGC TTG GGA GGC CAT TTT GTG AGA ACT GCT GGA AT GTGAGTGGAGAAA 
IN Y D C L G G H F V R T A G II 
3200 	3210 	3220 	3230 	3240 	3250 	3260 
AAACTAAAACATCGGACAGTATTTTCGTTGATGAAATCCGGTCTTGCTTCTTGACTTCTAAAAGTTTGAAAAA  
3270 	3280 	3290 	3300 	 3310 	 3320 
CTATTGAGACTAATTACCACATAATCTCACATTTTACATTTTCAG T GGA ATG CCT TGC GAA ACA 
G M P C E T 
3330 	 3340 	 3350 	 3360 	 3370 	 3380 
GAC CAA GAT TGT ATT CAC AAC ATG GAA CCC AAT GAG TGG TGT AAC TCT GAA AGA 
ID Q D C I H N M E P N E W C N S E R I 
3390 	 3400 	3410 	3420 	3430 	3440 
AAT GGC TAC CAA TGG AC GTGAGTGTACAACTTTCACTTTG CTTCATCTCAGA 
IN G Y Q W T 
3460 	 3470 	 3480 	 3490 	 3500 
ACT GCC GGC PGT CAC TGT GAC ATG AAG CTT AAG TCT TGC ATT GTT CAG AGG TTT 
A G C H C D M K L K S C I V Q R  Fl 
3510 	 3520 	 3530 	 3540 	 3550 
GAC AAG AGC TAT AAC GAA ATT CAA TGG GCT TTC TGT ACA CCA AGA AAT CGT TTC 
LD K S Y N E I Q N A F C T P R N R Fl 
3560 	 3570 	 3580 	 3590 	 3600 	3610 
AAG TGC GAA GTT TTG GAC CAT TGC TCA CCA CCA AAA CAT TAA ACTACGAGTTTCGA 
1K C 	E V L D H C 	S 	P 	P K HI * 
3620 	3630 
TTGAATAAATAATTAAAATTTAA 
Figure 5.12: Genomic and predicted amino acid sequence of Ce-alt. The amino acid 
sequence was deduced by sequencing of cDNA. The sequence starts at base pair 2752 
representing the longest transcript identified from 5' RACE products. The cDNA is 
polyadenylated at base 3635. Split codons are indicated by >. 
No upstream sequence from the cosmid was similar to the N-terminal acidic 
domain. The bases immediately 5' to the first predicted exon correspond to the 
consensus intron splice acceptor site TTT CAG (Blumenthal and Steward, 1997) 
suggesting that the identified sequence is incomplete. Amplification of cDNA with a 
gene-specific reverse primer and a SL- 1 primer and failed to produce a product as 
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did amplification of a mixed stage library using a specific primer in combination 
with a plasmid vector primer. 5 RACE using the GeneRacer Kit (Invitrogen) 
identified a cDNA corresponding to nucleotides starting at base 2753 of cosmid 
C08A9 and lacking a 5'SL sequence. The 5'RACE products allowed the 
identification of 60 extra N-terminal residues including a signal peptide and an 
additional intron in the upstream sequence (Figure 5.5). It is not clear whether an 
intron also exists in the same position in Bm-alt-i and -2. The section of alt-i and -2 
amplified to generate genomic sequence lies 6 nucleotides downstream of the intron 
position in C. elegans. Comparison of the N-terminal sequences showed divergence 
in the amino acid content of the Ce-ALT predicted protein: no stretch of acid 
residues is present. Bm-ALT-7 is the only other sequence identified to date that lack 
acidic residues in the N-terminus. A phylogram comparing only the conserved core 
regions of the filarial and C. elegans sequences also demonstrates that Ce-ALT is 
most close to ALT-7 (Figure 5.14) 
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- '1 90 bp 
- 240 bp 
Figure 5.13: Ce-ALT-I is an expressed gene. Lane 1: 100 bp ladder (Gibco BRL). Lane 2: A 
band of 240 bp is generated by PCR of mixed-stage C. elegans poly A-primed first strand cDNA with 
gene-specific primers Ce-aitFOR and Ce-a1tREV. The primers are designed from sequences in exons 
I and 2 respectively and therefore span the predicted 50 bp intron. Lane 3: PCR of C. elegans 






Figure 5.14: Unrooted phylogram showing relatedness of the ALT conserved core in filariae and 
C. elegans. The conserved core is defined as the central and C-terminal residues starting at position 
100 in the multiple alignment shown in Figure. 5.6 
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5.2.6 Stage-Specific Gene Expression 
Expression of alt-1 and alt-2 at different points of the filarial life cycle was 
assessed by RT-PCR. For alt-i and alt-2-specific PCRs primers binding to the 
region corresponding to the first 9 amino acids of the mature polypeptides were 
paired with primers binding to the 3 'UTR of the genes. PCR was carried out on poly 
A-primed first strand cDNA taken at daily intervals during development of parasites 
from the microfilarial stage to the infective larva in Ae. aegypti vector mosquitoes 
(Figure 5.15). This showed that both alt-i and -2 are switched on between 5 and 6 
days following uptake into the mosquito vector, and remain expressed for the 
duration of tenure in the insect. Similarly, parasites were recovered following 
infection of the rodent host M. unguiculatus. Here, alt-i expression terminated 
abruptly on transfer into the jird, although brief periods of transcription were 
detected between days 4 and 8, no subsequent expression could be detected (Figure 
5.16). alt-2 transcription was less rigorously controlled, with expression continuing 
for 3 days post infection, and recurring at intervals over the following 3 weeks. 
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Moult 	Moult 




1 	2 	3 4 5 	6 	7 	8 	9 10 11 	12 
Days Post Mosquito Blood Feed 
Figure 5.15: RT-PCR analysis of the expression of alt-1 and -2 and during larval development 
within the mosquito vector. U represents RNA extracted from mosquitoes fed on uninfected blood. 
Moult 	 Moult 




0 	2 	4 	6 	8 	10 	I? 	14 17 21 23 25 
Days Post Infection of Jird 
Figure 5.16: RT-PCR analysis of the expression of alt-I and -2 during the first 25 days of infection 
of the gerbil. Day 0 represents RNA extracted from vector-derived larvae. 
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5.2.7 Expression of recombinant ALT. 
The predicted full length mature ALT-i protein was expressed using the pET-
29T system (Novagen). Primers a1tpETFOR and a1tpETREV were used to amplify 
the gene for the L3 library (SAW94WL-BmL3). This product was then ligated into 
the T-ended expression vector pET-29T which produces fusion proteins with an N-
terminal S'Tag and a C-terminal hexahistidine Tag. Expression in BL-21 DE3 cells 
resulted in the production of soluble protein which was purified via the fusion 
protein's histidine tag on a metal chelating column under non-denaturing conditions. 
The purified protein ran at a molecular weight of approximately 25 kDa as judged by 
SDS-PAGE, higher that the predicted size of 17.4 kDa (Figure 5.17). 
Antibodies to recombinant ALT-i protein reacted specifically with a doublet 
of 20 kDa in soluble extract of L3 on Western blots (Figure 5.18), but no reactivity 
was detectable towards extracts of Mf and adult stages. Thus, at the protein level, 
ALT-1/-2 are effectively L3-specific. Thus ALT-i and —2 larval-specific expression 
parallels that of related proteins in D. immitis (Frank and Grieve, 1991; Frank and 
Grieve, 1996; Frank et al., 1996) and one of the 0. volvulus homologues, ALT-i 
(Joeseph et al., 1998). However the expression contrasts with alt family members 
from A. viteae (Pogonoka et al., 1999) and Ov-ALT-2 (Joeseph et al., 1998). 
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kDa 






Figure 5.17. 	Expression and purification of ALT-I. Lane I: Molecular weight markers 
(Pharmacia). Lane 2: total extract of induced cells. Lanes 3-7: sequential fractions e!utedfronz the 








Mf 	L3 Adult 
Figure 5.18.' Detection of ALT-] in extracts from different stages of the life cycle. Detergent-
soluble extracts of microfilariae, infective larvae and adult B. malayi were separated on a 15% SDS-
PA GE, transferred to lmmobilonTM (Millipore) and probed with antisera raised against recombinant 
ALT-I. 
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5.2.8 Human Recognition 
The prominence of the alt transcripts suggests that exposed humans may be 
serologically reactive to the ALT proteins. This was tested with sera from 40 
patients resident in a B. malayi-endemic area of Indonesia, drawn equally from the 
two categories of amicrofilaremic and microfilaremic. The former group will 
contain both parasite-free individuals and patients with subpatent infections; the 
latter group all have detectable blood-borne microfilariae. Because anti-filarial 
antibodies, measured to adult and microfilarial- stage antigens, are dominated by the 
IgG4 isotype (Hussain et al., 1987; Kurniawan et al., 1993; Maizels et al., 1995), all 
four IgG isotypes were individually assayed. 
Antibodies to rALT- 1 protein are found in members of both groups (Figure 
5.19). Interestingly, the antibody isotypes are predominantly IgGi and IgG3, and no 
IgG4 is observed. This contrasts with the profile observed for a B. malayi protein 
expressed by the adult stage, Bm33 (Dissanayake et al., 1993), which is the target of 
IgG4 isotype antibodies. There is also a discordance with observations on the 0. 
volvulus protein Ov-ALT-2 (86% identical to but 8 amino acids smaller than Ov-
ALT-i). This is constitutively expressed (Joeseph et al., 1998), and human 
onchocerciasis patients have high levels (95%) of seropositivity, including IgG4. 
Thus, in 0. volvulus ALT does not represent a larval-specific antigen. 
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Figure 5.19: Bin-ALT-I is not the target of IgG4 antibodies during human infection. Elisa using 40 
hunan B. inalayi infection sera against Bin-ALT- I and Bm-33 recombinant proteins. Upper panels 
show sera from amicrofilareniic endemic normals; lower panels show sera from patients with 
circulating microfilariae. Horizontal bars in the ALT-I panels represent the mean value +3 standard 
deviations of the non-endemic human control sera. Values for Bin-33 represent the net OD value 
following the subtraction of readings for each serum against the maltose binding protein Jision partner. 
ELISA assays and preparation of Bin-33 recombinant were performed by Dr A. Kurniawan-Atmadja 
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5.2.9 Protective Immunisation 
To assess the potential of ALT-i for vaccination, gerbils were immunised 
jirds with 4 doses of ALT-1 spread over 10 months, and challenged them with 300 
live L3. Four weeks later, the recovery of live parasites in the immunised group was 
76% reduced compared to the adjuvant-alone controls (Figure 20). This difference 
was significant at the p<0.05 level by Whitney-Mann nonparametric statistics. The 
data reported here indicate greater than 70% protection in jirds against a challenge 
infection; this is substantially better than any previous filarial recombinant antigen 
reported, and is in the range achieved by vaccination with radiation-attenuated 
larvae, of 44-91% (Yates and Higashi, 1985). Of previously tested antigens, 
paramyosin has yielded disappointing results (Li et al., 1993; Li et al., 1999), while 
heat shock protein 70, myosin and ui-type IV collagen have recently been shown not 
to stimulate protective immunity (Peralta et al., 1999). Thus, ALT-i and ALT-2 




B. ,nalayi L3 









Figure 5.20. B,n-ALT-1 reduces recovery of parasites from vaccinated animals by 76%. Challenge 
parasites were recovered 28 days after an intraperitoneal infection with 300 B. ,nalayi infective 
larvae. Circles represent recoveries from individual animals. The red and blue boxes represent the 
mean recovery from each group. 
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DISCUSSION 
Vaccination against helminth parasite organisms has proved problematic, 
both in identifying likely vaccine antigens from the wide repertoire of antigens 
expressed, and with respect to the immunopathological responses to many of these 
antigens (Maizels et al., 1999). A new approach is reported here, of selecting highly-
expressed, stage-specific products such as the ALT proteins, which are shown not to 
be present in the mature adult stage. This, coupled with the fact that ALT proteins 
are parasite-specific products unrelated to any host constituent, renders less likely 
any adverse consequences of immunisation. There is evidence from two other 
filarial species to associate ALT recognition with immunity (Frank and Grieve, 1991; 
Frank and Grieve, 1996; Frank et al., 1996; Joeseph et al., 1998), but the data 
provided here provide the first demonstration of protective immunity in a susceptible 
host using a single recombinant protein. The high level of sequence similarity 
between ALT sequences from B. malayi and W. bancrofti suggest that there will be 
immunological cross-protection between these two species, of which W. bancrofti is 
responsible for >90% of human infections but which does not infect laboratory 
animals. 
The C. elegans gene has not been identified as a predicted gene by 
GeneFinder because of its small size, the program excludes small open reading 
frames. In addition the gene is also not been identified within the 75,000 clones 
sequence tagged from a C. elegans libraries. This may be again due to its small size 
(clones with inserts less than 500 bp are not selected for sequencing) or perhaps the 
stage specificity of the gene makes it a rare transcript amongst the mixed staged 
population of nematode mRNA used in the library construction. 
The absence of a sequence encoding acidic residues upstream of the Ce-alt 
gene may indicate that this region is specific to parasites and may represent part of 
their adaptation to parasitism. Alternatively we may have to search further upstream 
for additional exon. Although C. elegans introns tend to be small (more than half are 
shorter than 60 bp) some very large introns are present, for example the first intron of 
the unc-7 gene is 18 kb (Stanch et al., 1993). 
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The variation seen in the Bm-alt-2 gene from single male worms is 
suggestive of allelic variation although sequencing of the amplified products to 
confirm that they are alt-2 gene products is necessary. This would also confirm 
whether the size variation is due to diversity in the intron 2 repeats. Repeat units are 
a common occurrence in the genomes of multicellular organisms. In C. elegans 
tandem repeats account for 2.7% of the genome and approximately half of these 
sequences are found within introns (The C. elegans Sequencing Consortium, 1998). 
In general, repetitive sequences are found in intragenic regions and are thought to be 
involved in maintenance and movement of chromosomes. However, within introns 
repetitive sequences have been linked with control of transcription. Intron 6 of the 
human interleukin- 1 alpha gene contains a 46 bp repeat region capable of binding the 
transcriptional factor SP1 (Haugen et al., 1989). Significantly 6 alleles have been 
described containing between 5 and 18 repeats and gene expression correlates 
negatively with the number of repeats (Bailly et al., 1996). 
The human antibody profile supports, in the context of natural exposure, the 
concept that ALT-1 is an L3-specific antigen as it has previously been shown that 
responses to the L3 overall are less dominated by IgG4 (Kurniawan-Atmadja et al., 
1998). It is notable that both Mf-negative and -positive groups contain individuals 
seropositive for ALT-i antibodies. This finding is in keeping with the notion of age-
acquired concomitant immunity, in which exposed individuals gain protection 
against new infection while being unable to eradicate the resident parasites (Day, 
1991; Day et al., 1991a; Day et al., 1991b). Thus, both endemic 'normals' and 
microfilaria-carriers may express protective antibodies, effectively negating the 
search for protective antigens by comparing antibodies from "immune" and 
"susceptible" individuals; such a comparison would have excluded ALT-i from 
consideration. 
The conservation of alt genes in all the filarial nematodes so far studied, and 
the very weak similarity to a single C. elegans locus, implies that ALT products are 
critical in a filarial-specific role. Moreover, this role evidently requires a remarkably 
high degree of expression at the point of initial entry by parasites into the 
Page 133 
mammalian host. If this role is essential to parasite survival, neutralisation by the 
immune response may be sufficient to ensure protection. Elucidation of the function 
of the ALT proteins, and the nature of the response induced by vaccination with 
these antigens, should greatly enhance our understanding of the immunology of 
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A multilayered extracellular cuticle surrounds all nematodes. Along with the 
surface coat, it forms a protective barrier between the animal and its environment and 
plays important roles in maintenance of morphology, motility and (Bird and Bird, 
1991; Blaxter and Robertson, 1998). In addition the cuticle of parasitic nematodes 
plays a critical role in host-parasite relationships as it represents the main body of 
tissue in contact with the host immune system. 
The entire cuticle is sloughed off and replaced at each of the four 
postembryonic moults giving rise to cuticles that are different in both observable 
structures and specific protein composition. Cuticle proteins are synthesised by the 
underlying syncytial hypodermis and once exported to the cuticle they are 
extensively cross-linked, conferring both elasticity and rigidity to the structure. The 
proteins can be broadly divided into those that are solubilised by reducing reagents, 
such as 2-mercaptoethanol, and those that remain insoluble. A large family of 
collagens are solubilised by reducing agents breaking intrachain disulphide bonds. 
Initially synthesised as low molecular weight proteins (pre-procollagens) they are 
further cross-linked by non-reducible bonds to give apparent molecular weights of 
50-160 kDa. The non-reducible cross-links are of two types: (1) di- and tri-tyrosine 
and (2) c-(y-glutamyl) lysine. Di-tyrosine cross-links are found within collagen 
subunits and also in additional cuticle components, termed cuticlin, found in the 
insoluble fraction of the cuticle. Two genes encoding components of the cuticlin 
residue, CUT-i and CUT-2 from C. elegans have been described: both contain a high 
proportion of glycine and tyrosine residues. Recombinant CUT-2 can be cross-
linked in vitro to high molecular weight product in the presence of hydrogen 
peroxide and horseradish peroxidase demonstrating a capacity to form. Both 
proteins have characteristics of highly cross-linked proteins within the insoluble 
residues of the larval cuticle and eggshell layers of insects. 
One abundant transcript identified from infective-stage larvae belongs to a 
family of small molecules rich in glycine and tyrosine residues from filariae and C. 
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elegans (Chapter 1 and (Gregory et al., 1997)). The transcript, named Bm-agt-1 for 
abundant g1ycine/yrosine rich protein, predicts a small protein of approximately 6 
kDa with an N-terminal signal sequence. Although not homologous to the CUT 
proteins the high content of glycine and tyrosine and the presence of a signal peptide 
suggest that they are substrates for cross-linking enzymes in the extracellular spaces 
of the nematodes, possibly in the cuticle. 
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RESULTS 
6.2.1 A family of agt-like proteins in filariae 
The Bm-agt-1, formerly called Bm-alt-3, has been renamed to avoid 
confusion with the growing family of genes with homology to alt- 11-2. The cDNA 
was first identified as an abundant band amongst vector derived L3 transcripts 
(chapter 1 and Gregory et al, 1997). The predicted mature 3.8 kDa protein contains 
22.2% glycine and 8.3% tyrosine (Figure 6.1). Although not particularly tyrosine 
rich, a homologue identified amongst B. malayi ESTs, originally called Bm-alt-4 and 
now renamed Bm-agt-2, is a 5.3 kDa protein which, without its predicted signal 
peptide, contains 43.1% glycine and 19.6% tyrosine. The two proteins are 34% 
identical (49% similar). All ESTs representing agt-1 come from vector-derived L3 
libraries, however agt-2 appears less stage-specific with ESTs from both vector-
derived L3 and adult male libraries. 
The agt-1 gene in B. malayi is not amongst the most abundant in the EST 
dataset: 13 ESTs are identified by BLAST searching. Significantly 9 of these 
sequences are from a library constructed from vector derived L3 SL-1/oligo-dT PCR 
products (JHU93SL-BmL3) representing 3% of sequences from this library. In 
contrast only 0.14% of EST from the conventional vL3 library are agt- 1. This over-
representation in the library and amongst the abundant transcripts (chapter 1) may be 
due to the preferential amplification of small transcripts by taq polymerases or the 
abundance of this transcript amongst those that receive the SL-1 sequence. 
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______ 	 50 
IGGTTAGPTACCCAAG TGAG1TAATTATCAGATTTTAATrGGAAAA ATG AGG AAC ATA TTG 
H R N I L 
100 	 4 
ATA TTA TTG ATT GTC TTA TTA ATA ATC GTA AAT GTA GAG TCG TTT GGT TGG GGA 
I L L I V L L I I V N V E S F G W G 
A033pETFOR 	 io 	A033pETREV 
TAC TCA TAT TAC GGT GGA CAA TCA CAA G.T TTT GGA GAP TTC CCA GCG TTT AAT 
Y S Y Y G G Q S Q D F G D F P A F N 
200 
CCA GGG TCA GCG ATC GCT GGT GCT GTA CTG GGC AAG AAG AAA TAA 




300 	 350 
TATTTTTAAGTGTTGAAAAGGTCATACGTTTATCAGAATATCATTGTATTTGGAAGATTTAATGATATCA 




Figure 6.1: Nucleotide and deduced amino acid sequence of Bm-agt-1. The nematode 
spliced leader SL-1 is boxed. The putative signal sequence is in bold. Oligo pairs used for 
RT-PCR (A033pETFOR and A033 3 VTR) and cloning into pET 29 (AO33pETFOR and 
A033pETREV) are indicated. 
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Signal peptides 
10 	 20 	 30 	 40 	 50 
8m -GTR - 1 	M R N I L I L L I V L L I I V N V E S F (3W G V S -- - - - - - - - - - - - - - - - G Q s 
Bm-GTR-2MEGTKSIWVLLVILLLFEYVESyGWGVpGGYyGGV - - - - - - - - - - - RPYG 
Bm -GTR -3 M E S M K N M L I L L V I LLAF EC I E S Y E W G Y P N Y G A G Y Y G - - - - - - - - - RRJSI 
Ov-ALT-3 M E N M K N I L V L L I V L L A I A S V E S F 0 W G V S V V C G - - - - - - - - - - - - - -  Q Q D F 






- - - - - - 
  




-P F N S 
R0985.2 M L R F III L L V A I VA I S - - - SAQWICYNSVG -- - -- - - - - - - - - YGNYGGY 
R09B5.9 	M L R Y I L V L L V A I I A M S - - - S A QjG V C P Y C G Y 0 G - - - - - -G Y P 0 M Y C C V 
R0985.8 MLRSVLVILA L LHAC - - - - V A Q Y C V 0 P M M 0 G Y G p 0 M M G G V G P GM M C G V 
R09B5.3 	MI R S I L   L L V A L  AF S - - - TAQYGYGGYP G M M G G - - - Y G G Y PGMMGCY 
R09B5. 10 M L R F T C I L L L A M L A L A - - -
~NA
A Q W G V N S Y (3 0 Y N S - - - - - - - - V C N Y G G V 
F35B12.7 	MNKLLLLFVLVAVIAMA - - - AQWGGGFVGGYGP - - - - - - - - RGYGGGY 
B0213.6 M I S T S S I L V L V V L L A C F M A A 	Q W G V 0 C V G 
]RGG 
 Y 0 - - - - - - - - - - C Y (3 C V 
80213.4 	M I S I S S I L V L V V L L A C F M A A S A Q  G V G G V G G Y C - - - - - - - - - - G Y G G V 
B0213.2 M I S I S S L L I L V V L L A C F M A A S A Q W C V G - - C  P Y G - - - - - - - - - - G Y G G M 
80213.5 	M I S T S S I L I L V V L L A C F M A A S A Q W (3 V C C V G 	Y G ----------0 Y C C Y 
B0213.3 M I S T S S I L I L V F L L A C F M A T S A p wG V G G V C G Y 0 - - - - - - - - - - G Y C (3 V 
60 	 70 80 	 90 	 100 
Bm-GTR-IDFGD -FPAFN - 	- 	- 	- 	- 	PGSAIAG - 	-  - 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	AVLGKKK 
8m -GTR -2 C V G F - V C G V R - 	- 	- 	- 	- 	P 0 	G G M - 	- 	- 	- 	- 	- 	- 	- 	F G K 0 F 0 0 LS 	L L C K K K 
Bm -GTR -3 C L H N G V G P V G S C W S A P L G T P 
TSF 
- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	H G S 	F G L T L T G 
Ov -ALT-3 C I G D - y p 	i F N - 	- 	- 	- 	- A C G 	------------------ -A 	I 	L G K K K 
Ov -ALT-4 G T G D - Y P 	T F N ----- A G G 	- 	- - 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	A 	I 	L G K K K 
R0985.2 GG - 	- 	- YPM[]GG - - YGMNGGYGG - 	-  - 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- GGLLGMFLGKKK 
R09B5.9 G M R P -VC - - - - 	MYGGVGMG - - 	- 	- 	- 	- 	- 	- 	- 	- MYR PGLLGMLI G  
R09B5.8 G P G M - M C 
---- 	-  
GG - 	 - 	 - P G M M G C V C M S P - 	 - M Y C G Y G M Y R F C L L C M L L C 
R09B5.3 GMRP -VG -- 	- 	- 	- 	- 	- 	- 	- 	MGY GMGMGC- K 
R09B5.10 G 0(3 	- 	 - V N N G Y G - - V N A N L 	V CO (3 R G 
-MG- - - - MYRPGLLCMLM
dGG- 	- 	- 	- 	- 	- 	- 	- 	- --- 	G 	0 	L  G G L L K K 
F35B12.7 GGGR -VGGVGG - -RGPYGGVGGRGPYGYGGRGPYIGGGGLVGALL 
80213.6 G - R G - V C G V G - G V G R G V G G V G 	G M - - - Y G C V G R P Y G (3 V G W C K 
80213.4 GRGM -VGGVG - - - RGMYGGYGRGM ---YG. GYGRGMYCGWGK 
80213.2 CGYG -MGGVG - 	- 	- 	- 	- 	- 	-  MGVRRRM ---WGSPYGGYGGYGGYGGWK 
B0213.5 G - RG -VGGVG - - - - RGYCCYGRGM ---WG - - 	RFYGGYGWjK 
80213.3 GRGM-  VGGYG - - - RGMYGCYCRGM ---YG - 	- 	.GWGK 
Figure 6.2: Alignment of the five filarial abundant glycine/tyrosine-rich proteins with homologues from 
C. elegans. Accession numbers are as follows: Bm-AGT-1; U80974, Bm-AGT-2; consensus of EST 
sequences R47601, N43123 and N99335, Bm-AGT-3; consensus of EST sequences A1083376, A192083, 
A187702 and A1919654, Ov-ALT-3; Joseph and Lustigman, unpublished, AF020587, OV-ALT-4; consensus of 
EST sequences AA610980, AA680592, AA294475, A.A294034 and A1692149. C. elegans sequences from 
cosmids R09B5, B0213 and F35B12 are found in GenBank under accession numbers AF039046, AF039050 
and Z74032 respectively. Vertical red bars indicate the positions of introns within the C. elegans sequences. 
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The closest database hit to Bm-agt- 1 is an 0. volvulus gene (Joeseph,G.T. and 
Lustigman, S., unpublished, GenBank accession number AF020587) with 27% 
glycine and 10.8% tyrosine residues. In contrast to the B. malayi genes the 
homologue in 0. volvulus is represented 29 times in the EST dataset: all but one of 
these sequences are from the vector-derived L3 (vL3) library (0.4% of all ESTs from 
this library) while only one sequence comes from a library of larvae undergoing the 
L3-L4 moult. Interestingly a variation of this sequence is also found in the dataset, 
which we have termed Ov-alt-4. Amongst these ESTs the predicted protein varies 
consistently at nine residues and also includes an insertion of a glycine residue, all in 
the N-terminal portion of the protein. This variant is much more prominent in the 
moulting library: 41 ESTs (1.6%) come from this library while only 3 come from the 
L3 library. The sequence of the variant also lacks the first three N-terminal residues 
of Ov-ALT-3. In Ov-ALT-4 the N-terminus starts with MKK (Figure 6.2). 
6.2.2 A agt-like family in C. elegans 
The protein sequences for both Bm-AGT-1 and -2 were used to identify 
possible homologues in C. elegans. A family of 11 predicted genes was identified. 
All genes were located on chromosome 5 and clustered into 3 regions covered by 3 
cosmids: B0213, R09135 and F35B12 (Fig. 6.3). Each gene is interrupted by a single 
intron. Five genes are arranged tandemly on both B0213 and R09B5 although the 
direction of transcription is distinct: the genes on B0213 are transcribed in the same 
direction but the middle 3 genes in the R09B5 cluster are in the opposite orientation 
compared with the flanking genes. This appears to have arisen from an inversion of 
the middle genes. Both arrays are found downstream of 
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Signal peptides  
Tj 20 
9m-GTR-1 M R N I 	L I L L L \ V 
9m-GTR.2 M E G T K S I  LV LL Y  
Bm-GTR-3 M E S M K N M L L LLA CI 
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Ov-ALT-4 M K K I L L 	I L L S \ 
R0985.2 M L R F I 	I L V Al 
R0985.9 M L R Y 1 	1. L V Al 
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R0985.3 M I 	R S 	I 	L LV \ L 	I 	All , 	 - 
R09B5I0 M L R F T C L [ \I I.. A  - 
F35912.7 MN K L L L L I L V AI\l \ 	- 
80213.6 MIS IS S 	F LV LLAI IMA 
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90213.2 MISTSSL! LV1 LLAI 
90213.5 MISTSSI LV LLAI IM\ 
80213.3 MISTSSI LV jj f MA 
30 	 40 	 50 
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E WGYIl - 	GYGGY - - - - - - - - - - - RPYG 
	
WG yI V G -\ 	V 1 0 --------- R RmSu 
[SI 	woyL  -  -- --   -  - - - - - - - - -  - - QQDF 
i s -- wo Vt - V 0 - ----- ------ - -- ---- - 
SAQWGVI 	YG ------ - - - - - -  -  - YG- 	001 
SAQWGVI 	-YG 	GO - - - - - - GYPG\I 	001 
TA QTG Vl '3 V 0 P 0MM G 0 1 o P 0 '3 G 0 1 
jJAQHGYIHVI 	\IMGG- - -YGGYPG'3GGY 
ISAQWG'J\ 	YG NS -------- VG 	GGY 
AQWG 	VG 	GP -------- RG' 	GGY 
jAQWGY1GkYG  --------- -  
SAQWGYI 	YGkVG ------------ GGY 
S A Q W 0 	l 	G'3 P Y 0 ---------- - - --0 0 
SAQWGYIYGRHVG ---- -- -----_GGY 
SAQSj(YGRHVG ----------- - -001 
60 lv 80 	 50 700 
9m-GTR-1 DFGD -FPAFN - 	- - 	- 	- 	PGSAIAG 	- 	- 	- - 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	AVL KKK 
Bm-GTR-2 lOP 0 	R 	----- - 	- 	- 	- 	- 	- 	- 	FGRGFGGLSLL KKK 
Bm-GTR-3 L H N o P 	0 S 0 W S A P L 
- 	- 	- 	- 	- 
 0 T P - - 	- 	- 	- 	- 	- 	- 	- 	- 	- 	H 0 	S 	F 0 	L T 	L I 
Ov-ALT-3 100- PTEN 	- 	-  - 	-- - 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- -AlL KKK 
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80213 4 K C '3 1 G V C, 	- - 	N 0 '3 	- [G 1 0 P C M - - 	- V 0 - 	- 	- - 0 Y 0 R 0 M V 	0 W 0 K 
902132 0 1 '3 0 Y C 	------ K K M - - - W 0 S P V 0 0 1 0 0 V 0 ci V 0 ci WK 
802135 G 	P C V C C, T C 	---- R C 
nGY 
W 0 - -- R P 1 G G Y 0WK 
802133 GI1'3'3 VG(,Y(, - - RGM RCM - - 	-10- 	- 	- 	- 	GWGK 
Figure 6.2: Alignment of the five filarial abundant glycine/lyrosine-rich proteins with homologues from 
C. elegans. Accession numbers are as follows: Bm-AGT-1, U80974, Bm-AGT-2; consensus of EST 
sequences R47601, N43123 and N99335, Bnz-AGT-3; consensus of EST sequences A1083376, A192083, 
A187702 and A1919654, Ov-ALT-3: Joseph and Lustiginan, unpublished, AF020587, OV-ALT-4; consensus of 
EST sequences 4A6 10980, AA680592, AA294475, AA294034 and A1692149. C. elegans sequences from 
cosmids R09B5, B0213 and P35812 are found in GenBank under accession numbers AF039046, AF039050 
and Z74032 respectively. Vertical red bars indicate the positions of introns within the C. elegans sequences. 
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genes with homology to ODR-10, part of a large family of odorant receptors, 
suggesting that the two clusters arose from a duplication event and that this synteny 
has been maintained, at least in part. Also upstream of the genes on cosmid B0213 
are six tandem copies of a gene with homology to cytochrome P-450 and an enzyme 
capable of catalysing the oxidation of tyrosine in the formation of dityrosine. A 
protein involved in yeast cell wall maturation has significant homology to 
cytochrome P-450 and is linked to the formation of dityrosine bonds found within the 
spore wall (Briza et al., 1990). 
1 468 	 11k6 	 05kB 	 1.4kB 	 1 1kB 
R09B5 
(Chromosome 5) 	R0985 7 	 809853 	
R0985 8 	809859 	80985 10 	809852 
so 04 	 00 	 44 	 Do 
Similarity to 
008-10 
1.36kB 	 21kB 	 1.868 	 3 A 	 12kB 
B0213 
(Chromosome 5) 	B0213.7 	 802136 	 802135 	 802134 	









Figure 6.3: Schematic representation of the organisation of genes on the cosinids containing the 
C. elegans homologues of Bin agt-i and -2. Genes are identified by their cosnzid number. Those in 
blue are agt honiologues. Arrows indicate the direction of transcription. Each gene consists of 2 
exons and sizes of intragenic regions are also given. 
Page 142 
6.2.3 Analysis of agt expression during development using RT-PCR 
Expression of Bm-agt- 1 was assessed by RT-PCR using staged sets of RNAs 
representing the larval development within the mosquito and also during the first 25 
days of development in the mammalian host. This confirmed that expression is 
largely confined to the L3 stage. Expression begins at day 5 post-infective blood 
feed and continues until the larvae enter the mammalian host. Expression falls below 
the sensitivity of the assay within 24 hours of infection. In agreement with the EST 
data the agt- 1 signal in vL3's does not appear as abundant as Bm-alt- 1 or Bm-cpi- 1 
under identical conditions. Larger amplification products are seen at days 0 and 5 of 




Li 	 L2 	 L3 
Tubulin 	
123456 	7 I0 ii 12 
Days post mosquito blood feed 
Mquit 	 Moult 
L3 	4, L4 	 Adult 
gtr 1 	 __ 
77 
rJ, 
b u ii n - 	 - - 	- 	- 	-w 
0 	2 	4 	6 	8 	10 	12 	14 	17 21 23 25 
Days post infection of jird 
Figure 6.4: Expression analysis of the Bm-agt-1 gene. RT-PCR was used to assess the presence 
of agt-1 transcripts during the complete development in the mosquito (panel A) and through the 
first 25 days of development in the jird (Panel B). Poly A primed 1st strand cDNA was used as a 
template for the PCR with agi-] -specific primers. U represents RNA extracted from mosquitoes 
fed on uninfected blood. Day 0 represents RNA extracted from vector-derived larvae. 
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6.2.4 Expression of Bm-AGT-1 in E. coli 
The mature Brn-agt- 1 protein was expressed as recombinant protein in E. coli 
using the plasmid vector pET 29. The recombinant protein consisted of agt-1 
without its signal peptide (amino acids 5 –55) along with fusions encoded by the 
vector: an N-terminal hexahistadine tag and a C-terminal S'Tag. The recombinant 
protein has a calculated molecular weight of 9.7 kDa with approximately 5.9 kDa 
representing the fusion partners. The expressed protein was soluble in His-Tag 
binding buffer but substantially more protein was extracted from the binding buffer 
insoluble fraction by the addition of 6M urea to the buffer. Protein was therefore 
purified on a metal chelate column from a 6M urea extract. Figure 6.5 shows the 
purification of AGT-1 from the urea-soluble extract. Once purified the protein 
remains soluble until dialysis into PBS is attempted. As this protein was initially 
required for antibody production, mice were immunised with partially precipitated 
protein at protein concentrations assessed on estimates taken prior to dialysis. 
— 1.__ • 
.4 








Figure 6.5: Expression and Purification of Bm-AGT-1. Lane 1: low molecular weight markers. 
Lane 2: His-Bind binding buffer of expressing BL-21 cells. Lane 3: Urea extract of binding buffer 
insoluble material. Lanes 4-6: Sequential fractions eluted from the His-Bind column. Proteins were 









Interest in the agt sequences arose from their high glycine and tyrosine 
content. Tyrosine residues are able to cross-link proteins forming di- and tn-
tyrosine bonds and these bonds have been reported in the insoluble residue of 
nematode cuticles (Fetterer and Rhoads, 1990; Fetterer et al., 1993). The role of 
tyrosine cross-links in the formation of insoluble of structures such as the insect 
eggshells (Li et al., 1996), yeast cell walls (Briza et al., 1986), sea urchin fertilisation 
envelopes (Kay and Shapiro, 1987) and plant call walls (Waffenschmidt et al., 1993) 
have also been described. The bond can be formed in vitro by the action of 
peroxidases in the presence of hydrogen peroxide. As the agt sequences also predict 
signal sequences it is possible they are also localised to the cuticle and serve as 
substrates for cuticular cross-linking enzymes. 
Proteins rich in glycine and tyrosine residues include those forming one 
family of the keratin associated proteins (KAP) (Fratini et al., 1993). They are small 
proteins (6-9 kDa) that contribute to the insoluble scaffold of hair, nails and the outer 
layer of the skin. They are insoluble below pH 10 due to their unusual amino acid 
content. Their glycine and tyrosine residues are not found in any particular order and 
the family members have low nucleic acid homology arguing for the formation of the 
family by convergent evolution. 
Chorion proteins, in contrast, are evolutionarily conserved and many contain 
tandemly repetitive peptides with glycine and tyrosine in their N and C terminal arms 
(Tsitilou et al., 1983). In this respect the nematode agt proteins more closely 
resemble chorion proteins, and indeed database searches with the agt protein 
sequences give weak hits to this family. These proteins form part of the insoluble 
outer shell of insect eggs and cuticle. Their gene structure and organisation also 
shows some similarity to the C. elegans agts. Grouping of the chonion proteins by 
homology has allowed the designation of 3 families A, B and C. Along one 
chromosome the genes are found in A/B pairs and several such pairs can be found 
together in a 10-15 kb segment. Interestingly transcription of the A/B pairs are often 
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in opposite directions (Kafatos et al., 1987), similar to that found in the C. elegans 
gene cluster on cosmid B0213. Additionally chorion genes and the nematode agts 
contain only one intron. The function of the Gly/Tyr-rich segments of the chorion 
proteins is not yet known although it is possible that they are involved in cross-
linking as Li et al has demonstrated di- and tn- tyrosine bonds in A. aegypti chorion 
proteins (Li et al., 1996). 
Proteins forming the cuticle of the adult locust, Locusta migratoria, are 
highly insoluble however the unhardened cuticle of the larval stages is more soluble. 
Approximately 100 proteins can be identified of which the majority are basic. N-
terminal sequences of a number of these proteins showed that they contain a number 
of similar amino acid compositions (Højrup et al., 1986). A striking similarity is the 
dominant occurrence of either glycine, leucine and tyrosine or alanine and proline in 
certain regions. 
Although not homologous a common feature of both insect cuticle and 
chorion proteins is the presence of regions dominated by relatively few amino acids. 
The nematode agts however do not contain these different regions as most of their 
length is dominated by glycine and tyrosine, especially the C. elegans sequences. 
These groups of proteins, although encoded for by genes of low nucleic acid 
homology, have a unifying property in that they tend to perform a structural or 
protective role. As yet there is no data on the localisation of the AGT proteins in 
filariae and it would be informative to know whether they localise to the insoluble 
zones of the cuticle. Gly/Tyr-rich proteins from plant cell walls (Waffenschmidt et 
al., 1993), locust cuticles (Højrup et al., 1986) and silk moth chorion (Tsitilou et al., 
1983) contain the repetitive motif YGGY found in the nematode grt family. 
Addition other proteins such as Schistosoma japonicum egg shell proteins contain 
tyrosines spaced 3-4 residues apart usually with glycine used as the "spacer" amino 
acids (Henkle et al., 1990). This motif is common in most of the nematode agts. 
Although this consensus sequence is small, its occurrence in different insoluble, 
structural proteins may be an indicator of a related function. The motif may orientate 
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tyrosine residues within the protein ensuring their accessibility to cross-linking 
enzymes. 
The expression pattern of agt- 1 is unexpected, as many structural components 
of the cuticle described to date have been shown to be transcribed during synthesis of 
the new cuticle below the old cuticle. Expression of agt-1 is first seen once the L2 
moult has been completed and is terminated after transmission, around 8 days before 
the L3 moult. During the eight days of expression the larvae increase in size from 
0.8 mm to 1.4-1.9 mm. Although no expression of collagens is usually seen in the 
intermoult period (Selkirk et al., 1989) and growth is accompanied by the stretching 
of the preexisting cuticle (Howells and Blainey, 1983) it is possible that some 
components of the cuticle cannot accommodate this increase in size and are be 
expressed during growth. The cut-i and -2 genes are the only insoluble components 
of the cuticle of C. elegans described so far. Both genes are transcribed at a time 
when new cuticle is being made (Lassandro et al., 1994; Sebastiano et al., 1991). 
Other possible functions of agts are the formation of structures other than the 
cuticle. Immunoelectromicroscopy with the antisera generated against the 
recombinant protein will help resolve these issues. 
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CHAPTER 7 




7.2.1 Characterisation of the Bm-tph-1 cDNA 
7.2.2 Abundance of tph-1 mRNA throughout the life cycle 
7.2.3 Expression of recombinant TPH 
7.2.4 Detection of Bm-TPH- 1 in parasite extracts. 




A key feature of successful parasitism is the prevention of functional 
antiparasitic responses in the host (Bloom, 1979; Maizels et al., 1993). During many 
helminth infections there is a striking block of cellular responsiveness along with a 
profound bias of the immune response towards a Th2-type response in both humans 
and animal models. The pathways underlying this phenomenon are unknown and a 
variety of mechanisms have been proposed to explain the domination of Th2 
responses along with the down-regulation of antigen-specific Thi responses. In a 
mouse model of infection with B. pahangi it has been shown that the L3 stimulates 
IL-4 transcription in the draining popliteal lymph node as early as 24 hours after 
infection leading to a detectable Th2-type response from day 4 post infection 
onwards (Osborne and Devaney, 1998). As IL-4 is both a product of and the 
stimulus for a Th2 response, identifying the primary source of this 'early" IL-4 is a 
focus of recent research. Double negative (CD4, Cb8) ab T cells have been 
identified as early IL-4 producers in B. pahangi-infected BALB/c mice (Osborne and 
Devaney, 1998). It is not clear, however, whether this population of cells responds 
to a parasite molecule, initiating the biasing of the response, or is responding to other 
sources of IL-4. Parasite molecules capable of initiating this response have not yet 
been identified. 
Upon stimulation basophils are capable of releasing considerable amount of 
preformed IL-4. In a search for molecules capable of inducing histamine release 
from basophils, MacDonald and colleagues have shown that a molecule secreted by 
macrophages, termed histamine releasing factor or HRF, is capable of inducing the 
release of IL-4 at the same time as histamine (MacDonald, 1996; MacDonald, 1997; 
Schroeder et al., 1996; Schroeder et al., 1997). This process was initially described 
as IgE-dependent as removal of IgE from the basophil surface abrogated the effect. 
Moreover it relied on the presence of a particular, undefined, subset of IgE on the 
surface of the basophil, termed 1gW IgE from patients not responding to HRF were 
termed IgE although passive transfer of 1gW from responder patients restored the 
activity (Schroeder et al., 1996). Unexpectedly, HRF does not bind directly to IgE 
but probably signals through its own receptor on the basophil surface (Wantke et al., 
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1999). Cloning of HRF identified it as the already described translationally 
controlled tumor protein (TCTP) (MacDonald et al., 1995) a highly conserved family 
of proteins described in animals, plants and yeast (Bhisutthibhan et al., 1998; 
Haghighat and Ruben, 1992; Pay et al., 1992; Thiele et al., 1998). The human 
protein is found in a wide variety of cell types (Sanchez et al., 1997). These proteins 
are preferentially synthesised during the early growth phase of some types of tumour, 
but are also expressed in normal cells. In this context the physiological function of 
TCTP is still not known although recent evidence suggests that it is capable of 
microtubule stabilisation via tubulin binding (Gachet et al., 1999). 
The identification of a close homologue of TCTP amongst the abundantly 
expressed larval transcripts (chapter 1 and (Gregory et al., 1997)) raises the 
possibility that the B. malayi protein, termed B m-TPH for tumour protein 
homologue, is a candidate "early IL-4" inducer. 
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RESULTS 
7.2.1 Characterisation of the Bm-tph-1 eDNA 
The B. malayi homologue of human histamine-releasing factor/translationally 
controlled tumour proteins was identified and cloned as a 750 bp abundant band 
amongst trans-spliced transcripts from the L3 stage (chapter 1 and (Gregory et al., 
1997)). The cDNA predicts a protein of 181 amino acids with 32 - 67% identity to 
TCTP and HRFs in GenBank (Fig. 7.1). The predicted molecular weight is 20.76 
kDa with an isoelectric point of 4.42. The B. malayi sequence contains the two 
signature patterns selected for TCTP by PROSITE at the Swiss Institute of 
Bioinformatics (available at http://www.expasy.ch/cgi-bin/nicedoc.pl?PD0000768)  
and indicated in Fig. 7.2. The predicted protein lacks a conventional signal sequence 
(von Heijne, 1986) and does not contain any potential N-glycosylation motifs 
although other TCTPs have a potential N-glycosylation (Fig. 7.2), forming part of the 




GGTTTAAPTACCCAAGTTTGAGGTAAAAATTTTATGAACAAGTGAAGTGTGCTTGCAACGAT ATG TTG 
M L 
TCTPpETFOR oligo 	 100 
ATC TTC AAG GAT GCA TTC A A GAT GAC GAG CTT GCG TCG GAC TCG TTC CCA ATG 
I F K U A F T U U E L A S U S F P M 
150 
AAG TTA GTA GAT GCA TTG ATT TGG GAG TTC AAA GGA CGG CAA GTA GTA AGG AGA 
K L. V D G L I W E F K G R Q V V R R 
200 
GAA GGA GAA ATT CAG CTT GCT GGT GCA AAT CCT TCA GCT GAA GGT GAA GAT GGT 
K G E I Q L A G A N P S A E G E D G 
250 
GAT GAA GGT AGC GAA GAA TGT GTT GAA CGG GGT ATC GAT TTT GTG CTC AAC CAT 
D E G S E K C V E R G I U F V L N H 
300 
CGG CTA CAA GAA ATG AAT TGT TAT GAG GAT TTG GTA ACC TTC AAG TCG TAC TGC 
R L Q K N N C Y E U L V T F K S Y C 
350 
AAA TCA TTT ATG AAA AAA GTA GTT GAA CTA ATG CAA AAA AAT GGC AAA TCG GAA 
K S F M K K V V E L M Q K N G K S K 
400 
GCA GAA ATT AGC GAG TTT AAG CGG AAG ATT CCA GCT TGG GTT GTA TCA CTT CTG 
A E I S E F K R K I P A W V V S L L 
450 	 500 
AGC AAG GAC CGA TTT AAA CAG TTG CAG TTC TTC ATC GGT GAG CGT ATG GCC GAA 
S K D K F K Q L Q F F I G K R M A K 
550 
GGT CAA GGT GAG GGA CAA GTA GCT GTA GTA GAA TAT CGA GAT GAA GAA GAT GGT 
G Q G K G Q V A V V E Y K U E K U G 
TCTPDETREV oligo 	600 
GAG GTG CCC TAT TTG ATG CTT GTG AAG GAG GCA CTC ATT GAA GAA AAA CAA TGA 





Fig. 71: Nucleotide and deduced amino acid sequence of Bm-tph-1. The nematode 
spliced leader sequence SL-1 is boxed. The oligo pair indicated were used for RT-PCR and 
expression in pET-29. 
Page 153 
IC 	 20 	 30 	 40 	 50 
TCTP_BRUMA MLI FKOAFTDDELASDSFPMKLVD -IL IWEFKGRQVVRRE- - GEIQLAGA 
TCTP_C.AEEL ML IYKDI FTDDELS SOSFPMKLVD.DLVYEFKGKHVVRKE- -GEIVLAGS 
TCTP_ABIT M I I Y R D L I S H D E M F S D I Y K I RJ I A GL C L E V E G KM V S R I E C N I D D S L I C C 
TCTP_LUMRU MIt FKDVFFGVELFSDSFPVSLVN. ETVYKVKGKLRTDTF-AIDDKAIGG 
TCTP_CHICK MI IYRDC I SQDEMFSDIYKI REVANGLCLEVEGKMVTRTEGQIDDS L I G G 
TCTP_HUMAN MI I Y R D L I S H D E M F S D I YK IRE I A D G L C L E V E G K M V S R T E G N I DDS L  G  
H. brasiliensis M L V Y Q D L L T G D E L L S D S FP Y K E I H N G I L W E V E G K W V V Q G A - - - V D V D I GA 
TCTP_Fn4AN MLVYQDLLSGDELLSDSFPYKEIQNGVLWEVDGKWVVQGA - .VDVDIGA 
7C7P9YS4 	LVYQDLLTGOELLSDSFPYREIENGILWEVDGKWVVQGA --- IDVDIGA 
N.tabacum MLVYQDLLSGDELPSDSFSYTELGNGVLWEVQGKWVVQGAVDVNIGA 
TCTP_ScHPO MLLYKDVI SGDELVSDAYDLKEVD-DI VYEADCQMVTVKQ. -GGDVDIGA 
60 	 70 	 80 	 90 	 100 
TCTP_BRUMA N1'SAEGEDG- -  DEGS EECVERGIDFVLNHRL EMNCYEDLVTFKSYCKSF 
TCTP_C4EEL NPSAEEGAE - .DDGSDEHVERG IDIVLNHKLVEMNCYEDASMFKAYIKKF 
TCTP_RABIT NASAEGPEG...EGTESTVITGVDIVMNHHL ETSFTKEA --YKKYIKDY 
TCTPLUMRU NASAEGGE - . - EGTDAASKQGVDIVMNSRLVEYALSKKD - -  YMTHIKSY 
TCTP_CHICK NASAEGPEG - ECTEATV I T G V D I V INHHLQETSFTKES . . YKKY IKDY 
TCTP_HUM4N NASAEGPEG - - E G T E S T V I TGVDIVMNHHLQETSFTKEA - - YKKY IKDY 
H.brasiliensiS N1'SAEGADE- DEGVDDQAVI(VVDIVDTFRLQEQPAFDKKQFVTYMKRF 
TCTP_FhA4N NPSAEGADADADEGVDDQTVKVVDIVDTFRLQEQPPFDKKQFVTWVKRY 
TC7P_OHYSA NI'SAEGGGD - DEGVDDQAVKVVDIVDTFRLQEQPPFDKKQFVTFMKRY 
N.tabacum 	NI'SAECADE- DECVDDQA1KVVDIVDTFRL EQPSFDKK-QFVAYMKKY 
TCTP_ScHFO NI'S AEDAE 1 - 	ENAEEGTETVNNLVYSFRLS PTSFDKKS - - YMSYIKGY 
TCTP- 1 signature 
110 	 120 	 130 	 140 	 150 
TCTP_RUMA M K K V V E L M Q K N G K S E A E IS EFKRK I P A W V V S LLS KDRFKQLVFF 1 GE RA TCTP_C4EEL M K N V I D H M E K N N R D K A D V D A F K K K I Q G W V V S LLAKDRFKNLI G E R A A 
TCTP_RABIT MKS I K G K L E E Q R P E R V K P F M T G A A E Q IKH I LAN - FKNY IGENMN 
TCTP_LUMRU MKS V K D K L Q E T K . FADS E L F Q K N V Q P F I K E V L N D . - FKEYCGESMG 
TCTP_CHICK M K A IKARLEEHK - PERVKPFMTGAAEQ I K H I LAN - - F K N Y Q F F V G E N M N 
TCTP_HUM.4N MKS I KGKLE E Q R - F E R V K P F M T G A A E  I Kill LAN - F K N Y Q F F I G E N M N 
H.brasiliensis IKL LTFKLDEEK ----- QES F K K N I E G A T K F L L S K-- LSDLQFFVCESMH 
TCTP_FRA4J'1 IKL LTPKLEGEQ - - - - - QETFKKNI E G A T K F L L S K- - L S D L Q F F V G E S M G 
TCTP_ORYSA 	I K N L S A K L D A E K - - - - - Q E E F K K N I E C A T K V L L G K - - LD L Q F F V C E S M H 
N.tabacum IKNLTPKLGAEQ - - - - - EEVFKNNIQGATKYLLS K- - LSDL FFVG EIS MIA 
TCTP_SCHPO M K A I K A K L Q E S N - P 0 R V P V F £ K N A I C F V K K I L A N - - ED V D F V I C EIS LM JD 
160 	 170 	 180 	 190 	 200 
TCTP_BRUM.4 0 C Q G E G Q V A V V E JYR D E ED C - £ VPV LM L V K E A I K K K
TCTP_CAEEL EGA £NGQVA I I EDV - OCT EVPT LMLVKEA I I EEKC
TCTP_RABIT P...DGMVALLD..EDGVTPFMIFFKDGLEMEKC 
TCTP_LUMRU P - - - EGMLALMKW - - - - DGET - PYMFFFKHGLDEEKV 
TCTP_CHICK P. - - DGMVALLDPR - -EDGVT- P Y M I FFKDGLE I EKC 
TCTP_HUM4N P. - - DGMVALLDYR - -EDGVT - PYMI FFKDCLEMEKC 
H.braslliensis D- - - DGSLVFAYYR - - .GGATDPTFLYFAYALKEVKC 
TCTP_Ffl4AN 0-- 
-T
DTS L V F A S Y K - - - EGATDP IF I YFAHGLKEVKC 
TCTP_ORYSA 0-- .GLVFAYYK - - DGATDPTFLYFSHGLKEVKC 
N. tabacum 	0 - - - 	 GM V F A Y V K - -- D GA T D PT F L Y L A H CL K K V K C
7CTPSGHFO P -- - 
	
MVVLMNYR - -EDGI T - PYMI FDGLVSEKF 
TC1P.2 signature 
Figure 7.2.: Alignment of Bm-TPH-1 with its closest homologues. Sequences are identified by their 
SwissProt identifier, if one has been assigned . SwissProt entry numbers are as follows: Bm-tph-
1(TCTP_BRUMA); P90697, C. elegans (TCTP_CAEEL); Q93573, Rabbit (TCTP_RAB!T); P43348, Humus 
cart hworm(TCTP_LUMRU); 018477, Chicken (TCTP_CHICK); P43347, Human (TCTP_HUMAN); 
P13693, Strawberry (TCTP_FRAAN); 003992, Rice (TCTP_ORYSA); P35681 and Schizosaccharomyces 
pombe (TCTP_SCHPO); Q10344. GenBank accession numbers for Rubber tree (Hevea brasiliensis) and 
common tobacco (Nicoliana tabacum) are AF091455 and AF107842 respectively. Boundaries of the TCTP-
1 and -2 signatures used to identify all TCTPs are indicated. 
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7.2.2 Abundance of Brn-tph-1 mRNA throughout the life cycle 
Primers spanning the entire predicted open reading frame were used to 
amplify by PCR from polyA-primed first strand cDNA synthesised from parasite 
RNA collected during the first four weeks of infection. This time course includes the 
L3 - L4 moult (at around day 8) and the L4 to adult moult (at around 17 - 23 days). 
Although expression can be seen at most time points there are periods when 
expression appears to increase when compared to tubulin control (Fig. 7.2.3). In 
contrast to its abundant expression amongst trans-spliced transcripts tph-1 does not 
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Figure 7.2.3: Expression analysis of the Bm.tph gene. RT-PCR was used to access the presence of tph-] 
transcrips during the fist 25 days of expression in the jird. PolvA -primed first strand cDNA was used as a 
template for PCR with tph-1 and tubulin-specific pruners. Day 0 represents RNA extracted from vector-
derived DNA. 
assessed during the vector stage of development. Analysis of ESTs representing tph-
1 from the stage-specific libraries constructed by the Filarial Genome Project 
suggests that expression continues throughout the life cycle with peaks of expression 
at certain stages. Table 7.1 lists the numbers of tph- 1 ESTs from each library, along 
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with the percentage of total ESTs that this represents. All libraries except the day 9 
L3 have transcripts in them identified by ESTs with the adult female and mf 
containing the highest percentage of transcripts. This agrees well with the result of 
library PCRs shown in chapter 3. Libraries constructed from PCR products from SL-
oligo dT amplifications are enriched compared to their conventionally constructed 
counterparts again suggesting that tph-1 is prominent amongst trans-spliced 
transcripts. 
tph- 1 ESTs 	Total ESTs 	% of library 
mf 22 3355 0.66 
L2SL* 2 615 0.33 
L3 3 2761 0.11 
L3SL* 2 292 0.68 
Day 6 L3 1 1545 0.06 
Day 9L3 0 259 0 
L4 2 541 0.37 
L4SL* 16 1619 0.99 
Young adult (day 25) 1 191 0.52 
Adult Male 18 4201 0.43 
Adult Female 25 3775 0.66 
Table 7.1. Survey of tph-1 ESTs from B. malayi stage-specific libraries. * denotes that libraries are 
constructed from SL-dT PCR products. 
7.2.3 Expression of recombinant Bm-TPH-1 
The predicted full length Bm-TPH-1 has been expressed in E. coli using the 
plasmid pET 29. This system produces a fusion protein with an N-terminal S•Tag 
and a C-terminal hexahistidine tag adding approximately 5.9 kDa to the size of TPH. 
The calculated size of the fusion protein is 26.7 kDa although the expressed protein 
1-2 kDa higher as judged by SDS-PAGE (Fig. 7.4). The fusion protein was soluble 
allowing the purification of the protein under non-denaturing conditions (Fig. 7.4). 
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Antibodies to recombinant TPH were produced in BALB/c and CBA mice. All 
immunised mice recognised the recombinant and a sera pool of all immunised mice 
was used in subsequent experiments. 







- 	 _ 
Figure 7.4: Expression and purification of Bm-TPH-1 expressed in E.coli. Cells expressing TPH-1 
from a pET-29 plasmid were solubilised in His-Bind binding buffer (Lane 2) and the soluble 
supernatant purified on a metal chelate column. Lanes 3 - 8: Purified fractions elated from the 
column. Lane I Pharmacia low molecular weight markers. 
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7.2.4 Detection of Brn-TPH-1 in parasite extracts. 
The expression of some members of the TCTP/HRF family have been shown 
to be under both translational and post-translational control (Bohm et al., 1989; Xu et 
al., 1999). It is therefore important to detect the protein as well as the mRNA at 
different points in the life cycle. A 25 kDa protein is detected in each stage by 
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Figure 7.5: Detection of Bm-TPH in different life cycle stages. PBS/i .5%nOG soluble extracts 
were prepared from mf (Lane 1), L3 (Lane 2) and adult worms (Lane 3). Proteins were separated 
on a 15% SDS-PAGE gel, transferred to nitrocellulose and probed with antisera to recombinant 
BinTPH-1. 
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7.2.5 Secretion of Bm-TPH-1 
Antisera raised against recombinant TPH- 1 were used to assess whether the 
native protein was released from the parasite in culture. A culture of mixed sex adult 
worms was initially depleted of any endogenous methionine pool by incubation in 
methionine-free RPMI overnight. 35 S methionine was then added to the culture for 
the following 2 days at which point the culture was terminated. Without any 
additional processing the culture supernatant was immunoprecipitated with anti-
recombinant antisera. This identified a major band of approximately 25 kDa, 5 kDa 








Figure 7.6. Secretion of Bm-TPFJ by adult parasites maintained in culture. Adult parasites were 
maintained in culture for a total of 3 days. After the first 24 hours of culture i,nCi 35S ,nethionine 
was added. At the end of the culture period the culture supernatant was immunoprecipitated with 
antisera to recombinant ALT-1 (lane 1) and THP-i (Lane 2). Antisera to recombinant ALT-], 
expressed with the same fusion partners as TPH-J, was used as a negative control. Precipitated 
material was resolved on a iS% SDS-PAGE gel. 
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DISCUSSION 
A homologue of human translationally controlled tumour protein/histamine 
releasing factor has been identified in B. malayi. Originally cloned as an abundant 
trans-spliced eDNA from larval parasites (chapter 1 and (Gregory et al., 1997)). RT-
PCR and analyses of ESTs from different stage-specific libraries demonstrate that the 
gene is expressed at most points throughout the life cycle. 
The role(s) of TCTP/HRF is still unclear. It was first described as a tumour-
related protein in mouse ascitic tumour and erythroleukaemic cells (Chitpatima et al., 
1988; Yenofsky et al., 1983). Subsequently it has been found in a variety of tumour 
and normal human cells (Sanchez et al., 1997). Although expression of TCTP/HRF 
is not restricted to tumour cells its expression is growth-related with transcription of 
the gene demonstrated after mitogenic stimulation (Bohm et al., 1989; Walsh et al., 
1995). Expression is controlled at both the transcriptional and translational levels 
with calcium involved at both of these steps (Bohm et al., 1989; Thiele et al., 1998; 
Xu et al., 1999). The peaks of expression in B. malayi, as judged by RT-PCR, do not 
have an absolute correlation with growth. After transmission to the jird B. pahangi 
larvae increase their length from 2 mm to 11 mm between the third moult (day. 8) and 
the fourth moult (days 20-25) (Howells and Blainey, 1983). Expression of Bm-tph-1, 
as detected by RT-PCR, is only seen sporadically during this period (Fig. 7.3). In 
addition mf and mature adults, which undergo little growth, both have levels of 
protein detectable by western blotting. This apparent lack of a growth related 
expression indicates that Bm-tph- 1 expression is unrelated to growth, or that it serves 
more that one function. 
TCTP/HRF is also found extracellularly. It is secreted by a variety of cell 
types inducing the release of histamine and IL-4 from basophils (Schroeder et al., 
1996). Current evidence suggests that this may involve its own receptor, as yet 
undefined, (Wantke et al., 1999). IL-4 and histamine are found in culture 
supernatants of recombinant TCTP/HRF-treated basophils within one hour. As the 
biasing of the immune response against filariae is thought to occur very soon after 
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infection (Osborne and Devaney, 1998), this timing and the presence of Bm-TPH-1 
in larvae suggest that it is one of the candidate "Th2 inducers" in filariasis. J 
common with its homologues Bm-TPH-1 lacks a conventional signal sequence but is 
found extracellularly. Although unusual, both human and mouse TCTP/HRFs do not 
posses signal sequences, which may suggest an alternate route of secretion for these 
molecules (Muesch et al., 1990; Rubartelli et al., 1990). Secretion in the absence of 
a signal sequence has also been noted for OvB20, an 0. volvulus vaccine candidate 
(Abdel-Wahab et al., 1996). Adult worms were chosen to illustrate secretion as this 
stage can be individually monitored for viability. It is however possible that TPH is 
released during the birthing process. The finding that adult worms actively secrete or 
release Bm-TPH- 1 may indicate that a constant source of IL-4 is needed to maintain 
an immune response appropriate for the parasites survival. 
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GENERAL DISCUSSION 
The rational behind these studies is that genes expressed abundantly or in a 
highly stage-specific manner will have important functional roles in the parasites' life 
cycle, and thus may provide targets for the development of novel immuno- or 
chemoprophylatic agents. Consequently the long-term goal of this work is the 
definition of function. For cDNAs that have homologues in the databases, a possible 
function can usually be implied. Even so there are many proteins, such as cystatins, 
whose precise function remains unclear. Additionally, close sequence matches in the 
genetically tractable nematode C. elegans sometimes do not prove useful in 
determining possible functions. For example, from this study Bm-alt-1 and Bm-cpi-1 
do not appear to have close counterparts in C. elegans although their nearest 
sequence similarities are with C. elegans sequences. As such these genes may prove 
to have a role closely linked to parasitism. 
This study has focused mainly on antigens expressed at the L3 stage of 
development as this has been demonstrated to be susceptible to immunity induced by 
irradiated larvae. It is hoped that by targeting incoming larvae pathology attributed 
to adult stages during chronic infection with lymphatic filariae will be avoided. In 
addition, for many of the genes identified in this study the lack of strong homology 
with genes from the human host provides excellent targets for chemotherapy and 
immunotherapy. Also notable in this study is the high number of cDNAs from 
vector-derived larvae encoding potential signal peptides, indicating that they may be 
surface and/or secreted proteins. Indeed, Bm-CPI-1 has been shown to be secreted 
by larvae in this study and ALT homologues from Onchocerca and Dirofilaria are 
well characterised secreted proteins. This may indicate that a large part of the 
parasites' activity at this point is devoted to biosynthesis of molecules that may help 
it establish or maintain an infection rather than be involved in general metabolic 
activity. 
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The RT-PCR technique used to identify the abundant gel is simple and 
economical such that it can be applied to the study of a variety nematode species. 
The wide diversity amongst nematodes has been illustrated in a number of recent 
studies that have reported sequences specific to particular species (Blaxter et al., 
1996; Daub et al., 2000; Joshua and Hsieh, 1995; Maizels et al., 2000; Moore et al., 
2000). Clearly the complete genome sequence of the free-living nematode will have 
a large impact on nematode research, however there is still a need to identify these 
unique sequences for use in targeted therapies and also in diagnosis of infections. An 
understanding of these genes would also contribute to understanding the biology 
underlying the diversity amongst parasitic life styles. 
The abundance of Bm-tph- 1 recommends it for further study although early 
analysis of its presence in the stage-specific libraries showed it to be expressed 
constitutively and abundantly (Williams et al., 2000). It's homology to mammalian 
histamine-releasing factors suggests that it may play an important role in immune 
modulation. 
Further studies on the proteins identified in this study would benefit from 
recombinants produced in organisms other than E. coli. While both CPIs expressed 
as functional recombinants in E. coli, other molecules such as ALT, which contains 
eight cysteine residues potentially forming disulphide bonds, are more likely to be 
folded correctly when produced in other organisms, such as yeast or baculovirus. 
Preliminary NMR studies on the Bm-ALT-1 recombinant described in chapter 5 
suggest that very little secondary structure is present. A structural model for ALT 
may provide a hypothesis of the function of this novel protein. 
Work on the development of ALT as vaccine candidates will benefit greatly 
from the L. sigmodontis model. This filarial parasite undergoes full development in 
inbred laboratory mice and can be used to dissect the immune response to ALT. This 
study has identified two isoforms of the alt-2 gene differing in their intronic 
sequence. These may represent important polymorphic loci in filariae. It would be 
interesting to see if different geographical isolates also exhibit this poymorphism and 
whether these isoforms act as alleles. 
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Studies are now underway in collaboration with Benedicte Manoury and 
Collin Watts at the University of Dundee to investigate the effects of the Brugia CPIs 
on antigen processing in mammalian cells. As both of these proteins are secreted by 
parasites in culture they have the potential to interfere with host cells. Bm-CPI-2 has 
been shown to be effective in blocking cysteine protease-dependant processing in 
mice. The recombinant can effectively inhibit processing of tetanus toxoid by a 
recently discovered cysteine protease, asparaginyl endopeptidase (Manoury et al., 
1998). Further work will involve testing the specificity of this inhibition and to test 
whether CPI-2 can block processing of the invariant chain, a process known to 
involve cysteine proteases. Processing of other antigens should also be tested to 
assess the generality of CPI-2 inhibition. Initial studies with CPI-1 show that it is not 
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